The development of protein-functionalised plasma polymer biointerfaces for orthopaedic applications by Stewart, Callum
The development of protein-
functionalised plasma polymer 
biointerfaces for orthopaedic applications 
 
 
 
 
 
 
 
 
 
 
Callum Arthur Charles Stewart 
 
 
A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy 
 
 
 
 
 
 
 
 
School of Physics 
The University of Sydney 
2019 
Statement of Originality 
 
 
This is to certify that to the best of my knowledge, the content of this thesis is my own work. All the 
assistance received in preparing this thesis and sources have been acknowledged. This thesis has not 
been submitted for any degree or other purposes. 
 
 
 
 
 
 
 
 
 
_______________________________ 
 
Callum Arthur Charles Stewart 
 
 
  
Thesis Abstract 
 
Orthopaedic implants are an ever-growing global industry with hundreds of thousands of 
operations performed annually. Titanium alloys are the standard material for load-bearing 
orthopaedic devices because of their biocompatibility and favourable mechanical properties. Despite 
a variety of surgical strategies, a significant number of implants experience post-operative 
complications, such as bacterial-film formation and fibrotic encapsulation, or long-term implant 
loosening due to bone resorption. Biomolecule functionalisation with proteins or peptides is a 
promising approach to create a biologically-active surface that reduces the potential for adverse post-
operative complications and encourages bone formation. The biomolecules commonly utilised for 
enhancing bone formation either increase cell recruitment by simulating the natural extracellular 
matrix or accelerating the bone formation through mineralisation. An optimum functionalisation 
would include multiple active biomolecules so that attachment and mineralisation would be enhanced 
simultaneously. Previously, biomolecule-functionalisation of titanium surfaces was performed 
through physical adsorption, chemical covalent linker molecules, or plasma-based technologies that 
require subsequent wet chemical processing. Few techniques have provided a simple, reproducible, 
and scalable approach to transition from the laboratory into a manufacturing setting. There is 
currently no approach that enables the covalent immobilisation of multiple biomolecules to a surface.  
This thesis explores the application of radical-functionalised plasma polymers films (rPPFs) as 
multifunctional protein biointerfaces for orthopaedics. rPPFs are a dry, plasma deposited coating that 
modifies surfaces for covalent attachment of biomolecules through embedded unpaired electrons. 
The mechanical and biological properties of rPPF coatings were optimised for titanium substrates, and 
the effects of the radical fluxes on surface chemistry and cell behaviour were investigated. Two 
multifunctional protein surfaces were developed and comparatively examined against the component 
proteins for bone formation potential with primary osteoblasts and mesenchymal stem cells. Overall, 
this work shows the versatility of rPPFs and opens a potential avenue for translating multiple 
biomolecule-functionalisation into the manufacturing environment. 
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Chapter 1 – Introduction  
 
 
The subject of biomolecule-functionalisation with applications in orthopaedic devices is examined in 
this chapter. The current materials used for orthopaedic devices and their limitations that drive the 
need for biomolecule-functionalisation are highlighted. The surface properties that govern protein-
surface interactions are explained, before reviewing and discussing the progress in biomolecule-
functionalisation of orthopaedic surfaces performed via adsorption, chemical covalent immobilisation, 
and physical covalent immobilisation. The immobilisation mechanisms for each approach are 
examined, and the strategies are evaluated according to their complexity, efficacy, reproducibility, and 
scalability. Finally, the motivation for the application of radical-functionalised plasma polymer 
coatings for bio-functionalisation of orthopaedic surfaces is outlined. 
 
The chapter is adapted from a manuscript invited for submission at Progress in Materials science 
based on a prior editorial review: ‘A review of biomimetic surface functionalization for bone-
integrating orthopedic implants: Mechanisms, current approaches, and future directions’, by Callum 
Stewart, Behnam Akhavan, Steven G. Wise, and Marcela M. M. Bilek.  
 
1. Literature review 
 
1.1 Biological interactions with orthopaedic implant surfaces 
 
The prevalence of orthopaedic or bone implants has greatly increased worldwide. For example, 
in Australia alone, close to a million total hip and knee replacement operations have been performed 
since 1999, around 10% of which required revision surgeries due to problems associated with poor 
bone integration [1]. Despite strategies such as optimised surgical implant techniques, aseptic surgical 
conditions, and increased postoperative care [2], a significant proportion of implants fail due to poor 
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integration with adjacent bone tissue. Failure to rapidly promote the growth of new bone on their 
surface leaves implants susceptible to encapsulation by fibrotic tissue in a process known as the 
foreign body reaction [3-5], and bacterial colonisation leading to biofilm formation on the implant 
surface [6, 7]. Biofilm formation leads to infections that can often only be eliminated by surgical 
removal of the implant; whilst the presence of fibrotic tissue at the bone-implant interface often 
interferes with implant fixation and function, also often requiring repeat surgical intervention [2, 3]. 
The costs, risks, and patient discomfort of revision surgery provide a compelling need for surface 
modifications that facilitate rapid osseointegration or the growth of new natural bone on and around 
the implant surface. With the increasing number of orthopaedic implants performed annually 
worldwide and the need for longer implant lifetimes as lifespans increase, the need for optimally 
osseointegrating bone implants is becoming more significant. 
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Figure 1.1. A diagrammatic representation of the initial stages of implant osseointegration for non-
functionalised (current orthopaedic implants) and biomolecule functionalised implants. After implantation, the 
implant surface interacts with the biological environment. The surfaces of non-functionalised implants become 
coated in proteins from the environment forming a variable protein layer (as described by the Vroman effect). 
The cellular response to the variable protein layer changes with the composition leading to unfavourable 
immune response, infection, or failure to integrate. Biomolecule-functionalised surfaces produce a defined layer 
of biomolecules for a more controlled biological response leading to improved osseointegration.    
 
Orthopaedic implants are categorised into non-load bearing and load bearing, depending on the 
application of the device. Non-load bearing implants are devices like screws or maxillofacial plates 
that provide structure but do not support weight. The preferred materials for non-load bearing devices 
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are resorbable ceramics chemically similar to bone, such as hydroxyapatite (HA) [8, 9], or 
biodegradable polymers, such as polycaprolactone (PCL) [10-12]. In this case, the role of the implant 
is to facilitate the formation of natural bone that gradually fills the volume of the implanted scaffold 
as it degrades. Load bearing implants, like artificial knees and hips, on the other hand, must be able 
to support the patient’s weight during movement. Materials used for the fabrication of these implants 
must be capable of retaining their shape under significant mechanical forces applied repetitively. 
Polymeric materials are not generally strong enough to support repetitive loading without plastic 
deformation [13]. The exception is polyether (ether ketone) (PEEK) which has mechanical properties 
close to those of natural bone and has found applications in spinal implants [14-17]. Ceramic materials 
do not exhibit the necessary flexibility due to their high degree of ionic bonding [18]. Metallic 
materials, however, demonstrate the required mechanical strength to support physical loading and 
the level of elastic deformation needed to resist failure under cyclic physiological stresses.  
Three metallic alloys have been widely investigated during the development of orthopaedic 
implants over the last century; stainless steel, cobalt chromium (CoCr), and titanium (Ti). Initially 
proposed in the 1940’s [19], Ti and its alloys have been used almost exclusively for the latter half of 
the twentieth century. Numerous Ti alloys have been investigated for the fabrication of bone implants 
and have been thoroughly reviewed elsewhere [20-22]. One of the later developments has been the 
production of porous Ti alloys that show enhanced osseointegration [23], but possess lower 
mechanical strength because the pores act as stress concentrators [24, 25].  
For orthopaedic implants, titanium alloys are superior to stainless steel and CoCr alloys due to 
their lower modulus of elasticity and greater biocompatibility. Titanium alloys have an elastic modulus 
of between 50 - 118 GPa as listed in Table 1.1 [20-22]. This modulus is half that of stainless steel (216 
GPa) and CoCr alloys (240 GPa) but is still 2 to 5 times higher than hard cortical bone (10-30 GPa) [26-
28]. The disparity between the elastic moduli of bone and the implant results in a condition known as 
‘stress shielding’, where the bone is resorbed from around the implant [29-31]. The structure of bone 
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tissue results from the forces experienced by the bone and undergoes a constant formation-
resorption cycle, as dictated by Wolff’s Law [32]. Upon the insertion of a titanium implant, the hard 
bone tissue no longer experiences the necessary mechanotransductive forces for bone formation, 
causing the surrounding hard tissue to be resorbed. The lack of physiological feedback leads to implant 
loosening that requires revision surgery to correct [33].  
Titanium-based alloys are generally well tolerated in vivo [34, 35], whereas, stainless steel and 
CoCr alloys have detrimental effects on surrounding tissue due to the leaching of metallic ions [36-
38]. Fe, Co, and Cr ions are strongly cytotoxic to the surrounding cells, while Ti ions are significantly 
less cytotoxic [39]. These advantages have made titanium-based alloys the dominant material used in 
modern load-bearing orthopaedic implants.  
Table 1.1. Properties of Ti and its alloys applied for the fabrication of bone implants. The values for the 
mechanical properties are obtained from [20] unless otherwise cited. 
Alloy Description Elastic 
modulus 
(GPa) 
Yield strength 
(MPa)  
Tensile strength 
(MPa) 
Biocompatibility 
Commercially 
pure (CP) -Ti  
 
Pure titanium (α – 
phase) first used for the 
fabrication of implants.  
101 – 110  170 – 485  240 – 550 Greater osseointegration 
than SS and CoCr alloys 
Ti-6Al-4V 
Ti 6-4 
Grade 23 
α-β phase Ti alloy with 
higher strength than CP-
Ti  
101 – 110  729 – 847  954 – 976  Similar biocompatibility to 
CP-Ti. Leaching of Al and V 
may induce apoptosis in 
osteoblasts [37, 40]. 
  
Ti-29Nb-13Ta-
4.6Zr  
(TNTz) 
“Gum metal” 
β phase low modulus 
alloy [41] 
50 – 80 [42] 547 – 864  596 – 911  Reduced bone atrophy 
due to stress shielding 
compared with stainless 
steel and Ti-6-4.[43-45]  
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Titanium is biologically inert due to the formation of an unreactive oxide layer with a thickness of 
~ 5 nm on the surface (also referred to as the passive layer) [34, 39, 46, 47]. Although titanium is well 
tolerated in vivo, it fails to actively encourage osseointegration on the cellular level. Once titanium is 
placed inside the body, proteins from the biological environment rapidly adsorb on the implant 
surface to minimise the free energy of the interface [48, 49]. Adsorbing proteins reduce the free 
energy of an interface that is more hydrophobic than the local aqueous environment by unfolding to 
expose their inner hydrophobic regions to the surface and concentrating their hydrophilic domains in 
the aqueous medium. The proteins on the surface may aggregate with or be displaced by proteins 
arriving later, leading to a layer of varying composition and conformation. The adsorbed proteins act 
as markers and signalling agents, governing the interactions between the surface and the biological 
environment [50]. An unstable protein layer containing molecules with non-native conformations 
triggers a foreign body response in which the implant is encapsulated by fibrotic tissue [2, 3]. The 
functionalisation of a titanium implant via the immobilisation of desirable proteins or their bioactive 
fragments in their native conformations is a promising approach to overcome the bioinertness of the 
surface, leading to improved osseointegration. Protein immobilisation cannot eliminate the 
underlying problem of elastic modulus mismatch as the elastic modulus is a bulk material property. 
However, protein immobilisation can reduce the net impact of stress shielding in regions susceptible 
to bone resorption by encouraging more optimal bone integration. 
Protein immobilisation, first performed on glass substrates, stemmed from peptide 
immobilisation. Originating in 1990 [51], a limited number of studies were published prior to the 
2000’s [52]. Protein immobilisation has since become a large field with a variety of processes and 
proteins investigated. The proteins considered for enhancing osseointegration can be categorised into 
two classes: (i) proteins that provide signals stimulating bone formation and (ii) extracellular matrix 
(ECM) proteins that provide adhesion sites for cells. BMP-2, known to stimulate cortical bone 
Page 25 of 214 
 
formation in surgical procedures [53, 54], has been immobilised on Ti surfaces and found to stimulate 
the proliferation and differentiation of bone marrow stem cells and osteoblast-like cells [55-57]. Cell 
adhesion proteins, including fibronectin, collagen, tropoelastin [58], silk fibroin (SF) [59, 60], and 
sericin [61], are proteins immobilised to facilitate the indirect formation of bone tissue. These proteins 
create ECM adhesion sites allowing osteoblastic cells to attach and initiate the osseointegration 
process. The initial functionalisation investigations utilised simple methods, such as physisorption, for 
the immobilisation of proteins. However, the initially simple processes have developed into intricate 
systems as time progressed [2]. This chapter reviews the fundamentals of surface – protein 
interactions that underpin the techniques used for functionalisation of orthopaedics surfaces.  Protein 
immobilisation techniques applied to orthopaedic surfaces are evaluated with respect to their 
complexity, reproducibility, scalability, and properties of the functionalised surfaces focussing on 
stability and biological efficacy. 
 
1.2 Protein – surface interactions 
 
Protein immobilisation mechanisms on orthopaedic surfaces are governed by a number of 
surface properties which influence the permanence, orientation, and conformation of the immobilised 
proteins. The fundamental properties of a surface that govern protein – surface interactions are 
topology and chemistry. These two properties together determine the surface free energy (SFE) and 
charge, which in turn controls the forces of interaction (hydrophobic/hydrophilic and electrostatic) 
between proteins and the surface, as depicted in Figure 1.2. Therefore, by manipulating the surface 
topology and chemistry, it becomes possible to tune the protein-surface interactions and achieve 
optimal bioactivity.  
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Figure 1.2. A visualisation of the contributing factors affecting the protein-surface interactions as derived from 
the surface chemistry and topology of an implant. 
 
1.2.1 Surface chemistry 
 
The chemical composition of any solid material at its interface with another phase, such as the 
aqueous environment of the human body, is referred to as surface chemistry. The surface chemistry 
determines the distribution of electric dipole moments and charges at the interface, which results in 
electrostatic interactions with proteins in the aqueous environment. The electron distribution within 
the bond determines the electric dipole moment of a chemical bond. Polar molecules are those with 
an electron bond density biased towards the more electronegative atoms (atoms that attract bonding 
electrons), that form net asymmetric positive (+Q or +δ) and negative (-Q or -δ) regions within the 
molecule [62]. Non-polar molecules, in contrast, demonstrate a symmetrical charge distribution, and 
therefore, no net dipole moment. Typical examples of polar and nonpolar molecules containing polar 
bonds are CO and CO2. Both molecules contain polar bonds between the more electronegative O and 
less electronegative C. The C=O molecule has a single polar bond resulting in an asymmetrical 
distribution and, therefore, is a polar molecule; whereas the net charge distribution is symmetrical in 
the case of CO2 (O=C=O), making the molecule overall nonpolar. 
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Surface charge at the interface is derived from the molecular groups that possess a net positive 
or negative charge due to the addition or removal of ionised species, such as a proton (H+). The surface 
charge is thus affected by the environmental pH, i.e. proton concentration [63]. The isoelectric point 
(pI or IEP) of a chemical group is the pH where the group has no net charge in the statistical mean. 
The chemical groups become increasingly deprotonated (negatively charged at pH > pI) or protonated 
(positively charged at pH < pI) as the pH diverges from the pI [63]. For example, at the physiological 
pH 7.4, carboxylic acid groups (COOH) are negatively charged (COO-), while amino (NH2) groups are 
positively charged (NH3+) [64].  
The surface free energy (SFE) depends on the chemical groups present and whether they are 
charged or have dipole moments. The chemical composition and resulting SFE, therefore, governs how 
the surface interacts with the aqueous biological environment and the proteins within, as 
schematically illustrated in Figure 1.3. The SFE determines the surface affinity with water and is 
typically measured by the water contact angle (WCA). The WCA is determined by the relative strength 
of the adhesive forces between the polar water molecules and the surface on the one hand, and the 
cohesive forces between water molecules on the other hand. A surface is classified as hydrophobic or 
hydrophilic based on WCA >90˚ and WCA <90˚, respectively [65, 66]. Surfaces with higher 
hydrophilicity (and SFE) possess greater adhesive interactions with the polar species in vivo, such as 
water molecules [62]. In addition, electrostatic interactions can assist in attracting and orienting 
proteins based on charged regions in the structure, as demonstrated by the electrophoretic deposition 
of silk fibroin [59, 60]. Proteins demonstrate a tendency to change conformation during interactions 
with surfaces [67]. The protein’s environment changes from liquid to a solid-liquid interface once it 
encounters a solid surface. To accommodate the influences of the surface, the protein refolds from 
its native conformation which corresponds to a low free energy state in aqueous solution, to a new 
conformation to achieve a free energy minimum at the interface. The strongly bound layer of water 
molecules on a hydrophilic surface prevents strong interactions between the protein and the surface, 
allowing the protein to maintain its native conformation [68]. Highly hydrophilic surfaces, therefore, 
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are protein repellent and do not adsorb proteins from aqueous solutions [69, 70]. In contrast, the 
interface of a hydrophobic surface with water presents a significant energy penalty and the system 
will evolve to a lower energy state through the adsorption and unfolding of proteins. In such 
rearrangements, the hydrophobic groups are placed on the surface and the polar hydrophilic groups 
become the interface with the water. The new conformation will be significantly different from the 
native conformation, potentially rendering the protein useless for the desired biological signalling 
[71]. Highly hydrophobic surfaces, therefore, result in the irreversible build-up of non-functional, 
denatured proteins. This phenomenon is referred to as protein fouling and has been reviewed 
elsewhere [72].  
 
 
Figure 1.3. An illustration of protein-surface interactions for given hydrophobicities of smooth (a, b) and 
roughened (c, d) surfaces. The roughening of substrates enhances the pre-existing hydrophobicity. For 
hydrophobic surfaces (a, c) the roughened surface increases the protein adsorption quantity but results in 
protein fouling. Hydrophilic surfaces possess a water layer which impedes protein adsorption but maintains 
native protein conformation (b). Enhancement by roughening (d) produces a non-fouling surface due to the 
increased water attraction preventing protein adsorption.  
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1.2.2 Surface topology and roughness 
 
Surface topology is defined as the physical roughness and morphology of the interface. 
Roughness is the height variation from the statistical mean across the interface and is reported as the 
average roughness (Ra) or root mean square roughness (RRMS), while, morphology is the form the 
roughness takes, e.g. pores, grooves, or random formations. The process of altering the surface 
topology towards roughness and inducing morphological changes is referred to as roughening and can 
be performed through multiple means, e.g. grit blasting, acid etching, or plasma treatment [73]. 
Roughening processes increase the effective surface area at the interface, multiplying the quantity of 
chemical groups accessible to the contacting fluid, which in turn, enhances the pre-existing 
hydrophobicity/hydrophilicity of the interface. Accordingly, polymeric materials have been shown to 
become more hydrophobic as the surface roughness increases [74], whereas metallic surfaces 
experience an increase in hydrophilicity [66] (Figure 1.3). 
The types of interactions that determine implant biocompatibility have been shown to occur at 
different roughness scales [75-77]. The micron-scale improves mechanical interlocking [78], the 
submicron scale affects cellular activity [75, 76, 78], and protein interactions are influenced by the 
nanoscale morphology [79-81]. Proteins of different molecular sizes, charges, and surface affinities 
will interact differently with identical nanoscale topologies. [82]. The effect of surface roughness on 
protein adsorption has been investigated only for a limited number of proteins. Nanoscale surface 
topology accommodates protein attachment greater than could be accounted for by an increase in 
the surface area alone, and the mechanism is believed to be through protein conformational changes 
[79, 80]. It has also been shown that roughening on the submicron scale will affect the attachment of 
proteins based on the interactions between the individual protein and the enhanced 
hydrophobic/hydrophilic nature of the surface [83]. Surface roughening has been incorporated into 
current titanium orthopaedic devices to take advantage of the increase in biological interactions it 
affords. 
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1.3 Protein immobilisation approaches 
 
Protein immobilisation on an orthopaedic surface allows greater control over the biological 
interactions between the implant and the body. Several methodologies have been investigated since 
the inception of protein functionalisation for orthopaedics. The following section reviews the 
mechanisms of methodologies investigated and evaluates their complexity, reproducibility, and 
scalability. The properties of the functionalised surfaces, specifically their stability and biological 
efficacy, are also discussed. Titanium-based alloys are the standard for orthopaedic implants, and as 
such, the body of work on protein immobilisation methodologies for orthopaedic applications are 
focussed on titanium substrates. Immobilisation techniques that have been applied to PEEK are also 
addressed due to its potential to replace titanium in some orthopaedic devices. 
  
1.3.1 Physical Adsorption 
 
Physical adsorption, also referred to as physisorption, is the simplest method to immobilise 
proteins on substrates. It utilises hydrophobic and electrostatic interactions to non-covalently attach 
proteins to the surface. The adsorption of proteins occurs whenever a surface is placed in contact with 
a protein-containing medium, whether intentionally through incubation in a specific protein solution, 
e.g. BMP-2 in buffer solution, or unintentionally through exposure to serum-containing cell media or 
an in vivo physiological environment. The unintentional adsorption of serum proteins is usually 
neglected in the case of cellular studies, despite the fact it always occurs. The literature suggests that 
surface pretreatment of metals via acid or alkali solutions (e.g. HNO3 or NaOH) or treatment through 
electrochemical methods [84-86], primarily used for cleaning, are beneficial for cell attachment. This 
improvement is due to the increased hydrophilicity resulting from polar groups formed at the protein 
– surface interface. The increased hydrophilicity allows adsorbed protein molecules to retain native-
like conformations. The beneficial effects of pretreatment are also likely to be related, in part, to the 
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increase in available surface area due to a change in nanoscale topology. Similar advantages can be 
achieved on polymers, such as PEEK, using chemical modifications that introduce COOH and OH 
groups [87, 88]. The physisorption process is also utilised for the intentional attachment of selected 
proteins to influence the biological response. The pre-treated substrates are immersed in a protein 
solution for a given time before being transferred into the biological environment. Currently, research 
is focused primarily on the adsorption of proteins onto porous alloys and other porous structures, 
usually with a view to achieving controlled protein release rather than permanent immobilisation [89, 
90]. 
The main advantage of non-covalent protein immobilisation is the simplicity of the process, 
making it attractive for manufacturing [91]. However, the non-covalent nature of adsorption presents 
a number of disadvantages including low effective protein concentrations, protein denaturing, and 
unfolding. The effective concentration of a protein is the quantity that interacts with the physiological 
environment per unit of area. Physisorption does not usually perform well in this respect because 
attachment strength is low on hydrophilic surfaces; while proteins tend to unfold and spread on 
hydrophobic surfaces where the forces of interaction are strongest [68, 71]. 
Two chemical modification strategies have been developed for the adsorption process in an 
attempt to address the issues of low effective protein attachment, steric effects, and denaturing. The 
first strategy is the substitution of buffer solutions with hydrogels to deposit proteins. The desired 
protein is loaded into a hydrogel, the substrate is immersed and then removed to be air dried [2]. This 
approach increases protein deposition and retention on an interface and overcomes protein 
denaturing through enclosure within the hydrophilic environment of the hydrogel [92]. However, once 
placed within the aqueous environment, the hydrogel rehydrates and swells allowing the proteins to 
become displaced from the hydrogel via diffusion or hydrogel erosion, depending on the size ratio 
between the hydrogel pores and the protein [93]. Hydrogels are not widely utilised in orthopaedic 
devices for protein immobilisation due to the potential for mechanical removal. They have, however, 
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become popular in tissue engineering scaffolds and for drug and protein release applications [94-97]. 
The application of hydrogels for biomolecule delivery and release has been reviewed elsewhere [98, 
99].  
The second strategy aiming to improve the performance of adsorption-based processes is the 
introduction of alternative chemical groups on the substrate, resulting in Chemisorption (adsorption 
through the formation of temporary chemical bonds). Surfaces presenting hydroxyl groups, such as 
titanium, can be modified using a process known as tresylation. In this process, schematically depicted 
in Figure 1.4, trifluoromethane sulfonyl (Tresyl) chloride molecules are chemisorbed to the hydroxyl 
groups on the surface. Tresyl molecules (SO2CH2CF3) are attached to the surface through ionic 
chemical bonding between the terminal sulphur and a surface hydroxyl [100-103]. During the protein 
immobilisation process, the tresyl group acts as a molecular guide being displaced via nucleophilic 
substitution by the incoming protein resulting in a strong electrostatic bond between the positive 
amine of a protein and the negative surface hydroxyl.  
 
 
Figure 1.4. Protein chemisorption via tresylation. Step 1: The tresyl groups attach to the substrate and release 
Cl, forming a temporary O-S bond. Step 2: The incoming protein undergoes SN2 nucleophilic substitution via an 
amino group, disrupting the O-S bond. Step 3: Protein is chemisorbed to the surface through an O-N bond. 
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Hayakawa et al. have demonstrated that the concentration of protein adsorbed to a tresylated 
substrate is greatly increased over a non-treated surface. The ionic bonding forms a more rigid protein 
layer that is less susceptible to protein desorption [104-107] and surfaces functionalised with proteins 
via tresylation have indicated a beneficial response both in vitro [108] and in vivo [109, 110]. However, 
the reversibility of this form of bonding leads to three disadvantages. Firstly, Tresyl groups can be 
removed through hydrolysis at the S-O bond [102, 103] potentially reducing the number of binding 
sites for protein immobilisation. Secondly, care must be taken to avoid the presence of other 
nucleophilic groups during protein incubation, as they would compete with the protein in the 
substitution reaction [105, 106]. Finally, adsorbed proteins could potentially be replaced in vitro/vivo 
by proteins with higher affinities in a similar nucleophilic substitution.   
While each adsorption approach has particular strengths, a major disadvantage of all physical and 
chemical adsorption processes is that proteins are susceptible to competitive replacement, also 
known as the Vroman effect (depicted in Figure 1.5). Vroman et al. [111] noted that clean surfaces 
placed in contact with blood first adsorb a layer of low molecular weight proteins present in high 
concentrations, such as albumin. The adsorbed proteins are replaced over time by higher molecular 
weight proteins, such as fibrinogen, which have a greater affinity for the surface. Although the process 
of the Vroman effect is not fully understood, the formation of a transitional protein complex that 
rotates to release the originally adsorbed protein has been observed [112]. Physisorbed protein layers 
would be expected to experience similar displacement through competition with other proteins in a 
physiological environment. The likelihood of displacement is a function of relative protein 
concentrations and surface affinities [113, 114]. The primary application of physisorbed protein layers 
has, therefore, focussed on applications requiring protein release.   
 
Page 34 of 214 
 
 
Figure 1.5. Protein adsorption to substrates via physical forces, scaffold entrapment through hydrogels, and 
tresylation. Substrates adsorbing protein via physical forces rely on electrostatic and hydrophobic interactions. 
The effectiveness will vary depending on the surface chemistry and topology. The adsorbed proteins are readily 
displaced in the medium through interactions with environmental proteins. Protein entrapment within 
hydrogels increases protein quantity. However, hydrogels experience degradation and swelling in medium, 
resulting in the exchange of proteins. Tresylated substrates attach protein through nucleophilic substitution, 
producing a strong, non-covalent bond between the protein and substrate. The proteins are still susceptible to 
displacement via nucleophilic substitution and desorption. 
 
1.3.2 Covalent immobilisation via chemical methods 
 
The inability of adsorption processes to permanently attach proteins to an orthopaedic surface 
highlighted the need for an alternative approach to protein functionalisation. For permanent 
attachment to occur, the surface chemistry of both metallic and polymeric substrates must be altered 
to facilitate covalent reactions between the surface and the desired protein. The covalent attachment 
can be achieved either directly via surface functional groups or indirectly through a separate linker 
molecule that mediates the binding between the substrate and the desired protein.  
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1.3.2.1 Direct Chemical immobilisation 
 
PEEK substrates have demonstrated the potential to be chemically modified to allow direct 
covalent protein immobilisation. Chemical modifications must be performed before proteins can be 
covalently bonded to the surface due to PEEK’s chemical inertness [115]. Hydroxyl functionalisation 
(PEEK-OH) is the first step for all the chemical modification reactions. The untreated PEEK is refluxed 
in dimethyl sulfoxide (DMSO) and sodium borohydride (NaBH4) at 120˚C for 3 hours and subsequently 
washed with water, acid, and alcohol [87, 115]. The PEEK-OH can be further reacted to produce other 
surface functional groups such as amines [115], isocyanates [87], and carboxyl groups [116]. 
Isocyanate (NCO) functionalised PEEK is synthesised by further treating PEEK-OH with hexamethylene 
diisocyanate and diazabicyclooctane in toluene for three days. PEEK polymers functionalised with NCO 
are able to directly bind proteins covalently through a nucleophilic addition mechanism [87]. PEEK-
NCO can be further hydrolysed with NaOH and dioxane to bear amine groups. PEEK has also been 
functionalised with carboxylic acids and aldehyde groups. To produce carboxylic acid or aldehyde 
groups, the surface must be reacted with methylhydroquinone to form methylated PEEK (MePEEK). 
After bromination under UV light, the aldehyde functionalisation is formed through dehydration [116]. 
The aldehyde groups are then treated with sodium chlorite solutions to achieve oxidation to carboxylic 
acids as mild oxidative conditions are needed. The potential of chemically functionalised PEEK for the 
covalent attachment of biomolecules has not yet been explored for biomedical applications. This 
might be due to the complexity of the reactions and difficulties in scaling the process to apply to the 
3D structures used in implantable devices. Nevertheless, the carboxylic acid and aldehyde groups 
presented at the chemically modified PEEK surface can be used to covalently tether biomolecules to 
the surface through subsequent chemical reactions. 
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1.3.2.2 Chemical linker-mediated immobilisation 
 
Both PEEK and titanium have been functionalised with biomolecules through linker-mediated 
immobilisation. Chemical linkers represent the most common method used for covalent 
immobilisation on titanium surfaces to date as opposed to direct chemical functionalisation 
potenitally due to reaction time and complex chemistry outlined in section 1.3.2.1(see Figure 1.6). A 
pre-treatment step is required to expose the native oxide layer terminated by hydroxyl groups for the 
covalent attachment of the linker molecules via dehydration/condensation reactions [57, 117]. Linker 
molecules are generally carbon chain molecules either synthetic, like silane and polyethylene glycol 
(PEG), or biologically derived, like heparin, dopamine, and chitosan. 
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Figure 1.6. A schematic of protein immobilisation via direct and linker-mediated covalent chemical attachment. 
Linker-mediated covalent immobilisation has been performed on Ti and PEEK substrates. Direct chemical 
immobilisation has been performed on PEEK only. Direct chemical immobilisation starts with a hydroxylated 
surface (step 1) and undergoes sequential chemical reactions to produce a reactive chemical functional group 
(step 2). Linker-mediated chemical immobilisation also starts with a hydroxylated substrate. The linker 
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molecules are added and undergo a condensation reaction with the hydroxyl groups and attach to the surface 
(step 2). The surfaces functionalised with chemical groups are exposed to the desired protein solution and 
treated with the required chemicals for immobilisation, e.g. EDC/NHS (step 3). Chemical covalent immobilisation 
has been shown to prevent protein displacement in the medium. 
 
The two most commonly used synthetic linker molecules for protein immobilisation in 
orthopaedics are silane and PEG. Silanisation of orthopaedic substrates, first reported in 1995, has 
become the most widely applied method for the immobilisation of proteins and is still currently in use 
[118-120]. Alkylsilane linkers attach to hydroxylated substrates via a condensation reaction between 
the head groups of the alkylsilane and the OH groups on the surface, resulting in an O-Si bond, as 
shown in Figure 1.7. Alkylsilane compounds are chemically versatile with many variations having been 
developed over the last two decades to provide further functionalisation. These variants are classified 
by the functional groups used to immobilise biomolecules, located either on the head groups or the 
alkyl tail: Aminosilanes (containing primary or secondary amines), glycidoxysilanes (containing an 
epoxide group), and mercaptosilanes (containing a thiol functional group) [121]. An initial in vivo study 
by Voggenreiter et al. [122] demonstrated covalent immobilisation and retention of BMP-2 biological 
activity through silanisation. The histological analysis showed new bone formation on the 150-200 ng 
BMP-2 immobilised substrates was equal to that formed in the presence of 1 μg solubilised BMP-2 
(Figure 1.8) [122]. Silanes have also been used to immobilised type I collagen [123] and a branched 
adhesion biomolecule [124] both inducing a significant improvement in osseoconduction and 
osseointegration in vivo.  
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Figure 1.7. An outline of surface functionalisation with the chemical linkers silane and PEG, examining an 
individual molecule. Step 1: the hydroxylated substrate is exposed to the linkers in solution. Step 2: Silane linkers 
undergo a condensation reaction with the surface hydroxyl groups, releasing H3COH, to form Si-O bonds. PEG 
will attach to the surface either via a condensation reaction, releasing water, or electrostatic attraction. The type 
of surface bonding is derived by the available surface charges, thus, condensation reactions can be preferentially 
increased by a strongly basic pH or through the use of electrodeposition [125-127]. The presence of multiple 
linker molecules will result in cross-linking of self-assembled monolayers. Step 3: The desired protein is attached 
to the surface via the chemical functional group on the linker, i.e. carbodiimide, Schiff-base, or disulphide. 
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Figure 1.8. a) A graphical representation of the examined histological parameters; bone volume, bone surface, 
trabecular number, implant-bone area, osteoid area, eroded perimeter and osteoid perimeter, for the titanium 
control (red), 150-200 ng BMP-2 coated implant (green), and 1 μg free-solution BMP-2 (blue). 
Microphotographical comparison of stained implant preparations implanted with soluble free (b) and chemically 
immobilised (c) rhBMP-2. The histological information demonstrated equal bond formation under both 
conditions, proving that smaller quantities of BMP-2 can be surface immobilised to produce the same biological 
effect. Reprinted with permission from [122]. 
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PEGylation of orthopaedic substrates has previously been used to immobilise proteins but the 
main focus of the last decade has moved towards utilising PEG’s highly hydrophilic nature to improve 
the antifouling properties of surfaces [128-130]. The standard approach to surface PEGylation makes 
use of the pre-existing hydroxyl terminals to chemisorb the PEG molecules to the substrate, as 
schematically illustrated in Figure 1.7. Recently, terminally modified PEG molecules have been used 
in place of unmodified PEG for immersion and electrodeposition relying on the presence of 
electrostatic interactions between the selected terminal groups and the hydroxylated surface [131]. 
Amine- (NH2 – PEG- NH2) and carboxyl- (COOH–PEG-NH2) functionalised PEG are used for protein 
immobilisation via carbodiimide reactions. These modified PEG molecules are used either individually 
or together with a co-linker, such as an alkylsilane, to immobilise biomolecules [132, 133]. Further 
exploration of PEGylation can be found within [92].   
Recently, research focus has shifted from silane and PEG towards other biologically - derived 
linkers that have individual biofunctionality. In theory, the use of such molecules would provide a 
beneficial effect from unconjugated regions in addition to the immobilised proteins, as chemical 
linkers do not always provide 100% surface immobilisation. The biologically active molecules widely 
used as linkers include; dopamine (DOPA)  [134, 135], chitosan [136], and heparin (HEP) [137-139]. 
These molecules have been investigated both as individual and copolymer linkers. The deposition of 
these biomolecules on substrates predominantly occurs through immersion reactions, as listed in 
Table 1.2, requiring at least 12 hours to initiate the protein immobilisation.  
Dopamine which shows activity in extracellular matrix (ECM) signalling, is a strong mineralisation 
inducer [134] and has been used to immobilise a number of proteins since the early 2000’s  [134, 135, 
140-144]. Chitosan is a recently discovered biopolymer that has been used in biochemical linker 
immobilisation due to its antibacterial properties [136, 145-147]. First published by Dodane et al., this 
biopolymer is extracted from exoskeletal structures of arthropods, i.e. crustaceans, as well as fungi 
and insects [148]. Carboxymethyl-functionalised chitosan is commonly used for orthopaedic 
Page 42 of 214 
 
applications relying on the presence of COOH groups for carbodiimide reactions. This variation has 
also been used for tissue engineering scaffolds [98, 148, 149] and nanomaterials [150]. DOPA and 
chitosan attachment utilises condensation reactions with the hydroxyl-functionalised surface. 
Chitosan-functionalisation of a substrate requires exposure to the protein solution via immersion or 
electrodeposition (see Table 1.2). The original synthesis method for DOPA was complex, as the 
reactive oxygen catchetol side chains had to be protected from oxidation and cross-linking when 
applied as a self-assembled monolayer [151]. However, an easier alternative approach has been 
developed, requiring an overnight immersion in a DOPA/HCl - Tris buffer solution [142, 152-154]. The 
Tris buffer attachment process results in crosslinking of dopamine and the formation of an 
interconnected scaffold layer with exposed amine groups [152]. In vivo studies have been performed 
for DOPA functionalised with lovastatin, a bone-forming drug, and bacitracin, an antibiotic. Lovastatin-
functionalised DOPA demonstrated an increased bone formation (as shown in Figure 1.9 below) [155], 
while bacitracin greatly impeded biofilm formation in vivo on the surface of the implant [156]. 
Investigations into in vivo Ti/Chitosan conjugated with biomolecules remains to be performed.  
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Figure 1.9. a) Fluorescence microscopy images of DAPI and F-actin stained MC3T3 cells on pristine, β-CD-DOPA, 
and lovastatin-functionalised Ti at 1, 3, and 7 days. Proliferation rates (b), alkaline phosphatase activity (c), and 
calcium deposition (d) of MC3T3 cells on the investigated surfaces were compared to tissue culture plastic. The 
β-CD-DOPA and lovastatin-functionalised Ti demonstrated a significant increase compared to pristine control, 
with lovastatin-functionalised Ti exhibiting consistently higher activities than the β CD-DOPA. e) Histological 
imaging of Ti screws revealed the formation of lamella bone and bone ingrowth in β-CD-DOPA-, and lovastatin-
functionalised Ti not present in the pristine titanium. Reprinted with permission from [155]. 
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Heparin is an anti-thrombogenic protein originally used in cardiovascular applications for bypass 
circuits, synthetic vascular grafts, and coronary stents [157]. Heparin does not react directly with the 
hydroxylated surface. Instead, it requires an aminated surface to attach via a condensation reaction. 
As such, heparin has been immobilised with other compounds such as DOPA [56] or silane [158] that 
provide an amine terminal. Alternatively, Kim et al. outlined a click chemistry procedure utilising 
propargyl bromide and 2-azidoethanamine for amine-functionalising titanium substrates before 
attaching the heparin [139]. In vitro and in vivo studies of orthopaedic implant surfaces and scaffolds 
have been performed using heparin to immobilise BMP-2 [159-161]. Kim et al. have shown that the 
impermanent nature of the heparin-protein bond allowed the BMP-2 to be released into the biological 
environment which results in greater bone formation than controls in an in vivo dog model (Figure 
1.10)[56].  
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Figure 1.10. a) F-actin and DAPI stained fluorescence images of MG63 cells on Ti (a.a), adsorbed BMP-2 (a.b), 
and BMP-2/heparin/Ti (a.c). b) Cell proliferation of cells grown on the investigated surfaces at 1, 3, and 7 day 
time points as determined by CCK-8 assays. c) The release kinetics of adsorbed BMP-2 on titanium and 
heparin/Ti, respectively. The degree of mineralisation for MG63 cells was determined via alkaline phosphatase 
(ALP) levels (d) and calcium content (e). The BMP-2/Heparin/Ti surface demonstrate statistical increases over 
both the untreated Ti and the adsorbed BMP-2 Ti. In vivo investigations revealed significant increases in bone 
formation for the BMP-2 releasing surfaces, as shown in (f). In descending order: Ti (top row), BMP-2/Ti (middle 
row), and BMP-2/Heparin/Ti (bottom). Analysis of the histological results showed significant increases in bone 
growth in defect areas (g), bone-implant contact (BIC) angle of new bone (h), and bone density between the 
screw threads (i). Reprinted with permission from [56]. 
 
1.3.2.3 The chemistries of protein immobilisation 
  
There are three main types of chemistries utilised for direct and linker-mediated protein 
immobilisation: disulfide, Schiff-base, and carbodiimide reactions. The chemical reactions are outlined 
in Figure 1.11. In each case, the particular functional groups as shown must be present at the surface 
for the immobilisation to proceed. Surfaces functionalised with epoxy groups, although not widely 
applied, have been reported to immobilise proteins via nucleophilic substitution ring opening 
reactions involving the amine groups on the amino acid (AA) side chains [162].  
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Figure 1.11. An outline of the reaction steps for EDC/NHS carbodiimide, Schiff-base, and disulfide reactions 
commonly utilised in biomolecule immobilisation chemistry. EDC/NHS carbodiimide reactions: The desired 
protein, EDC, and NHS are exposed to the substrate in an optimised molar ratio. EDC attaches to the OH of a 
carboxylic acid on the protein (step 1) before being substituted with NHS (step 2). The NHS is replaced with the 
amine group at the surface (step 3) resulting in covalent immobilisation (step 4). Carbodiimide reactions will also 
occur with the locations of the amine and carboxylic acid groups interchanged. Schiff-base reactions: Protein 
amines undergo nucleophilic addition to an aldehyde group on the surface (step 1) forming a temporary imine 
bond (step 2 and 3). The imine can be chemically reduced to form a covalent N-C bond (step 4). Disulfide 
reactions: A sulfuric functional group can form a temporary S-S bond with a cysteine amino acid in the protein 
structure through oxidation. The bond can be reduced in mildly acidic conditions, as often occurs in aqueous 
environments.  
 
Thiol functional groups can be utilised for protein immobilisation through the formation of 
disulphide bonds (R-S-S-R’) with cysteine amino acids. The use of the disulphide chemical process in 
protein immobilisation allows for specific attachment, as cysteine is the only amino acid capable of 
forming disulphide bonds. Mercaptosilane linker molecules can utilise disulphide bonds to attach 
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proteins through the cysteine [163] or undergo sulfo-SMCC linker modification to immobilise proteins 
via carbodiimide reactions [164]. Disulphide bonds are reducible in mildly acidic conditions [165] and, 
therefore, may not provide sufficiently persistent protein functionalisation for use in implantable 
biomedical devices. 
Schiff-base reactions involve the formation of an imine (R/R’-C=N-R”) via nucleophilic substitution 
of an amine group on the double bonded carbon-oxygen (-C=O) of an aldehyde or carboxylic acid, 
resulting in the release of water [166]. This process targets amino acids with nucleophilic amines in 
their structure, such as histidine. Imine bonds are, however, hydrolysable and reduction of the C=N 
bond to a C-N bond is required for permanent immobilisation [165, 166]. Hence, Schiff-base chemistry 
may be useful for delayed release applications. For example, Kim et al. immobilised BMP-2 protein to 
a heparinised surface through Schiff-base chemistry and observed the gradual release of BMP-2 
together with significantly increased mineralisation of MG63 cells [56].  
The most common linker chemistry utilised for protein immobilisation is the carbodiimide 
reaction, which forms an imide bond (R-N=C=N-R’) between amine and carboxylic acids groups. 
Carbodiimide chemistry employs 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-
hydroxysuccinimide (EDC/NHS) or glutaraldehyde (GA) to attach proteins via the positively-charged 
lysine and arginine amino acid or the negatively-charged glutamic and aspartic acids, through surface 
attached carboxyl or amine groups, respectively. The synthetic linker molecules, amino silanes [61, 
103, 167-171], and NH2-PEG and COOH-PEG [133], are typical examples of linkers that immobilise 
proteins through carbodiimide chemistry (Figure 1.11).  
PEEK has been functionalised with Gly-Arg-Gly-Asp (GRGD) peptides through EDC/NHS reactions 
to the 7-Oct-1-enyltrichlorosilane (OETS) linker surface monolayer [117]. Titanium has been 
functionalised with collagen using EDC/NHS with the linkers aminopropyl-triethoxysilane (APS) [120], 
and a two-step attachment process linking (3-Aminopropyl) trimethoxysilane to COOH-PEG [133]. The 
biologically-derived linkers, dopamine and chitosan, almost exclusively utilise EDC/NHS chemistry to 
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covalently immobilise proteins through their presented amine groups. Biomolecules that have been 
immobilised through this chemistry include BMP-2 [136, 142, 172], heparin [56], and collagen [134]. 
EDC/NHS chemistry has also been used to cross-link immobilised collagen to improve the stability of 
the layer [173]. The cross-linking of collagen does not appear to negatively affect cell growth [134].  
EDC/NHS has also proved effective in stabilising self-assembled monolayers (SAMs) by cross-
linking. SAMs rely on physical interactions to produce a layer with well-defined structure and surface 
chemistry [174, 175]. They consist of surfactant molecules containing an alkyl chain tail and a 
functional head group that self-assemble on the substrate to form organised monolayers through 
electrostatic and hydrophobic/hydrophilic interactions [176, 177]. A variety of monolayer coatings can 
be assembled with different functional groups for the structural inclusion of the protein [174], or 
covalent immobilisation through chemical reactions, such as epoxy ring opening [178] and 
carbodiimide chemistry [179]. Covalent attachment of a SAM to a surface offering improved stability 
can be achieved by chemical reactions between the substrate and the contacting region of the 
individual SAM molecules. Such chemical attachment requires appropriate chemical modification of 
the substrate and the external end of the SAM surfactant molecules. Nevertheless, the physical 
interactions underpinning the SAM structure may result in insufficient stability for demanding 
applications such as in implantable biomedical devices. Stabilisation can be achieved through 
EDC/NHS cross-linking of the SAM itself [174, 179].  
 
1.3.2.4 Evaluation of chemical linker-mediated immobilisation approaches 
 
Chemical immobilisation methods successfully mitigate the problems of protein exchange via the 
Vroman effect after implantation, as shown in several in vivo studies [56, 122, 123, 155, 156]. 
However, direct and linker-mediated chemical attachment introduces several issues. The main issues 
arise from process complexity, reaction time, the toxicity of reactants, and the lack of scalability and 
reproducibility. The chemistry behind both direct and linker-mediated chemical immobilisation is 
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often complex and time-consuming, with each step of the process needing to be confirmed through 
characterisation. A linker-mediated protein immobilisation process requires a minimum of three 
steps: (i) preparation of the surface to present the required chemical groups (e.g. hydroxylation); (ii) 
reaction of the prepared surface with the linker molecule; and (iii) immobilisation of the protein to 
the linker. The total processing time is typically in the order of days as listed in Table 1.2. Direct 
chemical immobilisation of proteins to PEEK surfaces eliminates the required steps for linker molecule 
surface attachment. However, the chemical modification required to prepare the surface often takes 
longer to perform than the attachment of the linker and protein [115, 116]. The chemical reactions 
involved are sensitive to slight variations in environmental conditions, reactant quantities, and 
handling for each step, which may compound into much larger fluctuations in yield between batches. 
Additional side reactions also occur with each step further reducing the overall yield and 
reproducibility [180].   
The majority of techniques utilised for chemical protein immobilisation are not scalable. Many of 
these techniques have shown success under laboratory conditions by skilled chemists, a situation that 
is not common in manufacturing environments. The chemicals required are potentially hazardous, 
expensive, or currently unavailable to be purchased in the bulk quantities required for manufacturing. 
For example, γ-aminopropyl-triethoxysilane used for silanisation is corrosive and flammable. EDC, 
which appears in multiple linking chemistries, causes skin irritation, eye damage, and organ damage, 
according to the Safety Data Sheet. The use of such chemicals would also require additional safety 
facilities and equipment under work safety regulations and introduces significant hurdles concerning 
waste disposal and regulatory approval.  
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Table 1.2. Protein-functionalisation of titanium surfaces through linker-chemistry methods. A summary of 
deposition processes, synthesis times, investigated proteins, and biological testing.  
 
Linker 
molecule(s) 
Application/ 
deposition processes 
Synthesis Time (excluding 
substrate preparation)  
Proteins 
immobilised  
In vitro/vivo testing  
Silanisation 
[121] 
 
e.g. 
Aminosilanes  
Glycidoxysilanes  
Mercaptosilanes  
1) Immersion  
[61, 103, 167, 168, 
170, 171] 
 
2) Self Assembling 
Monolayer (SAM) 
[179] 
 
1) Immersion: 3 hours [103] to 10 
hours [61] immersion and drying 
overnight   - Followed by the 
required chemistry. 
 
2) SAM: Silane was added and 
allowed to react for 3 hours, 
followed by washing and overnight 
drying. Protein immobilisation was 
then performed (2 hours).  
Collagen [120, 123, 
181, 182] 
 
Bovine Serum 
Albumin (BSA)  
 
Trypsin  
 
A branched 
adhesion 
biomolecule [124] 
 
BMP-2 [57] 
 
Heparin  
 
Bone marrow stem cells 
[57] 
 
Rat Osteoblasts [103] 
 
h-Mesenchymal stem 
cells and in vivo rabbit 
model [120, 123] 
 
PEGylation [92]  
 
1) Individual 
i) Electrodeposition  
ii) Immersion  
 
2) Copolymer 
Conjugated with 
Silanes [133]/ 
Ethyl 3-
Mercaptopropionyl-
Succinic Acid (EMPSA) 
[132] 
1) Individual 
i) 300s for electrodeposition 
excluding the drying step [131]. 
ii) (time) incubation in PEG buffer 
solution 
 
2) Copolymer 
 Step 1: 42 hours for the synthesis of 
silane-PEG-Col. 
Step2: 3 days for the preparation of 
EMPSA conjugated PEG [132] 
Collagen  
 
BMP-2 
HUVEC ECV304 
endothelial cells 
 
Platelets [133]  
Heparinisation  
[138] 
 
1) Individual 
Click reaction [139]  
 
2) Copolymer 
Solution incubation 
with DOPA 
1) Individual 
Amine-functionalisation of 
substrate required for heparin 
attachment, followed by incubation 
in buffer and protein 
immobilisation. 5-6 days [139, 184] 
 
BMP-2 [56] 
 
Lactoferrin [135] 
MG63 Osteosarcoma 
[135]  
 
In vivo Dog model (13 - 
15 kg) [56] 
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[56, 135, 138, 139] 
Solution with Collagen 
[183] 
 
2) Copolymer 
Immersion in DOPA solution for 24 
hours, followed by exposure to an 
EDC/NHS/Heparin solution (time 
unspecified). Protein 
immobilisation was then performed 
for 6-24 hours depending on the 
protein. 
Polydopamine 
 
1) Individual  
Tris(hydroxymethyl) 
aminomethane (Tris) –
hydrochloric acid 
solution overnight. 
[134, 152-154] 
 
2) Copolymer 
See Heparinisation  
[56, 135, 138, 139] 
 
1) Individual 
Overnight immersion in DOPA – 
Tris/HCl buffer, followed by protein 
immobilisation.  
 
 
2) Copolymer 
Refer to heparin co-polymerisation 
synthesis time above. 
BMP-2 [142, 172],  
Chitosan [136] 
 
Fibronectin [185] 
 
collagen [134]  
 
RGD peptide and 
nanoparticles [142] 
Rat bone marrow-
derived osteoblast-like 
cells 
 
MC3T3-E1 transformed 
mouse osteoblast-like 
cells 
 
Immortalized human 
mesenchymal 3A6 Cells 
[142] 
Rabbit model [155, 156] 
Chitosan 1) Individual 
Electrodeposition 
[186] 
 
 
2) Copolymer 
Solution with DOPA 
[136, 145-147, 187] 
1) Individual 
Electrodeposition: Stirring in water-
acetic acid solution for 24 hours. 
Deposition for 400 seconds at 10 
V/cm.[186] 
 
2) Copolymer 
DOPA was first deposited overnight 
and allowed to dry. Carboxymethyl 
chitosan was prepared and added in 
EDC/NHS solution for 16 hours, 
followed by protein immobilisation.  
 
 
BMP-2 
 
 
In vitro: 
S. aureus 
 
S.epidermidis  
 
Osteoblasts 
 
Human Mesenchymal 
stem cells (hMSCs) 
[136] 
 
Sarcoma osteogenic 
SaOS-2 [146] 
Self-assembling 
monolayers 
(SAMs) [175] 
1) Electrodeposition 
[176] 
 
2) Incubation and 
Protein inclusion in 
SAM structure [174]  
1) Electrodeposition: 250 - 400 
seconds after 24 hours surface 
preparation [176, 188] 
2) Immersion time depends on the 
monomer used: 
Alkyl Phosphonic Acid (1-5 days) 
[176, 189], Silane (2 days- see 
above) [179]. Protein inclusion in 
SAM requires 4 hours preparation 
plus lyophilisation, followed by 5 
hours deposition [174]. 
 
Bovine serum 
albumin (BSA) 
[179] 
Mesenchymal stem 
cells [179]  
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1.3.3 Covalent immobilisation via dry and plasma methods  
 
Chemical immobilisation proved that it was possible to covalently immobilise proteins to 
orthopaedic substrates, overcoming the unintentional protein release observed in adsorption 
approaches due to the Vroman effect. However, the complexity of the wet chemistry, time 
requirements, batch variability, and waste disposal issues have encouraged the development of dry 
plasma-based approaches to the biological functionalisation of surfaces.  
 
1.3.3.1 Physical surface treatment procedures 
  
A variety of plasma-based processes have been applied for surface engineering of orthopaedic 
implants. These techniques utilise plasma, referred to as the fourth state of matter, to treat the 
surface of the implant. Plasma discharges produce a partially ionised gas comprising of electrons, 
photons, and ionised and neutral species [190]. Plasmas are considered “quasi-neutral” due to an 
overall charge neutrality between electrons and ionised species [191, 192]. However, local regions of 
like-charges can form and influence the random motion of charged species. Electrons, ions, and 
neutral particles undergo collisions and energy transfer, giving rise to a thermodynamic equilibrium. 
Plasmas referred to as “hot plasma” are those where all the electrons, ions, and neutrals are in 
equilibrium, such as in the Sun. Plasmas referred to as “cold plasma” are those where the electrons, 
ions, and neutrals are not in equilibrium. Cold plasmas are typically used for surface modification [193-
195]. As outlined in Figure 1.12, there are two general categories of plasma-based technologies: i) 
non-depositing plasma treatments which implant ionic species into a surface to modify it, e.g. plasma 
immersion ion implantation (PIII or PI3), and ii) depositing plasmas that coat the surface with an 
additional layer of new material. This section will focus on the depositing processes suitable for the 
modification of orthopaedic devices, and the use of the non-depositing technique, plasma immersion 
ion implantation (PIII or PI3), to modify the surfaces of PEEK substrates.  
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There are two plasma enhanced (PE) deposition techniques for coating orthopaedic implants: 
physical vapour deposition (PVD) and chemical vapour deposition (CVD). Physical vapour deposition 
uses physical processes to generate a vapour from a solid or liquid source such as electron or laser 
beam ablations, sputtering, or thermal evaporation. The vapour is transported in vacuo to the 
substrate, where it recondenses into a thin film [196]. PVD is used for the deposition of calcium 
phosphates (CaP)/ hydroxyapatite (HA) coatings for orthopaedic applications and has been applied to 
commercial products [197-199]. CaP and HA layers have not been used for covalent protein 
immobilisation. However, it is possible to immobilise proteins through Schiff-base reactions on 
hydrazine modified calcium phosphonates [200]. The use of CaP as orthopaedic coatings has been 
reviewed elsewhere [201, 202].  
Chemical vapour deposition generates reagent vapours from liquid or gaseous sources and relies 
on chemistry occurring on the substrate surface to form a thin film coating. A substrate is exposed to 
volatile reactant gases under vacuum. The process uses heat as a source of energy, typically between 
600˚C - 1200˚C, to initiate chemical reactions in the gas phase. The condensable chemical species 
deposit on the substrate where they form a thin film [196]. The application of high temperatures 
increases the mobility of species at the interface promoting the formation of an interfacial mixing layer 
between the substrate and the thin film. However, high temperatures restrict the number of suitable 
substrates and coating materials to those with high thermal tolerance [202]. CVD and its variants have 
become increasingly popular for biointerface applications and have been reviewed elsewhere [196, 
202]. 
Plasma enhancement is used to provide additional energy in the PVD and CVD processes. The 
additional energy creates more reactive, excited, or ionised species and is often used to reduce the 
operating temperature. In both processes, the precursor vapour is excited into the plasma state. The 
electrons in the plasma are used as the form of energy input and excite the reactant gases, resulting 
in ionisation, radical fragmentation, and enhanced plasma phase chemistry. Plasma enhanced physical 
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vapour deposition (PEPVD) has been used to deposit CaP layers onto orthopaedics [203-205]. 
However, these layers have not been used for protein immobilisation. The processes and applications 
of PEPVD have been reviewed elsewhere [206].  
PECVD is used to produce plasma polymer interlayers commonly used for biointerfaces [196, 
207].  A nano-thin layer of coating, comprising primarily of carbon, is deposited on any substrate 
exposed to the plasma. Highly cross-linked polymer structures are formed through a radical 
fragmentation-recombination process [193]. The PECVD process is versatile, allowing the production 
of coatings with a range of surface chemistries, SFEs, and charge by tuning the precursor gas 
composition and deposition parameters, such as precursor gas pressure and energy coupled into the 
plasma. The carbon-based thin film interlayers are typically biocompatible and functionalisable with 
subsequent plasma or wet chemical treatments to incorporate additional surface chemical groups 
suitable for protein immobilisation (see Figure 1.12). The surface modification achieved by plasma 
polymerisation is substrate independent [208], and therefore, plasma polymer (PP) interlayers, thin 
films (PPFs), and coatings deposited on substrates other than titanium are also reviewed here as they 
could potentially be applied to orthopaedic materials. Further explanations of PECVD processes and 
mechanisms can be found within [196, 207].  
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Figure 1.12. An outline of plasma processes used for biomolecule immobilisation. Plasmas used for treatments 
are categorised as non-depositing and depositing plasmas. Non-depositing plasmas generate radicals in the 
existing substrate which are then used for covalent biomolecule immobilisation. The depositing plasmas used 
for biomolecule immobilisation focus on the deposition of polymeric thin film coatings. These can then be used 
to immobilise proteins through further wet chemical reactions (chemically functionalised PPFs) or through 
radicals embedded in the coatings (plasma activated coatings). 
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1.3.3.2 Protein immobilisation onto plasma polymer interlayers 
 
Functional molecules can be immobilised on PP films through two approaches: multi-step 
attachment through chemical linkers or direct attachment. Multi-step attachment by means of 
chemical linker molecules is applied through an intermediate wet chemistry step [209-214]. The 
linkers may also include polymer brushes [207, 215]. Direct immobilisation of the biomolecule to the 
PP surface is achieved through radicals and/or surface functional groups present on the coating, 
referred to as “moieties” here [216, 217]. 
 
Multi-step immobilisation on PP films through chemical linkers  
Post-synthesis grafting of functional molecules onto PP films can be performed through chemical 
linkers. The attachment of chemical linkers still requires subsequent wet chemistry steps to covalently 
bind the target proteins, but the use of PP films eliminates the need for substrate pretreatment and 
broadens the range of functionalisable substrates. Surface moieties can also be included as to improve 
the surface chemistry. The first use of post-synthesis linkers for protein immobilisation on PPFs for an 
orthopaedic application was by Puleo et al. [218]. The authors grafted BMP-4 onto an allylamine PP 
(ppAAm) through two chemical modification approaches: (i) a method based on the one-step 
EDC/NHS carbodiimide reactions (as depicted in Figure 1.11); and (ii) a two-step succinic anhydride 
and EDC carbodiimide process utilizing the amine groups on the PP surface (Figure 1.13) [218]. The 
authors proposed that the two-step approach was more effective in binding the test lysosome 
enzyme, and therefore BMP-2, due to the sequential exposure to the cross-linking components. This 
strategy removes the potential for protein-protein cross-linking reactions observed in the one-step 
process. This was demonstrated by the enzymatic activity which showed complete enzyme 
deactivation from the one-step method, while the two-step immobilisation retained 75-80% of the 
enzyme functionality. 
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Figure 1.13. A schematic illustration of the chemical reactions for the 2-Step carbodiimide chemistry. The 2-step 
immobilisation chemistry incorporates succinic anhydride to modify the amine-functionalised surface into a 
carboxyl-functionalised surface before commencing EDC/NHS reactions, as per the traditional 1-step approach 
outlined in Figure 1.11. The process changes the focus of the chemistry from modifying the proteins to modifying 
the surface moieties. The authors report an accompanying increase in biological activity and decrease in protein 
cross-linking. Adapted with permission from [218]. 
 
Following this application of PPFs, the field has developed multiple techniques capable of binding 
proteins. An extensive range of proteins and attachment procedures have been investigated, primarily 
using alkyl (carbon) PP interlayers [209-214]. Briefly, the polymer is deposited on the substrate by 
PECVD. The appropriate moieties on the coatings are then reacted with a chemical linker (e.g. silane 
or PEG), followed by further chemical reactions for protein immobilisation, as described previously in 
Section 3.2. 
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Protein immobilisation via plasma polymer brushes  
Polymeric molecules tethered to the surface to form brush-like structures are referred to as 
polymer brushes. These structures can be synthesised on PP coatings and attached to the substrate 
by means of either chemical reactions in solvents [219] or free radicals (atom transfer radical 
polymerisation) [220, 221]. Simply, a PP film is deposited onto the desired substrate which is then 
exposed to the brush monomer reagent, either as vapour [220, 221] or in solution [219]. Energy to 
promote the reactions is supplied as either heat or UV radiation. Polymer brushes have been 
synthesised primarily to prevent protein adsorption to surfaces as reviewed by Keating [222] and 
Krishnamoorthy [223]. Such structures can also be used for protein release applications [224, 225]. 
Polymer brushes could potentially be used for covalent protein immobilisation if the antifouling end 
groups were replaced by reactive groups such as those used for chemical linker-mediated 
immobilisation. 
 
Direct immobilisation on PP films 
Proteins can also be directly immobilised on plasma polymer coated substrates through covalent 
bonding with reactive functionalities present on the surface, as schematically illustrated in Figure 1.14. 
PP films that present reactive functionalities, such as amine or carboxyl groups, are known in the field 
as “functionalised PPFs” [195]. They have been developed over the last three decades and include 
those functionalised with specific chemical reactive groups and highly-reactive, non-specific radicals.  
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Figure 1.14. An outline of the biomolecule immobilisation procedure for free radical functionalised and 
chemically functionalised plasma polymer thin films (cPPFs). The PPFs are deposited on substrates inside a 
vacuum chamber either by a single or multi-step deposition (step 1). The PPF substrates are removed and 
undergo the required immobilisation procedures (step 2). For cPPFs, this includes wet chemical carbodiimide, 
Schiff-base, or disulfide reactions. For radical-functionalised PPFs (rPPFs), covalent protein coupling is achieved 
by a simple incubation step in the protein-buffer solution.  
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Direct Immobilisation through Specific Chemical Groups  
The inclusion of functional groups or moieties in the surface coating that can be reacted directly 
with groups on the protein facilitates direct covalent immobilisation without the need for a linker 
molecule (Figure 1.14). A variety of moieties have been integrated into plasma polymer coatings for 
this purpose, with the most common being amine [226, 227], carboxyl [228], and aldehyde [229, 230] 
moieties. More recently, epoxy moieties have also been used to achieve covalent coupling of proteins 
to PPF surfaces through ring opening reactions [212]. The chemically functionalised PPs films (cPPFs) 
are produced through single or multi-step deposition procedures before protein immobilisation, as 
listed in Table 1.3. The first stage involves the deposition of a carbon-rich PP thin film. The following 
step(s) may include exposure to vapours (which may be in the form of another plasma) containing 
reactive fragments which form the desired functional groups on the surface. The synthesis of PP 
coatings functionalised with reactive moieties is generally performed at low plasma specific energies 
to avoid extensive fragmentation and thereby retaining the chemical functional group of the precursor 
monomer [231-234]. The plasma specific energy (W/F) is the available energy per unit volume of 
monomer as denoted by the ratio of plasma input power (W) to monomer flow rate (F) [235, 236]. The 
surface functional groups allow for directed protein immobilisation by chemical reactions with specific 
groups on the proteins, such as carboxyl or amine groups.  
Amine and carboxyl moieties are the most studied surface functional groups in the literature. The 
amine and carboxyl moieties are produced through various procedures listed in Table 1.3, with the 
secondary treatments including N2 gas and nitrogen-rich compounds for amine groups and Ar gas with 
carbon-oxygen (alkyl) compounds to obtain carboxyl functional groups. Amine- and carboxyl-
functionalised PP films have been reported to considerably enhance cell attachment and proliferation 
without protein immobilisation via chemical coupling [237-242]. Specific to bone-forming cells, Jung 
et al. compared amine-, carboxyl-, and hydroxyl functionalised PPFs seeded with MC3T3-E1 cells [243]. 
They showed that the amine groups resulted in higher day 4 proliferation, whereas carboxyl groups 
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outperformed amine groups by day 7, as shown in Figure 1.15. It was proposed that the amino groups 
enhanced cellular adhesion, but the negatively charged carboxyl groups enhanced cell proliferation.  
 
 
Figure 1.15. Proliferation (a) and alkaline phosphatase production (b) of MC3T3-E1 osteoblast-like cells on tissue 
culture plastic (Control), smooth Ti (CP-Ti), roughened (SLA), and PPFs functionalised with COOH, NH2, and OH. 
Proliferation results showed an increase in cell number on COOH and NH2 coatings at all time points, while ALP 
production was found to be approximately equal, suggesting no significant increases in mineralisation. Reprinted 
with permission from [243]. 
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Liu et al. observed increased mineralisation in adipose-derived stem cells deposited on amine-
functionalised PPs, due to the upregulation of osteoblast-specific markers and positive surface charge 
[244]. It is generally accepted that such improvements in cell behaviour on surfaces are mediated by 
surface adsorbed proteins from the medium [50]. Both carboxyl and amine groups acquire surface 
charge in the medium and therefore enhance the surface hydrophilicity, which in turn results in better 
retention of the native conformation of adsorbed proteins (as outlined in Section 2). The ability to 
preserve native protein conformations is also essential for surfaces used for covalent immobilisation 
of proteins. Covalent protein immobilisation on amine- and carboxyl-functionalised surfaces require 
the use of EDC/NHS chemistry to form carbodiimide bonds [214]. Heller et al. used an amine-
functionalised PP film deposited from allylamine to compare the cellular response of human 
osteoblasts (HOBs) and umbilical cord cells (HUVACs) to fibrinogen, collagen, laminin, and osteopontin 
immobilised onto the PP surfaces [214]. Fibrinogen and collagen resulted in significantly higher cell 
coverage for HUVACs and HOBs compared to titanium as shown in Figure 1.16.  
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Figure 1.16. Fibronectin, collagen, laminin, and osteopontin were covalently immobilised to the amine-
functionalised plasma polymer film via EDC/NHS chemistry, as outlined in (a) and Figure 1.11. The cell growth of 
HUVACS (b) and HOBs (c) was fluorescently imaged with calcein-AM. HUVACs demonstrated a distinct 
preference for fibronectin and collagen producing consistently elevated proliferation compared to the untreated 
Ti control (b). The authors attribute the discrepancy between fibronectin, collagen, and laminin to be the 
expression of the RGD adhesion sequence and the absence of the laminin integrin sequence on the HUVACs. 
Osteopontin also possesses this RGD sequence but the concentration may have been insufficient for HUVACs 
stimulation. The authors suggest that the HOBs possess binding sites for both the RGD sequence and the laminin-
integrins thereby explaining increased attachment and proliferation across all functionalised surfaces compared 
to the control (c). Reprinted with permission from [214]. 
 
Aldehyde-functionalised PP films have not been studied as widely as their amine and carboxyl 
counterparts. These functional groups form hydrolysable covalent bonds with the target proteins 
through Schiff-base reactions that can be stabilised through a subsequent reduction reaction [165, 
166, 208]. Aldehyde moieties can be produced by the deposition of aldehyde-containing precursor 
monomers, such as acetylaldehyde, benzylaldehyde [208], and propionaldehyde [245]. Direct protein 
immobilisation to aldehyde-functionalised PP has been achieved with streptavidin [245, 246] and 
heparin [247]. These PPFs have also been used as platforms for the immobilisation of non-fouling [248] 
and antifungal agents [249]. 
The first epoxy-functionalised PP film was developed by Inagaki et al. using allyl glycidyl ether 
monomer through a one-step deposition [250]. Oehr et al. [251] and Tarducci et al. [252] suggested 
that the reactive chemistry of the epoxy rings can be used to immobilise proteins through ring opening 
SN2 reactions [162]. Experimental examination of protein immobilisation was performed by Thierry et 
al. [212], who immobilised lysozyme to an epoxy-functionalised PP film. Further biomolecule 
immobilisation applications, such as DNA probes [253, 254], have been explored but this PPF has not 
been applied to orthopaedics. 
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Table 1.3. Summary of direct immobilisation of proteins on functionalised plasma polymer films 
 
 
Direct immobilisation through non-specific reactive radicals 
Direct immobilisation of proteins by means of radicals can be performed through two techniques 
depending on the substrate: (i) plasma immersion ion implantation (PIII or PI3) for carbon-rich 
substrates such as most polymers [260-264], and (ii) a combination of plasma polymerisation and PIII 
treatment for the fabrication of radical-functionalised PP films on other substrates such as metals and 
ceramics [265-267]. Covalent immobilisation through reactions with radicals following these 
“Functio
nalised” 
PP  
Surface 
groups/moieties 
Polymerisation method 
 
Immobilised 
biomolecules 
In vitro/ vivo testing 
Amine Amine (-NH2) 
Amides (-N-R’/R”) 
Plasma polymerisation of allylamine [243], 
heptylamine [255] 
 
Addition of diamino cyclohexane (DACH)  
[216, 256] 
 
fibrinogen, collagen, 
laminin, osteopontin 
[214] 
 
MC3T3-E1 cells [243] 
Human osteoblast 
(HOB) and umbilical 
cord cells (HUVACs) 
[214] 
Adipose-derived stem 
cells [244] 
Carboxyl COOH   
COx 
 
Plasma polymerisation: 
Deposition of Acrylic acid [236, 243, 257], 
and propanoic acid [255, 258]. 
 
 
Grafting with polyethylene oxide [259] 
Collagen  
 
PtA-AF546 [257] 
MC3T3-E1 cells [243] 
 
 
Aldehyde R-C=O 
 
Plasma polymerisation of Alkyl/allyl 
aldehydes: acetylaldehyde, benzylaldehyde, 
propionaldehyde 
[208, 246, 248] 
ethylbutyraldehyde, capronaldehyde, 
nonylaldehyde [229] 
 
Collagen,  
streptavidin [245, 246],  
heparin [247],  antifungal 
agents [249]] 
 
Epoxy   
 
Plasma polymerisation of allyl glycidyl ether 
[250] 
Lysosome [212] 
 
DNA probes [253, 254] 
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processes is achieved upon contact with biomolecules in buffer solution without the need for chemical 
treatments [264].  
PIII is a non-depositing technique that utilises energetic ions to generate radicals for covalent 
immobilisation of biomolecules [268]. Simply, the substrate is mounted on a negatively biased holder 
inside a reactor and exposed to the plasma. A negative bias of several kV is pulsed as a function of 
time with the resulting electric field repelling electrons and attracting ionic species. This pulsed bias 
forms an ion sheath around the sample holder and implants the ions into the substrate at a depth 
dependent on the bias. A detailed explanation can be found within [217]. This process has been 
investigated extensively for PEEK, with a range of treatment conditions and immobilised biomolecules 
examined [264, 269-271]. The PIII technique has also been used to implant N, C, O, and other elements 
into the surface of titanium [272-276]. This research focussed on titanium surface hardening with 
nitrogen [276, 277] and the addition of antibacterial properties with the implantation of Cu [278]. 
However, this procedure does not allow for direct radical-mediated immobilisation of biomolecules. 
Radical-mediated immobilisation of biomolecules to metallic orthopaedic substrates can be 
performed through radical-functionalised PPFs. 
All PP interlayers contain radicals in the coatings as they are inherent to the fragmentation-
recombination mechanisms of plasma polymerisation [221, 279]. The immobilisation of compounds 
through radicals embedded in PP films has been investigated outside of protein immobilisation, mainly 
focussing on the formation and grafting of polymer brushes for non-fouling applications [220, 221]. 
Covalent immobilisation of proteins through embedded radicals in a PP film was first reported by 
Kondyurin et al. [280] using n-hexane as a precursor. Subsequent work showed that alternative 
carbon-containing precursors, such as acetylene [264], can be used. Radical-functionalised PP films, 
also referred to as plasma activated coatings (PAC), are deposited from carbon-rich monomers while 
the substrate is negatively pulsed biased. The pulsed biasing of the substrate enhances the ion-
bombardment, leading to PP structures with greater concentrations of radicals [58, 281, 282]. These 
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coatings have shown radical retention in aerobic environments for at least 15 days [58] and can still 
contain reactive radicals 4.5 months after deposition [283]. It is also possible to restore radical-
functionality to a polymer film by driving off the oxygen via annealing [283]. The chemistry and 
properties of radical-functionalised PPFs can be tuned by the addition of other reactive gases, such as 
N2, H2, and O2 during deposition [264, 266]. The immobilised biomolecules have also been shown to 
retain their bioactivity after immobilisation and also after freeze-drying [284]. Mechanical analysis of 
the PAC/protein system showed excellent mechanical stability through the formation of a graded 
interface between a stainless-steel substrate and PAC using magnetron sputtering during PAC 
deposition [264, 285]. In the case of carbide forming substrates, such as titanium and zirconium, the 
graded interface is not required due to the formation of covalent bonds between the substrate and 
the PAC layer [286]. Chrzanowski et al. created an adherent polymer layer by ion implanting a thin 
spin-coated polystyrene film on a NiTi substrate [287]. The samples were washed with 5% sodium 
dodecyl sulfate (SDS) (w/v) at 100˚C for 1 hour to evaluate the covalent binding capability of the 
radical-functionalised polymer layer. The radical-functionalised sample demonstrated an initial 
protein attachment of 1782 ± 110.0 ng/cm2 and a 63 ± 7% retention of a fibronectin-osteocalcin fusion 
protein (FN-OCN) post-SDS washing, while the non-functionalised polystyrene control presented an 
initial protein attachment of 880.0 ± 22.2 ng/cm2 and a 21 ± 2% protein retention, as shown in Figure 
1.17. The significant retention of protein on the radical-functionalised substrate indicated covalent 
immobilisation. 
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Figure 1.17. Atomic force microscopy (AFM) assessment of the immobilised FN-OCN protein on radical-
functionalised and non-functionalised polystyrene (PS) coated silicon pre- and post- SDS washing. a) AFM 
topographical images of the unwashed and SDS-washed substrates. The PIII-treated substrates demonstrate a 
higher density of proteins both pre- and post- SDS washing, while the non-functionalised PS retained a 
significantly lower concentration, suggesting non-covalent protein binding. Graphical depictions of the protein 
layer thickness, and thereby, protein quantity is shown in (b and c). The authors state that the radical-
functionalised PS demonstrated minimal changes to the protein layer thickness while a significant removal of 
protein is observed on the non-functionalised PS. Reprinted with permission from [287]. 
 
The authors also showed an increase in MSC differentiation into osteoblasts after 21-days 
through the immobilisation of the fibronectin-osteocalcin fusion protein compared to the bare and 
fibronectin controls. This was demonstrated by the elevated cell density, focal adhesion points (FAK), 
and osteopontin (OPN) as shown in Figure 1.18. More recently, Yeo et al. [58] demonstrated a 
significant increase in osteoblast-like cell proliferation and mineralisation using tropoelastin-
functionalised PAC on zirconium. These works show that radical-functionalised surfaces facilitate 
direct covalent biological functionalisation of a range of orthopaedic implant materials (Figure 1.19). 
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Figure 1.18. Phase contrast and immunostaining images of mesenchymal stem cells (MSCs) on control nickel-
titanium (CON), fibronectin immobilised PAC (FN), and fusion-protein immobilised PAC (FN-OCN). Phase contrast 
images (top row) show a significantly greater attachment of MSCs on the FN-OCN samples compared to FN and 
Control. The immunostaining images on the bottom row demonstrate an increased quantity of focal adhesion 
points (FAK) and osteopontin expression (OPN), indicating more cell differentiation into osteoblasts on the FN-
OCN functionalised substrates. Reprinted with permission from [287]. 
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Figure 1.19. a) PAC deposition and protein immobilisation schematic of tropoelastin (also outlined in Figure 
1.14). The calcium deposition of MG63 cells at 1, 10, 20, and 30 days post-confluence in non-osteogenic (b), and 
osteogenic (c) media was quantified with alizarinRed staining. Significant increases were recorded for substrates 
possessing tropoelastin, with the upregulation of ALP resulting in increased mineralisation at 20 days post-
confluence in (b) and 30 days post-confluence in (c). Reprinted with permission from [58]. 
 
1.3.3.3 Evaluation of physical immobilisation approaches 
 
Physical covalent immobilisation of biomolecules is the most recent approach to orthopaedic 
biomimetic functionalisation and possesses advantages over adsorption and chemical covalent 
immobilisation. The PIII treatment or the deposition of radical-functionalised PP films together with 
the subsequent protein immobilisation step can be performed in a few hours rather than the days 
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required for chemical immobilisation. Radical-functionalised PPFs (rPPFs) covalently immobilise 
biomolecules upon contact providing the strength of covalent attachment with a simple process more 
akin to adsorption. These plasma-based methods are relatively “green” and produce minimal waste 
compared to chemical approaches [288]. Protein immobilisation on conventional chemically 
functionalised PPFs (cPPFs) is not entirely waste-free due to the use of EDC/NHS for carbodiimide 
chemistry or other agents for Schiff-base reduction. The synthesis methods of PPFs can be effectively 
scaled up as PIII, PEPVD, and PECVD methods are extensively used in a range of industrial 
environments [288, 289]. 
The disadvantages of physical covalent immobilisation techniques are primarily associated with 
the capital costs of the power supplies and vacuum systems. The deposition techniques make use of 
volatile chemicals and pressurised gases which require the installation of compliant gas management 
facilities [288]. In a manufacturing context, this is likely to be offset by costs associated with the multi-
step complexity, monitoring, and purification required in wet chemical approaches for covalent 
coupling to ensure compliance with regulatory standards for implantable biomedical devices. 
Ageing of plasma modified surfaces is a potential problem for applications where biomolecules 
are to be immobilised in a separate process after long-term storage. All plasma polymers contain 
radicals and, therefore, undergo radical recombination and autoxidation (reaction with air) [207]. The 
recombination of radicals is the reaction of the radical with an electron accepting molecule. While the 
principle of recombination appears simple, the recombination behaviour can be complex depending 
on the conditions of PP film synthesis [290, 291]. Autoxidation is the oxidation of the PPF due to 
interactions between reactive species at the air-surface interface [207, 292, 293]. This effect is 
greatest over the first few hours and stabilises with time, as shown by dramatic initial changes in 
contact angle and surface oxygen concentration [292]. Polymer chain diffusion can also lead to ageing 
in PP films that are not sufficiently cross-linked to prevent individual polymer chains at the surface 
from diffusing into the bulk [294]. These processes, together, lead to a phenomenon known as 
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‘hydrophobic recovery’ in which high-energy species are removed from the surface leading to an 
increase in the water contact angle [295-298]. These mechanisms are responsible for ageing in radical-
functionalised surfaces resulting in the eventual loss of radicals and hence the capacity for direct 
covalent binding of biomolecules [264]. In addition, cPPFs experience moiety decomposition. Amine 
groups can decompose into amides (R-N-R’) or NOx groups [299, 300] and have been shown to lose 
70% of the initial surface functionalisation over 7 days [240]. Carboxyl and aldehyde groups follow the 
same decomposition route, fragmenting into aldehydes, alcohols, and COx groups. More detailed 
examinations have been published outlining the mechanisms and effects of amine, carboxyl, and 
aldehyde decomposition [208, 216]. The ageing of epoxy-functionalised PPFs has been observed. 
Camporeale et al. present surface group composition of an epoxy-functionalised PP under a series of 
conditions, two of which correspond to a 50-day time lapse [254]. The epoxy surface signal decreased 
from 18% to 9% over 50 days in air. An increase of carbon-oxygen single bonds was observed, 
suggesting the rings underwent opening reactions. The protein bonding ability of rPPFs is dependent 
on the quantity of imbedded radicals migrating to the coating surface to form covalent bonds with 
proteins rather than the presence of specific chemical groups at the interface.   
Implantation of orthopaedic devices is a highly mechanical process and the surface is likely to be 
damaged during the insertion. Scratching of the biofunctionalised surface will locally remove the 
biomolecules regardless of the immobilisation approach used. In the case of biomolecules 
immobilisation on surface coatings, there is an additional risk of delamination of the thin film coating 
following the exposure of the coating-substrate interface to the aqueous medium. Although plasma 
polymerisation is often referred to as a substrate independent process, the structure of the initially 
deposited layers depends on the chemistry of the PP-substrate interface [301-306]. The possibility of 
coating delamination in-vivo highlights the importance of interface engineering to ensure robust 
adhesion of the coating to the substrate.  
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Stability of the biofunctionalised surface in the long term depends on the stability of the protein 
molecules and the strength of the coupling to the surface. Physically immobilised biomolecules will be 
rapidly lost by substitution of molecules from the physiological environment [111, 112]. Covalently 
coupled molecules are susceptible to degradation or bond cleavage over the longer term [307]. The 
timescales for these phenomena will depend on the nature of the biomolecule and the linking 
chemistry used for immobilisation. Biomolecule immobilisation onto coatings may also suffer from 
swelling of the coating after exposure to the aqueous environment. This problem can be mitigated by 
ensuring a high degree of crosslinking within the coating by applying greater plasma input energies 
per unit volume of the precursor monomer [301, 308]. It has recently been shown that formation of a 
highly cross-linked layer close to the substrate provides enhanced stability in aqueous environments 
[309] (Figure 1.20). A limited number of studies report the mechanical and chemical stability of the 
linker layers. Stability studies were performed using pH 7.4 buffer and fluorescent dyes to evaluate 
the retention of adsorbed and covalently immobilised proteins [120, 169]. PP interlayer stability 
reports are more abundant than their linker-mediated counterparts [282, 286, 310-312]. The 
evaluation of stability typically includes exposure of the biofunctionalised substrate to a solution, e.g. 
water or buffer, followed by a surface analysis using techniques such as XPS [312], quartz crystal 
microbalance (QCM) [287], or an enzyme-linked immunosorbent assay (ELISA) [58]. Simulated body 
fluids (SBF) and sodium dodecyl sulfate (SDS or NaDS) have also been used to provide more aggressive 
environments for protein and coating stability assessments [58, 281, 286]. The stability assay time 
frame should be of considerable length given the decades spent in the body, but the majority of 
studies state short exposure times [120, 313-315].  
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Figure 1.20. a) A diagrammatic representation of the gradient approach to enhance stability through cross-
linking and retain chemical functionality. The ageing behaviour of 1 and 2 nm vertical gradient structures and 
non-gradient highly cross-linked or oxygen-rich structures in water at pH ≈ 6.2. Oxygen-to-carbon concentration 
ratio (O/C) of the plasma polymerised structures as a function of time as stored in air (b) and water (c). Water 
contact angle (WCA), are displayed as a function of the storage time in air up to 5000 hours (30 weeks) (d) and 
water up to 10 000 min (1 week) (e). Therefore, by depositing a highly cross-linked initial layer followed by a 
functional, the authors obtained chemical functionality (b, c) while retaining structural stability (d, e). Reprinted 
with permission from [309]. 
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1.4 Project Aims and Thesis Structure 
 
Load bearing titanium orthopaedic implants are mechanically strong and flexible, and well 
tolerated by the body [26-28, 34, 35, 39]. However, a number of short and long term problems still 
exist due to the biological inertness of the surface [3-7] and mechanical mismatch between the 
implant and bone [29-31]. Protein-functionalisation promises a bioactive surface capable of mitigating 
these effects by stimulating bone formation [57, 123, 184, 214], but current wet chemistry approaches 
are difficult to translate from the laboratory into cost-effective manufacturing due to the number of 
reagents and process steps required, as well as the potential for incomplete or side reactions. 
This thesis aims to develop commercially translatable, multifunctional biointerfaces for 
orthopaedic applications utilising radical-functionalised plasma polymer films (rPPFs). rPPFs can be 
deposited onto any substrate and are fabricated through a simple, reproducible, and scalable 
approach to enable protein-functionalisation of orthopaedic devices [264, 288, 289]. Chapter 2 
describes the techniques, including plasma deposition, physical and chemical surface characterisation 
methods, and cell culture assays, employed to investigate the utility of rPPFs for the biological 
functionalisation of titanium-based orthopaedics. The use of rPPFs in orthopaedics requires a coating 
that is mechanically robust, as coating failure (delamination) could have serious consequences. A 
series of coatings with varied N:C ratios in their surface chemistry are examined in Chapter 3 to 
determine the optimal coating conditions. Free radicals have been associated with numerous 
diseases, including osteoarthritis. Chapter 4 investigates the effects of radical flux migrating from the 
rPPFs on the surface chemistry and tests for potential radical-induced cytotoxicity with bone lineage 
cells. The single protein approach to biomolecule-functionalisation has shown some success. 
However, an evaluation of the bone integration process shows that a multifunctional surface is 
required for optimal integration. Fibronectin (FN), osteocalcin (OCN), and a custom osteocalcin-
fibronectin fusion protein (FN-OCN) are optimised for immobilisation on rPPFs, alongside a co-
immobilised ratio of FN and OCN (Chapter 5). The bone-integration potential of the multifunctional 
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and single protein functionalised rPPF surfaces were comparatively evaluated with primary 
osteoblasts and mesenchymal stem cells in Chapter 6. 
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Chapter 2 – Methods and materials 
 
A range of techniques from multiple disciplines were utilised for the synthesis, optimisation, and 
examination of protein-functionalised plasma polymer film (rPPF) biointerfaces. This chapter contains 
the experimental procedures utilised for the synthesis and characterisation of surfaces in multiple 
chapters. The experimental procedures unique to an individual study are presented in the chapter 
describing that study. The experimental protocols described within are subdivided into materials 
preparation and characterisation, cell maintenance and substrate seeding, and microscopy techniques. 
 
2.1 Material preparation and characterisation 
 
2.1.1 Substrate preparation  
 
Titanium – 6% aluminium – 4% vanadium (Ti-6Al-4V or Ti 6-4) was purchased from Firmetal 
(China) in thicknesses of 1 mm and 70 µm. The 1 mm Ti was subsequently cut into 0.8 cm x 0.8 cm 
pieces, referred to as ‘sheets’, prior to being polished. The 70 µm thick titanium was cut to the 
required size, referred to as ‘foils’, and remained unpolished so not to compromise its structural 
integrity. The Ti sheets and foils are collectively referred to as ‘substrates’ when describing processes 
common to both. 
Polishing was performed at the Australian Centre for Microscopy and Microanalysis (ACMM). A 
total of four Ti sheets were carefully affixed per epoxy block with superglue and left to dry overnight. 
The epoxy blocks were inserted into the multi-sample holder before undergoing sanding and polishing 
with a Struers Rotopol-22 polisher and an IntegralPol-25 polisher, respectively. The sanding and 
polishing conditions are listed in Table 2.1. The Rotopol-22 utilised increasingly fine-grained 
sandpaper disks to sand back the surface using water as the lubricant, while the integralPol-25 rotating 
platform with attached abrasive disks utilised lubricants containing fine particulates. Water was used 
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to wash the integralPol-25 platform between runs to prevent cross-contamination between the fine 
polishing lubricants. The sample holder was positioned off-centre relative to the abrasive disk to 
produce the desired surface polishing upon rotation.  
The polished sheets were immersed in acetone overnight to dissolve the super glue before 
washing in fresh acetone for 4-6 x 10 min as required to remove any remaining traces of the glue and 
other organic contaminants from the surface. The Ti sheets were then washed in milliQ water for 2 x 
10 min followed by immersion for 30 min in 35% nitric acid solution. The titanium sheets were then 
washed in 2 x milliQ water for 10 min followed by 2 x 70% ethanol for 10 min. The 70 µm thick titanium 
foils were cut to the required total size for the respective procedures before undergoing the nitric acid 
cleaning protocol described, minus the overnight acetone immersion to remove superglue.   
Table 2-1: RotoPol-22 and IntegralPol-25 sanding and polishing protocols 
RotoPol-22 
ISO/FEPA Grit 
designation (P) (Grit 
size) 
Normal Force 
applied during 
rotation (N)  
Time (min) Rotation speeds of the abrasive 
disks and the sample holder 
(RPM) 
Lubricant 
P 80 / 201 µm grit size 
30 1 
Abrasive disk = 150 
Sample holder rotation = 150  
Water 
50 1 
70 15 
P 120 / 125 µm grit size 70 2 
P 220 / 68 µm grit size 70 1 
P 500 / 30 µm grit size 70 1 
P 1200 / 15 µm grit size 70 1 
IntegralPol-25 
MD Largo – 9 µm grit 
size 
180 10 Abrasive disk = 150  
Sample holder rotation = 150 
Water – based 
diamond solution 
MD Chem - 0.09 µm grit 
size 
180 10 Abrasive disk = 150  
Sample holder rotation = 150 
(Counter rotation) 
OP-S colloidal 
silica 
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2.1.2 Plasma polymer coating deposition  
 
Titanium substrates (foils and sheets, collectively) were coated with radical-functionalised plasma 
polymer films (rPPFs) in the centre chamber of a three-chamber vacuum deposition system, shown 
schematically in Figure 2.1. Capacitively coupled radio-frequency (RF) power, produced by an RF 
generator (13.56 MHz Eni OEM-6) with a matching network (RFPP AM-5), and a DC pulsed substrate 
bias, produced by a RUP-6 DC pulsed voltage source (GBS-Electronik), were delivered to the lid-
mounted RF electrode (10 cm diameter) and the sample mounting plate (10 x 10 cm) inside the 
chamber, respectively. An InfiniiVision oscilloscope (DS-X 3024A, Agilent Technologies) was used to 
monitor the RUP-6 output. The gas flow rates were monitored via Alicat flow controllers and the ‘Flow 
vision’ software (Alicat Scientific, version 1.1.35). The reagent gasses were introduced via a shower-
head gas inlet, and the pressure was monitored by a Pfeiffer SingleGuage pressure gauge. The high 
purity N2, Ar, and C2H2 reagent gasses were obtained from BOC Australia. 
The Ti substrates and internal components of the deposition system were always handled with 
gloves as to prevent contamination with the oil from human skin. The Ti substrates were fixed to the 
sample mounting plate via double-sided conductive carbon or copper tape. The substrates were 
secured by applying gentle pressure with tweezers and the sample mounting plate slowly inverted to 
confirm attachment before being placed inside the chamber. The chamber was evacuated to below 1 
Torr with a screw backup pump (Ebara PDV250). The turbomolecular pump gate valve was then 
opened, and the turbomolecular pump (Edwards NEXT400) was used to evacuate the chamber to a 
base pressure below 5x10-5 Torr.  
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Figure 2.1. A schematic representation of the rPPF vacuum deposition chamber system. Insert: A top down 
view of the deposition chamber. 
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The substrates were plasma cleaned with argon at a gas flow rate of 40 standard cubic centimetres 
per minute (sccm). The turbomolecular pump gate valve was closed once the flow rate was stable to 
produce a working pressure of around 7x10-2 Torr. The pulsed high voltage RUP-6 was activated, and 
the output was adjusted to -500 V, with a frequency of 3 kHz and a pulse width of 20 µs.  An RF forward 
input power of 75 W was applied while the reflected power was minimised using the matching 
network (approximately 10 W). The argon cleaning was performed for 10 min, and the chamber 
returned to base pressure.  
Once the background pressure was reached, the gas flow rates of N2, acetylene, and argon were 
adjusted using the Alicat controllers to obtain the desired N:C ratios. The turbomolecular pump gate 
valve was closed, and the chamber pressure was adjusted to 1.1 x 10-1 Torr via the bypass valve. The 
deposition time was adjusted according to the desired coating thickness and the reagent gas ratios. 
The RUP-6 output remained at 500 V, pulse frequency of 3 kHz, and pulse width of 20 µs and the RF 
power was set to 50 W with a reflected power < 5 W. The timer was started immediately after the RF 
input power was matched. Finer adjustments to the RUP-6 voltage were performed during the 
deposition as necessary. The RF power, RUP-6 voltage, and gas flow were stopped after the required 
time, and the vacuum chamber vented for sample retrieval. 
 
2.1.3 Protein handling 
 
All protein stocks were prepared under sterile conditions to reduce the potential of 
contamination in quantification and cell assays. Fibronectin (FN) and osteocalcin (OCN) lyophilised 
powders were purchased from Sigma Aldrich (F2006 - purity > 85% and O5761 - purity >94%, 
respectively). Fibronectin was made into main stock solutions of 100 μg/mL (2.3 x 10-7 M) and 500 
μg/mL (1.1 x 10-6 M). Osteocalcin stocks were made to 100 μg/mL (1.7 x 10-6 M). The protein stock 
solutions were aliquoted into 1 mL volumes to limit freeze-thaw cycling and stored at -30˚C to extend 
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their lifetime. The FN-OCN fusion protein was supplied by Dr Jun-Hyeog Jang (School of Medicine, Inha 
University, Korea) in a 1000 μg/mL stock (2.5 x 10-5 M). The protein was left in the imidazole buffer 
and stored at 4˚C as instructed.  
To produce a working solution for protein immobilisation or cell assays, the desired protein was 
recovered from storage and equilibrated to 37˚C. The main protein stock was transferred into a sterile 
biological safety cabinet (BSC) as per proper aseptic technique. The required volume of main protein 
stock (V1) was calculated using the dilution equation (Equation 2.1) and added to the PBS to form the 
working solution. Any unused protein removed from the main stock was discarded. 
𝐶1𝑉1 = 𝐶2𝑉2      Equation 2.1 
Where: C1 is the main stock concentration, V1 is the required volume of the main stock, C2 is the 
working solution concentration, and V2 is the desired total working solution volume. 
 
2.1.4 Fibronectin – Osteocalcin fusion protein synthesis 
 
The FN-OCN fusion protein was produced by Jang et al. as previously described [287, 316]. The 
synthesis was initiated via polymerase chain reaction (PCR) amplification of the OCN and FN 
sequences. The OCN forward and reverse primers were 5′-TAGGAGCCCTCACACTCCTC-3 and 5′-
CTGGAGAGGAGCAGAACTGG-3′, respectively. A restriction site was generated using the forward 
primer 5′-AACAGATCTTACCTGTATCAATGGCTGGGA-3, for BglII site, and the reverse primer 5′-
AATGGTACCGACCGGGCCGTAGAAGCGCCG-3′, for KpnI site. The FN sequence was generated with the 
forward and reverse primers, 5′-GGTACCGGTCTTGATTCCCCAACTGG-3′ and 5′- 
AAGCTTTGGTTTGTCAATTTCTGTTCGG-3′, respectively. PCR was conducted over 30 cycles; annealing 
at 55 °C for 1 min; extension at 72 °C for 1 min, and denaturation at 94 °C for 1 min. The amplified PCR 
products were digested using BglII, KpnI and KpnI, HindIII then ligated into pBAD-HisB vector 
(Invitrogen, Carlsbad, CA), giving rise to a pBAD-HisB-FN-OCN. TOP10 cells were cultured at 37˚C 
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overnight in LB medium containing ampicillin after transformation. The bacteria were harvested and 
pelleted by centrifugation at 6000 g for 10 min, lysed in NaCl-Tris-EDTA (STE) buffer, and sonicated. 
The soluble extract was centrifuged at 13,000 g for 2 x 10 min. The supernatant containing the fusion 
protein was then purified by passing through a chromatography column containing a nickel-
nitrilotriacetic acid resin (Invitrogen, Carlsbad, CA) to 90% purity by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) analysis 
 
2.1.5 X-ray Photoelectron Spectroscopy procedure 
  
X-ray photoelectron spectroscopy (XPS) is a surface analysis technique used to measure the 
elemental composition of the surface of a solid material by probing it with high-energy x-ray photons 
[317, 318]. Incident photons of known energy cause electron to be ejected from the atomic orbitals. 
Only electrons within ∼ 10 nm from the surface have sufficient energy to escape the solid (Figure 2.2). 
The energy of the detected electrons is that of the photon minus the energy required to escape the 
atomic orbital and hence it provides information about the chemical identity and the chemical 
bonding of the atom from which the electron originates. The quantity of the ejected electrons is 
recorded as a function of electron kinetic energy loss. Since the incident radiation energy is known, 
the binding energy of the electrons can be determined using the following equation: 
𝐸𝑏𝑖𝑛𝑑𝑖𝑛𝑔 =  𝐸𝑝ℎ𝑜𝑡𝑜𝑛 − (𝐸𝑘𝑖𝑛𝑒𝑡𝑖𝑐 +  𝜙)  Equation 2.2 
Where the Ebinding , or binding energy (BE), of the electron correlates to the energy required to 
eject the electron from the atomic orbital position, Ephoton is the known energy input from the incident 
photons (hν), Ekinetic is the resultant detected energy of the ejected electrons by the detector, and φ is 
the work function of the detector itself. The chemical composition is then determined by comparing 
the resulting electron binding energies and quantities to the known atomic orbitals electron structures 
of the elements. 
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Figure 2.2. X-ray photoelectron spectroscope schematic. Reprinted with permission from [317]. 
 
The surface composition of rPPF-coated foil samples (0.8 cm x 1 cm) were examined using a SPECS 
SAGE spectrometer. The system was equipped with a monochromatic Al Kα (hν = 1486.7 eV) radiation 
source, a hemispherical analyser (PHOIBOS 150), and an MCD9 electron detector. The radiation source 
operated at 200 W (10 kV and 20 mA). The electron take-off angle was 90° with respect to the sample 
surface. The foils were affixed to copper sample holders and loaded into the examination chamber, 
which was evacuated to pressures below 5.0 × 10−8 mbar. The survey spectra were collected in an 
energy range of 0 − 1000 eV at a pass energy of 30 eV and a resolution of 0.5 eV. The resulting spectra 
were then analysed with the CasaXPS software (version 2.3.18PR1.0). 
The spectra were calibrated with reference to the 284.6 eV C1s peak and the peak regions 
isolated with the elemental detection function. The element peaks underwent linear baseline removal 
and area integration to determine the surface composition. The uncertainty associated with the 
elemental composition comes from the manual peak definition and baseline procedure. 
A high-resolution (0.1 eV) C 1s was collected at a pass energy of 20 eV and fitted to determine 
the ratios of different carbon-containing bonds. The peak baseline was subtracted, and the 
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component curves were fitted and added. The full width at half maximum (FWHM) and relative 
position constraints were applied to guide the fitting for the component curves. The predicted envelop 
was compared to the detected peak and the fitted component curves adjusted to obtain the closest 
possible match. An average of multiple ‘optimal’ fit values with uncertainty was reported for the high-
resolution component peaks. 
 
2.1.6 Fourier transform infrared spectroscopy (FTIR) 
 
Fourier-transformed infrared (FTIR) spectroscopy investigates chemical composition by measuring the 
infrared absorbances corresponding to vibrational and rotational oscillations of bonds in compounds 
with dipoles [319]. The Infrared (IR) region is commonly divided into near IR (400 to 10 cm-1), mid-IR 
(4000 to 400 cm-1) and far IR (14000 – 4000 cm-1). The instrumentation in this study utilised attenuated 
total reflectance (ATR) through a germanium crystal to measure the rPPF surface composition. IR light 
is passed through a crystal in physical contact with the surface under conditions creating total internal 
reflection within the crystal. However, at the site of contact, the IR beam partially penetrates into the 
sample in the form of an evanescent (or spatially decaying) wave  [320]. A general schematic for this 
process is shown in Figure 2.3. The specific frequencies corresponding to the excitation energies of 
the bond vibrations in the sample at the interface are absorbed, and the remaining IR frequencies are 
transmitted. 
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Figure 2.3. Schematic diagram of the ATR-FTIR spectrometer. 
 
The FTIR in attenuated total reflectance mode (FTIR-ATR) spectra from the Ti and rPPF samples 
were recorded using a DigiLabFTS7000 FTIR spectrometer fitted with a multibounce ATR accessory 
and a trapezium germanium crystal at an incidence angle of 45˚. The titanium and rPPF- coated foils 
(1.5 cm x 2 cm) were measured at a resolution of 4 cm-1 within the mid-IR range of 4000 – 850 cm-1 
and averaged over 500 scans. Pressure was applied evenly along the foil to ensure a firm crystal-foil 
interfacial contact. The contributions from Ti, CO2, H2O, and the air-crystal interface spectra were 
subtracted from the rPPF spectra using ‘Digilab Resolutions Pro 4.0’ software to leave only 
contributions from the rPPF coating. The spectral subtraction and baseline correction were carefully 
performed as over/under subtracting or incorrect baseline correction can introduce or remove 
spectral peaks. 
 
2.1.7 Contact angle and surface energy measurements 
 
The surface free energy (SFE) and wettability of an interface are important predictors of the 
biological interactions between a surface and the body, as discussed in Chapter 1, and can be 
determined by measuring the contact angles between solutions with different polarities and a surface 
(Figure 2.4). A common approach to calculating the SFE is to measure the contact angles of polar and 
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non-polar solutions and analyse the contact angles with the Owens–Wendt–Rabel–Kaelble (OWRK) 
model. The contact angle of a droplet is a result of the cohesive surface tension and the adhesive 
forces between the solution molecules and the surface. The internal angle produced at the liquid-solid 
interface is calculated from the reciprocal external angle formed by the vapour interfaces, and is 
substituted into Young’s Equation [321, 322]: 
𝛾𝑠𝑣 =  𝛾𝑠𝑙 +  𝛾𝑙𝑣  cos 𝜃     Equation 2.3 
Where: γsv is the surface energy of the solid-gas interface, γsl is the surface energy at the liquid-
solid interface, γlv is the surface energy of the liquid-gas interface, with cos θ being the internal contact 
angle. The OWRK model is used to calculate the γsl based on the polar and dispersive (non-polar) 
components of liquid-solid interface [323]. 
𝛾𝑠𝑙 =  𝛾𝑠𝑣 + 𝛾𝑙𝑣 − 2( √γ𝑠𝑣
𝐷 γ𝑙𝑣
𝐷 + √γ𝑙𝑣
𝑃 γ𝑠𝑣 
𝑃  )     Equation 2.4 
Where the γD and γP refer to the dispersive and polar components of a given surface, respectively. 
To calculate the surface free energy of the substrate (γsv) the accepted surface energy components for 
multiple test liquids are substituted into equation 2.4 and rearranging for γsv.  
 
Figure 2.4. Surface energy components of contact angle droplets. Reprinted with permission [321]. 
 
The surface energy of the PPF was examined using a Kru̎ss DS10 analyser equipped with a CCD 
camera. The contact angles of water (polar) and diiodomethane (non-polar) droplets (5 µL) were 
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measured on rPPF-coated foils. The contact angles were extracted from the captured images using 
the Kru̎ss drop shape analysis software (version 1.90.0.11) and averaged over multiple readings (n = 
5) with the sessile-drop method. The total, dispersive, and polar surface energies were then calculated 
by the Owens–Wendt–Rabel–Kaelble model.  
 
2.1.8 Electron paramagnetic resonance (EPR) spectroscopy 
 
Electron paramagnetic resonance (EPR) spectroscopy, also known as electron spin resonance 
(ESR) spectroscopy, measures unpaired electrons in a process similar to nuclear magnetic resonance 
(NMR) spectroscopy. EPR measures the change in electron magnetic moment (μe) under the presence 
of constant microwave energy and varying external magnetic field strength (B). The unpaired electron 
energy levels are shifted to produce Zeeman splitting [324, 325] according to: 
𝐸
±
1
2
= (±)
1
2
𝑔𝜇𝐵𝐵    Equation 2.5 
Where the energy of a spin state (E ±1/2) is determined by the g-factor, the Bohr magneton (μB), 
and the applied magnetic field (B). The sample is scanned with an increasing magnetic field until the 
constant microwave radiation causes photoelectric excitation of the electron. The positions and 
intensities of the spectral peaks allow for the determination of unpaired electron species and 
quantities. 
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Figure 2.5. A general schematic of an electron paramagnetic resonance spectrometer. Reprinted from [326]. 
 
 The concentration of unpaired electrons in the rPPFs deposited on polystyrene (PS) (25 μm, 
Goodfellow) were examined with a Bruker EMX PremiumX EPR spectrometer at room temperature. 
Polystyrene was used as metallic substrates are not compatible with the EPR detection process. The 
films deposited on PS were considered to be representative of those on titanium as PPFs are known 
to be substrate independent except for interface layers with a thickness less than approximately 10 
nm [286, 291, 327]. The PS control and rPPF – coated PS samples (7 cm x 8 cm) were rolled and inserted 
into quartz NMR tubes. The spectra for each time point (n = 6) were examined with a scan time of 
60.06 s using a centre field of 3513 G, modulation amplitude of 1.998 G, frequency of 100 kHz, and 
microwave frequency and power of 9.83 GHz and 0.025 W, respectively. The resonator detection 
cavity had a minimum signal to noise ratio of 400:1. A weak pitch (WP) control of known radical density 
(∼1 × 1013 spins/cm) was measured in conjunction with each sample set. The resulting spectrum was 
doubly integrated using Origin 8.5 to correlate the known linear radical density for the control within 
the 4 cm cavity to the area under the curve. This relationship was then used to determine the radical 
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density of the rPPF samples in the 4 cm x 8 cm examination region. The rPPF radial density was 
normalised to units of spins/cm3. 
 
2.1.9 Atomic force microscopy analysis  
 
Atomic force microscopy is a surface analysis technique that examines the 3D topology of a 
surface [328, 329]. A cantilever of a given shape and sharpness is traced along the surface (x-y plane) 
and the deflection of the tip (z plane) is measured via laser-induced current on the position-sensitive 
detector array (Figure 2.6). The signal is transferred through a feedback system where the laser 
deflection is converted into a physical height measurement. The cantilever tip can be tapped or remain 
stationary as the surface is being scanned. The cantilever tips can be modified with particular shapes, 
sharpness, and chemically-functionalities to investigate specific structures, compositions, or physical 
properties from the micro to nanoscales [328]. AFM can also be performed in aqueous or vacuum 
conditions and can be used for various nanolithography procedures. 
 
 
Figure 2.6. A representative schematic of an atomic force microscope [329]. 
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AFM was performed on Ti substrates to determine if surface topology was altered during the 
nitric acid cleaning or the rPPF deposition processes. The toluene and nitric acid cleaned Ti sheets and 
bare and rPPF-coated foils were examined with a molecular imaging PicoSPM atomic force microscope 
(AFM) at the Australian centre for microscopy and microanalysis (ACMM). The samples were 
examined as close to the preparation as possible to reduce the effects of surface artefact 
contamination (e.g. dust). The individual samples were attached to the sample plate for examination. 
A 0.6 μm sharp microlever (Park Scientific Instruments) was inserted into the probe and the cantilever 
laser was aligned to the tip. A random 30 μm x 30 μm section of the surface was selected, the detection 
and feedback parameters were optimised, and the surface traced for topology and roughness. The 
results were analysed with the ‘WSxM 5.0 Develop 8.5’ software as developed by Horcas et al. [330]. 
 
2.1.10 Enzyme-linked immunosorbent assay detection 
 
Enzyme-linked immunosorbent assay (ELISA) is a biochemical detection method for determining 
protein concentrations based on the specific interactions between antibodies, or immunoglobulins 
(Igs), and unique amino acid sequences in the target proteins [331]. The ELISA methodology in this 
study utilises a primary Ig that binds specifically to the target protein and a complementary secondary 
Ig conjugated with HRP that generates a colourimetric signal via the enzymatic breakdown of a TMB 
liquid substrate. A schematic outline of the ELISA process is shown in Figure 2.7. The samples were 
loaded into individual wells of a tissue culture well plate. Each ELISA test contained a negative bovine 
serum albumin (BSA) (Sigma Aldrich) control surface in triplicate to measure the background signal 
and an unblocked tissue culture plastic positive control surface to confirm successful ELISA detection. 
Each step is preceded by washing in PBS buffer to remove excess reagents. Step 1: Protein-
immobilised and negative control surfaces were incubated in a 5% w/v BSA blocking protein solution 
for 1 hr to block the non-functionalised parts of the surface. Step 2: The surfaces were incubated in 
primary antibody solution (1 hr). Step 3: The substrates were exposed to the secondary antibody 
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conjugated with HRP for 1 hr. Step 4: The samples were transferred to a clean well plate to eliminate 
signal contributions from antibodies adsorbed onto the well plate. The TMB substrate solution was 
added for 30 min. A colourimetric change from clear to blue was produced through the reduction 
reaction between TMB and peroxide catalysed by HRP. An equal volume of 0.2 M sulphuric acid was 
added to stop the reaction and the absorbance was read at 450 nm. 
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Figure 2.7. A schematic outline of the ELISA protein quantification process. 
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2.2 Cell maintenance and handling 
 
2.2.1 Cell media and buffer preparation 
 
Ham’s F12 media (51651C, Sigma Aldrich) was supplemented with fetal bovine serum (FBS) 
(12003C, Invitrogen), and Penicillin-Streptomycin (P.S) (P4333, Sigma Aldrich), were used to make 
complete cell media (c-media) for the Osteosarcoma MG63 tumour cells. The media was prepared in 
under sterile conditions inside a biological safety cabinet (BSC). FBS was heated to 56˚C for 1 hr for 
heat inactivation. Ham’s F12 and P.S were warmed to 37 ˚C. 50 mL of FBS (10% v/v) and 5 mL of 100 
μg/mL P.S (1% v/v) were added to the Ham’s F12 using a fresh pipette for each solution as to prevent 
cross-contamination. A 5 mL aliquot of c-media was transferred into a T25 cm2 cell culture flask 
(Corning) to test for contamination. The c-media was sealed with parafilm and stored in cold 
conditions (refrigerator). The remaining FBS and P.S were aliquoted into 50 mL and 15 mL volumes, 
respectively, and stored at -30 ˚C. 
Primary osteoblasts required a low glucose Dulbecco's Modified Eagle's medium (DMEM) (D5546, 
Sigma Aldrich). Non-osteogenic and osteogenic recipes of completed-DMEM (c-DMEM) were used for 
osteoblast maintenance. Both c-DMEM recipes contained 20% (v/v) FBS (100 mL) and 1% (v/v) P.S. (5 
mL). 50 μg/mL ascorbic acid (vitamin C) was added to the osteogenic media to promote osteoblast 
differentiation.   
Phosphate buffered saline solution without magnesium and calcium (PBS) was purchased from 
Sigma Aldrich (cat.56064C). 9.5 g of PBS powder was dissolved in 1L of deionised or milliQ water. The 
PBS solution was then sterilised by either a standard 2 hr ‘wet run’ autoclave routine or vacuum 
filtration with a 0.22 µm filter bottle-top vacuum filter (Corning). The sterilised PBS was stored under 
cold conditions. 
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2.2.2 MG63 osteosarcoma cell line culturing 
 
MG63 osteosarcoma cells are a permanent malignant cell line derived from a bone tumour. They 
are one of the three common cell lines used for orthopaedic research, along with the human-derived 
Sarcoma Osteogenic (SAOS-2) and the transformed mouse pre-osteoblast MC3T3-E1 cell lines [332].  
MG63 cells were provided by Dr W. Chrzanowski (Pharmacy) and Dr G. Yeo (CPC). A vial of frozen cells 
was retrieved from cryogenic storage in liquid nitrogen, equilibrated to 37˚C, and transferred into a 
15 mL tube with 5 mL of media. The cell suspension was spun down in a centrifuge at 1200 rpm for 5 
min. The supernatant was removed, the cell pellet resuspended in 2 mL of media, and transferred into 
T75 cm2 tissue culture flask (Falcon, Sigma Aldrich) with 20 mL of media.  
The cells were grown until they covered 80-90% of the surface, referred to as 80-90% confluence. 
The cells were washed twice with 5 mL PBS before the addition of 5 mL TrypLE express trypsin solution 
(Thermofisher Scientific). After the cells had detached from the flask (approximately 2-5 min), 5 mL of 
media was added to quench the TrypLE. The cell solution was transferred into a 15 mL tube and spun 
down at 1200 rpm for 5 min. The resulting pellet was resuspended in 2 mL of media and the cell 
concentration was determined via manual counting. 80 μL of 0.4% Trypan blue stain solution was 
transferred into a 1.5 mL Eppendorf tube followed by 20 μL of cell suspension. 10 μL of the mixed 
stained cell solution was transferred into one side of a haemocytometer and examined under a 
microscope. The average cell number per mL was calculated with equation 2.2 using the average cell 
number per square (0.1 µL) from 5 squares of the counting grid (Figure 2.8). Both sides of the 
haemocytometer were used to determine the cell suspension density for cell assays. Cell culture flasks 
containing complete media were then seeded at the required density for continued proliferation.  
Cell concentration (
𝑐𝑒𝑙𝑙
𝑚𝐿
) =  Cell average per 0.1 µL region xTrypan Blue dilution x 10,000   Equation 2.2 
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Figure 2.8. Standard Haemocytometer grid layout labelled with regions sampled for cell counting (A-E) 
 
2.2.3 Primary Osteoblast collection and culturing 
 
Primary osteoblasts were collected from sacrificed 7-week-old C57BL/6 mice following the 
accepted procedure [333, 334] at the Heart Research Institute (HRI). The experiments were conducted 
in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes. All personnel involved in the animal procedures have completed an approved animal care 
and ethics course. The abdomen was washed with ethanol. The femur, tibia, and fibula were cleaned 
and placed in a sterile Petri dish with PBS. The bones were transferred to a tube with 10 mL of 
collagenase II solution (heated to 37˚C) and mixed via shaking for 20 min. The samples were 
transferred to a fresh Petri dish where the epiphyses (ends of the bone) were opened and the marrow 
flushed out. The bone diaphysis (central parts of the bone) were cut into 1-2 mm2 pieces, washed 
several times with PBS, and incubated in 4 mL collagenase II solution at 37˚C. The solution was shaken 
vigorously every 30 min for 2 hr. The bone pieces were rinsed 3 times with media and the supernatant 
discarded. The bone fragments were transferred to a 6-well plate at 20-30 bone pieces per well. Non-
osteogenic media was added and the pieces were left to allow for osteoblast outgrowth. The cells 
typically migrated from the bone pieces after 3-5 days, being careful to avoid over-confluence around 
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the bone pieces, and were ready to be transferred after 11-15 days. The cells were trypsinated at 70 
- 80% confluence and transferred to a larger culture flask for cell expansion (seeding density 60 – 80 x 
104 cells /T175 flask). The OB cell subcultures were monitored through visual examination of the 
cellular morphology and staining with alizarin red. Any subcultures that indicated ingrowth of other 
cell types were discarded. 
 
2.2.4 Substrate seeding 
 
The Ti and rPPF coated 1 mm thick sheets, used for MG63 cell assays, were sterilised with UV light 
for 15 min on either side and transferred into individual wells of a 24-well plate (Corning). MG63 cells 
were suspended and seeded at a density of 10,000 cells/cm2, or 6500 cells per sheet, using a droplet 
seeding method. The droplet (approx. 80 µL) was left on the substrate surface for 2 hr to allow for cell 
attachment [335]. The well was gently filled to 1 mL and examined under a light microscope to 
visualise any cells displaced from the sheets. The samples were incubated at 37˚C and 4% CO2.  
The bare and rPPF-coated titanium foils were used for primary osteoblast investigations. The foils 
were cut to size (0.8 cm x 1 cm) and sterilised with UV light before being transferred into an 8-well 
chamber slide (Nunc®154534, Life technologies). Primary osteoblasts were seeded on foils at 4000 
cells per substrate in 0.4 mL of media, or 5000 cells/cm2. The media was replaced every 3 days. The 
end chamber of each row was seeded as a control to monitor cell health. 
 
2.2.5 Cellular proliferation assays 
 
MG63 cellular proliferation was measured at 1, 3, and 7 days post seeding using three cell assays: 
AlamarBlue (AB) metabolic assay, cell counting kit – 8 (CCK-8) proliferation assay, and cyQUANT DNA 
detection. The three tests were performed under dark conditions to reduce photobleaching and loss 
of signal specificity. Blank samples were run in conjunction with each assay for background 
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subtraction. The results were presented as background subtracted absorbances and proliferation 
ratios of day 1.  
AlamarBlue™ cell viability reagent (DAL1025, Thermofisher Scientific) is a non-toxic resazurin salt 
solution that acts as a cell metabolite, changing from blue resazurin to red resorufin as it is reduced. 
The cell media was removed, and the samples were incubated in 1 mL of AB solution (10% v/v in Ham’s 
F12 media) for 2 hr. After the allotted time, 150 μL aliquots were taken from each sample and the 
absorbance measured at 570 nm.  
The active compound in the CCK-8 proliferation assay is a non-toxic, soluble tetrazolium salt, 
WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, 
monosodium salt) (96992, Sigma Aldrich). The salt undergoes reduction reactions by dehydrogenase 
activities (NADP/NADPH+) within cells to produce a yellow formazan dye. The media was removed 
from the samples and replaced with 500 μL of 10% (v/v) CCK-8 solution. Aliquots from each sample 
were removed after incubation for 3 hr, and the absorbance was measured at 450 nm. 
CyQUANT NF is an endpoint assay that measures DNA quantity. The assay came as a multi-
reagent kit (#96992, Sigma Aldrich) and was mixed per the included instructions. Briefly, 11 mL of 1x 
buffer was made from milliQ water and the 5x Hank’s balanced salt solution (HBSS) concentrate 
provided. Next, a 22 μL aliquot of ‘component A’ DNA-binding dye reagent was added to the buffer (1 
/ 5,000 dilution). The cells were washed with PBS, 500 μL of cyQUANT solution was added to each 
well, and the samples were incubated for 30 min. 150 μL aliquots were removed, and the fluorescence 
was read at 485 nm excitation /530 nm emission. 
The primary osteoblasts were examined with the 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) endpoint cell assay due to the slow 
proliferation rates of the cells. The MTS assay produces yellow formazan through reaction with 
NADP/NADPH+ like the CCK-8 assay. MTS was made up to 40 mM concentration and frozen into 1 mL 
aliquots. Following cell growth for the allotted time, the media was removed from the samples 
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followed by the addition of 160 µL of non-supplemented DMEM and 40 µL of MTS solution. The 
samples were incubated for 2 hr under dark conditions followed by the transfer of 100 µL of each 
sample into a 96 well plate. The absorbance was read at 490 nm. 
 
2.2.6 Alizarin red mineralisation assays 
 
The mineralisation capacity of the different protein conditions was examined with the AlizarinRed 
stain (ARS), which binds to calcium. ARS was purchased from Sigma Aldrich (#A5533) and the solution 
made up via the standard protocol [155, 336, 337]. 0.7 g of ARS powder was dissolved in 25 mL of 
distilled water. The pH of the solution was measured and adjusted to the final pH range of 4.1-4.3 with 
0.5% (v/v) ammonium hydroxide solution. The solution was made up to 50 mL with distilled water, 
adjusting the pH as required. Phosphoric acid was used to increase the pH if excess ammonium 
hydroxide was added. The final solution was stored in a 50 mL falcon tube and wrapped in aluminium 
foil to prevent light exposure. 
The Ti, rPPF, and protein-functionalised surfaces were prepared as described in Chapters 2 and 
5, and primary osteoblasts were seeded at 10,000 cells per well. The cells were incubated up to 1 
month, and the media was replaced every 3 days. After gentle washing in PBS, the respective samples 
were stained with ARS for 2 hr. The excess was removed, and the samples washed gently before being 
placed into individual Eppendorf tubes. 400 μL of 10% (v/v) acetic acid was added before vortexing 
and heating to 85˚C for 10 min.  The samples were then centrifuged at 16000 g for 15 min, and 50 μL 
of ammonia hydroxide added to each sample. 200 μL aliquots were transferred to a 96 well plate, and 
the absorbance read at 405 nm. 
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2.2.7 Mesenchymal stem cell differentiation 
 
The upregulation of the alkaline phosphatase (ALP) enzyme in mesenchymal stem cells (MSCs) is 
a common approach for detecting osteoblastic differentiation, as MSCs do not produce the enzyme in 
their undifferentiated state. The detection can be performed through a variety of methodologies, such 
as enzyme-linked immunosorbent assays (ELISAs), polymerase chain reactions (PCR), and fluorescence 
imaging [336, 338-340]. ALP production in MSCs was measured via fluorescent microscopy following 
a similar protocol to cell attachment and spreading (Chapter 2).  
MSC harvesting and culturing were performed as described in the standard protocol [341]. Long 
bones were collected from 7-week-old mice and washed with 70% EtOH. The ends of the bone were 
removed as for the primary osteoblast extraction. The bone marrow was flushed out with DMEM 
solution and collected. The marrow solution was resuspended and filtered through a 70 μm cell sieve 
before being transferred to a well plate for culturing. The cells were cultured in complete DMEM 
without ascorbic acid as not to stimulate osteoblast differentiation and the media changed every 3 
days. The cells were expanded to working stocks and closely monitored for differentiation or ingrowth 
of other cell types. MSCs were seeded at 8000 cells/well on the protein-functionalised rPPF surfaces 
in an 8-well chamber slide. The media was changed every 3 days to ensure sufficient nutrients. After 
10 and 20 days, the cells were fixed to the foils with EtOH and washed in 0.1% Triton solution. The 
surfaces were stained with Vector Red Alkaline Phosphatase dye (Vector) and DAPI fluorescent 
mounting media (Agilent). The surfaces were then examined with a Zeiss Axio Imager.Z2 fluorescence 
microscope at 365/560 nm for the ALP dye and 358⁄461 nm for the DAPI. The images were analysed 
with the ‘ImageJ’ software. The degree of differentiation was determined by dividing the total area of 
the Vector Red (µm2) by the number of cells (blue nuclei). 
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2.3 Microscope procedures 
 
2.3.1 Cell preparation for scanning electron microscopy examination  
 
Titanium sheets were prepared for examination with a scanning electron microscope (SEM) to 
visualise the effects of cell growth on the coating integrity. MG63 osteosarcoma cells were grown on 
Ti sheets according to the proliferation protocols (Chapter 2) for 3 days and 7 days. The samples were 
washed with PBS, incubated in a 4% paraformaldehyde (PFA) solution for 1 hr, and stored in PBS buffer 
at 4˚C until visual examination. The SEM imaging was performed at the Australian Centre for 
Microscopy and Microanalysis (ACMM). The samples were immersed for 1 hr in a 1% Osmium 
tetroxide (OsO4) solution for secondary fixation and image contrast and washed with milliQ water. The 
samples were then dehydrated with increasing concentrations of ethanol from 30% to 100% (v/v) for 
3 x 5 min. A pre-made solution of 2% (v/v) hexamethyldisilazane (HDMS) was pipetted onto the sample 
in minimal volumes and any remaining solution was removed after 2 min. The samples were affixed 
to SEM mounting stubs with carbon tape and coated with a 20 nm layer of gold via sputtering (Emiteck 
K550X sputter coater). The samples were imaged with secondary emission detection using a neoscope 
JEOL tabletop SEM at a 10 V electron acceleration and working height of 48 mm. Three samples for 
each condition were examined at multiple sites (minimum n = 5) for each surface.   
 
2.3.2 Fluorescence microscopy for cellular attachment 
 
Cellular attachment after 1 hr was examined via fluorescent staining. Ti foils were cut to 0.8 cm x 
1 cm and sterilised under UV light before being transferred to an 8 well multichannel slide 
(Nunc®154534, Lifetechnologies). Primary osteoblasts and MG63 cells were seeded at the density of 
10,000 or 24,000 cells per well, respectively [171, 342, 343]. After 60 min, the seeding media was 
removed, the foils gently washed with PBS, and the attached cells fixed with 70% ethanol for 10 min. 
The samples were stored in PBS under cold conditions if imaging could not be performed on the same 
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day. After storage as required, the foils were exposed to a 0.1% Triton-x100 (Sigma Aldrich) solution 
for 10 min to remove potential contaminants. The cytoskeleton of the attached cells was stained with 
approximately 200 μL of an actinRED555™ (Invitrogen) solution per well for 10 min; 2 drops of 
actinRED555™ per mL of PBS. The nuclei were stained with 4',6-Diamidino-2-Phenylindole 
dihydrochloride (DAPI) fluorescent mounting media (Agilent) and the cells were placed between two 
glass slides for examination. Direct handling of the surfaces was minimised to reduce artefacts. 
The samples were examined at 540/565nm excitation/emission for actinRED555™ and 
358/461nm for DAPI with a Zeiss Axio Imager.Z2 fluorescence microscope. The magnification and 
fluorescence exposure time were kept constant between samples. The surfaces were examined under 
5x (≈ 4mm2) and 10x (≈ 1 mm2) magnifications. Minor post-capture adjustments were made uniformly 
to the colour intensity of all images using the “best fit” colour adjustment in ‘ZEN Pro’ software (Zeiss).  
The image analysis software “ImageJ” was used to calculate the average cell quantities and sizes. 
The images were split into the red and blue component colours and thresholded for the maximum 
distinction between cells. The image was further processed to fill holes and watershed connected cells. 
The resulting image was analysed for the number of cells and their average area. A minimum size 
limitation of 40 and 20 pixels was applied for cell size (red - cytoskeleton) and cell number (blue - DAPI) 
measurements, respectively, to exclude background artefacts. These results were tabulated and 
averaged over a series of images (n > 9) for the respective samples. A visual representation of the 
image analysis process is outlined in Figure 2.9. 
Page 104 of 214 
 
 
Figure 2.9. Pictographic flow of ImageJ analysis process. 
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Chapter 3 – Material optimisation and biological screening 
 
In this chapter, the mechanical and biological properties of radical-functionalised plasma polymer films 
(rPPFs) deposited with nitrogen atomic concentrations ranging from 0 -30%N are investigated. The 
rPPF coated titanium sheets were seeded with MG63 osteosarcoma cells for in vitro examinations of 
coating stability under cellular proliferation conditions. Scanning electron microscopy images 
demonstrated significantly greater robustness on the coatings with higher nitrogen content, with a 
preference towards the 30%N rPPF. Cellular proliferation assays showed little difference between the 
rPPF coatings, with a slight preference for the 20%N over the 30%N. Hence, both the biologically 
favoured 20%N rPPFs and mechanically favoured 30%N rPPFs were selected for further investigations.  
 
3.1 Introduction 
 
The primary requirements for orthopaedic surface coatings are a strong coating-substrate 
interfacial adhesion and coating robustness sufficient to resist the partial or complete removal of the 
coating, referred to as delamination. The products of a delamination event can trigger adverse 
immune reactions similar to that of metallic and ceramic wear [344-348], thereby, reducing the 
effectiveness and lifetime of the implant. Recently, plasma polymer films (PPFs) have garnered great 
interest in biomaterials and biointerfaces applications, such as orthopaedic implants, because of their 
versatile and substrate-independent surface chemistry [208, 243, 244, 253, 254, 349-352]. The 
resistance to delamination of PPFs depends on the initial layer formation and can vary based on the 
mechanical and chemical properties of the underlying substrate [286, 304]. For a constant precursor 
gas composition and other plasma deposition conditions, such as plasma input power, the PPFs can 
have vastly different mechanical adhesion on silica, stainless steel, and titanium. Radical-
functionalised PPFs (rPPFs) have been characterised on silicon wafers [283] and applied to stainless 
steel for cardiovascular stents [353-355], but had not been deposited on titanium before this work 
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[58, 356, 357]. Therefore, a new set of deposition parameters are needed for the deposition of a 
robust rPPF onto titanium surfaces that is capable of resisting delamination.  
Two approaches can be taken to improve the mechanical properties of PPFs: i) The formation of 
graded PPF layers, and ii) the incorporation of nitrogen. Graded layers eliminate a sharp substrate-
film interface prone to failure by creating a region through which the properties of the substrate 
gradually transfer to those of the film. Dramatically improved adhesion has been achieved through 
either compositional grading [264, 285], where the film deposition begins with deposition of the 
underlying metal onto a argon plasma cleaned substrate with the precursors gradually changing to 
the composition of the carbon-based film, or through structural grading [309], where a highly cross-
linked polymer layer is deposited onto the substrate to form a mechanically stiffer and robust 
foundation followed by the less cross-linked soft layers that contain the desired chemical 
functionalities. The graded layers approach is commonly applied to chemically-functionalised PPFs 
(cPPFs) due to the poor interfacial adhesion resulting from the low plasma specific energies used to 
deposit the desired chemical functionalities [231-234]. The second approach for improving the PPF 
mechanical properties is by the incorporation of nitrogen as applied typically to diamond-like carbon 
(DLC) coatings [358-360]. Nitrogen introduces a series of trigonal chemical structures, such as imines, 
amides, imides, and enamines, that possess a lower bonding energy configuration and increase the 
ratio of sp2:sp3 (double: single) bonded carbon [361, 362], improving the elasticity and robustness of 
the coating. The deposition of rPPFs utilises pulse bias voltages applied to the substrate for the 
embedding of radicals in the form of dangling bonds created via enhanced ion bombardment. At the 
initial stages of film growth these energetic ions implant into the substrate producing a small “ion-
stitched” graded layer at the interface that provides strong rPPF adhesion [285]. The energetic 
deposition and extensive cross-linking also results in higher degrees of internal coating stress. The 
incorporation of nitrogen into the structure of rPPFs increases the coating elasticity, reducing stress 
and producing robust rPPF coatings capable of withstanding the abrasive surgical implantation 
procedures. 
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The inclusion of nitrogen groups has also been shown to increase the biological affinity of PPFs 
[237-243]. The nitrogen-containing groups can become protonated under physiological pH conditions 
(pH 7.4), e.g. NH3+, and increase cell attachment and proliferation [237, 238, 243]. They can also 
increase the mineralisation of bone lineage cells and encourage the osteoblastic differentiation of 
stem cells [243, 244]. In this chapter, rPPF coatings are deposited on titanium surfaces from a variety 
of N2:C2H2 reagent gas ratios. The resulting coatings were examined with bone lineage cells to identify 
the reagent gas ratio that produces the most robust coating and any biological preferences.  
  
3.2 Methods 
 
3.2.1 Substrate preparation and rPPF deposition 
 
Titanium substrates were cleaned with the nitric acid protocol outlined in Chapter 2 and with an 
organic solvent protocol [58, 356, 357]. For nitric acid cleaning, the sheets were washed in acetone 
and water (2 x 10 min each) followed by a 30 min immersion in a 35% nitric acid solution. The sheets 
were then washed with water and ethanol (2 x 10 min each). In the organic solvent protocol, the 
sheets were sonicated for 1 x 10 minutes in 10-15 mL of toluene, acetone, and 70% ethanol (v/v), rPPF 
coatings were deposited on Ti substrates as outlined in Chapter 2. Briefly, the cleaned titanium 
substrates were treated with argon (Ar) plasma for 10 minutes (flow rate = 40 standard cubic 
centimetres per minute (sccm), RF power = 75 W, substrate bias voltage = −500 V, pulse width = 20 
μs, pulse frequency = 3 kHz). The rPPF coatings were then deposited with varying reagent gas ratios. 
The flow rate of argon was kept constant at 15 sccm while the flow rates of acetylene (C2H2) and 
nitrogen (N2) were varied as shown in Table 3.1. The chamber working pressure was adjusted to 0.11 
Torr and the coatings deposited to a thickness of approximately 60 ± 7 nm (RF power = 50 W, substrate 
bias voltage = −500 V, pulse width = 20 μs, pulse frequency = 3 kHz). The chamber was vented, and 
the samples were stored under aerobic conditions. 
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Table 3-1. Plasma deposition gas ratio conditions 
Nitrogen (sccm) Acetylene (sccm) Argon (sccm) Deposition time for 60 
± 7 nm layer (min, sec) 
0 15 15 1 min, 30 sec 
5 10 15 1 min, 44 sec 
10 5 15 2 min, 50 sec 
12.5 2.5 15 6 min, 32 sec 
 
3.2.2  X-ray photoelectron spectroscopy  
 
The surface composition of rPPF coated substrates with varying N:C ratios were examined after 
24 hours, according to the x-ray photoelectron spectroscopy (XPS) protocol outlined in Chapter 2. 
Briefly, the survey spectra were collected in an energy range of 0−1000 eV at a pass energy of 30 eV 
and a resolution of 0.5 eV. High-resolution (0.1 eV) C 1s spectra were collected at a pass energy of 20 
eV. The chamber pressure was below 5.0 × 10−8 mbar. The resulting spectra were then analysed with 
the CasaXPS software. 
 
3.2.3 Cell preparation for scanning electron microscopy examination  
 
Titanium sheets were prepared for examination with a scanning electron microscope (SEM) to 
visualise the effects of cell growth on the coating integrity as outlined in Chapter 2. MG63 
osteosarcoma cells were grown on Ti sheets according to the proliferation protocols (Chapter 2) for 3 
days and 7 days. The samples were washed with PBS, incubated in a 4% paraformaldehyde (PFA) 
solution for 1 hr, and stored in PBS buffer at 4˚C until visual examination. The samples were fixed with 
1% Osmium tetroxide (OsO4) solution then dehydrated with increasing concentrations of ethanol and 
a pre-made solution of 2% (v/v) hexamethyldisilazane (HDMS). The samples were affixed to SEM 
mounting stubs with carbon tape and coated with a 20 nm layer of gold via sputtering (Emiteck K550X 
sputter coater). The samples were imaged with secondary emission detection using a neoscope JEOL 
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tabletop SEM at a 10 V electron acceleration and working height of 48 mm. Three samples for each 
condition were examined at multiple sites (minimum n = 5) for each surface.   
 
3.2.4 Atomic force microscopy analysis  
 
AFM was performed on Ti substrates to determine if surface topology was altered during the 
nitric acid cleaning or the rPPF deposition processes, as described in Chapter 2.1.8. Briefly, the toluene 
and nitric acid cleaned Ti sheets and bare and rPPF-coated foils were prepared as close to the 
examination date as possible and examined with a molecular imaging PicoSPM atomic force 
microscope (AFM). The individual samples were attached to the sample plate, a 0.6 μm sharp 
microlever (Park Scientific Instruments) was inserted into the probe, and the cantilever laser was 
aligned to the tip. A random 30 μm x 30 μm section of the surface was selected, the detection and 
feedback parameters were optimised, and the surface traced for topology and roughness. The results 
were analysed with the ‘WSxM 5.0 Develop 8.5’ software as developed by Horcas et al. [330]. 
 
3.2.5 Cell proliferation assays 
 
The MG63 cellular proliferation was measured with the AlamarBlue (AB), cell counting kit – 8 
(CCK-8), and cyQUANT proliferation assays as per the protocols in Chapter 2. Briefly, the Ti and rPPF 
coated sheets were sterilised with UV light for 15 min per side and transferred into individual wells of 
a 24-well plate (Corning). The MG63 cells were seeded at a density of 10,000 cells/cm2, or 6500 cells 
per sheet, using a droplet seeding method. The droplet was left on the substrate surface for 2 hr to 
allow for cell attachment. The well was gently filled with 1 mL of cell media and placed in the incubator. 
Cellular proliferation was measured at day 1, day 3, and day 7 post seeding. The proliferation assays 
were performed under dark conditions to reduce photobleaching. Blank samples were run in 
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conjunction with each assay for background subtraction. The results were examined as background 
subtracted signal intensity and proliferation ratios compared to day 1. 
 
3.3 Results and Discussion 
 
3.3.1 rPPF deposition parameters and the resulting C:N ratios 
 
The rPPF coatings with varying N2: C2H2 gas ratios were deposited to a thickness of 60 ± 7 nm as 
determined by ellipsometry. The reagent gas ratios and deposition times are shown in Table 3-1. By 
increasing the N2: C2H2 ratio from 0: 15 to 12.5: 2.5, the incorporated nitrogen increased from 0 at% 
to 28 at% while the carbon content decreased from 93 at% to 66 at% (Figure 3.1). The majority 
concentration of carbon is typical for amorphous films deposited from carbon-based monomers that 
have been highly cross-linked through ion bombardment. Nitrogen is incorporated predominantly 
through the radical fragmentation-recombination reactions in the plasma before deposition and can 
also be included through ion implantation mechanisms. The presence of oxygen suggests that the 
rPPF-coatings have undergone autoxidation reactions between carbon-centred radicals and 
atmospheric oxygen [207, 292, 363].  
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Figure 3.1. The atomic composition of rPPF coatings deposited with varying nitrogen and acetylene precursor 
gas ratios.  
 
The C1s high-resolution peaks were curve-fitted with components at binding energies 
corresponding to C−C/C−H (284.6 ± 0.5 eV), C−O/C−N (286.5 ± 0.5 eV), C=O/N−C=O (287.5 ± 0.5 eV), 
and COOH (289 ± 0.5 eV) [309, 353, 364]. The C-H/C-C groups are the dominant component of C 1s 
spectra (red peak at 284.6 eV in figure 3.2). The C-O/C-N components increased relative to the C-H/C-
C components with the N2:C2H2 reagent gas ratios. The C-N/C-O peak fittings, along with the minor 
contributions of the COOH functionalities (green peak at 289 ± 0.5 eV), also illustrated autoxidation of 
the rPPF surfaces through the formation of predominately singly bonded carbon-oxygen groups. The 
organic polar groups formed as autoxidative products are known to be beneficial for cellular 
attachment and proliferation [243]. Overall, the nitrogen content in the rPPF coatings was shown to 
increase proportionally to the N2:C2H2 ratio and these coatings were further examined for robustness 
and biocompatibility. 
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Figure 3.2. High-resolution C1s fitting of rPPFs with increasing nitrogen content after 24 hours of atmospheric 
exposure post deposition. The increase in the C-N/C-O fitted peak (blue) compared to the C-H/C-C fitted peak 
(red) indicates the incorporation of nitrogen roughly proportional to initial reagent gas ratios. The presence of 
the COOH fitted peaks (green) in conjunction with the C-N/C-O peak in the 0%N coating indicates autoxidation 
of the rPPF-coatings. 
 
3.3.2 rPPF robustness in biological environments 
 
To test the mechanical suitability of the varying N:C ratio rPPF coatings in biological 
environments, bare and rPPF coated Ti sheets were seeded with MG63 cells and examined for coating 
failure with a scanning electron microscope at the day 3 and day 7. The day 3 images demonstrated a 
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predominately homogenous cell distributed on the bare Ti surfaces, while all rPPF surfaces produced 
cell clustering. A closer x600 magnification examination showed more pronounced coating swelling 
and creases on the 0%N and 10%N surfaces compared to the 20%N and 30%N surfaces (Figure 3.3). 
The day 7 images showed the formation of cell multilayers across all surfaces. The multilayers 
produced on the Ti surfaces were homogenously distributed while the multilayers on rPPFs resembled 
converging grain boundaries as suggested by the day 3 cell distributions. Cell loss was observed on all 
surfaces due to the preparation procedures. However, coating and cell layer delamination were 
frequently observed on the lower nitrogen rPPF coated surfaces. The higher 20%N and 30%N rPPF 
coated surfaces experienced considerably less cell loss and virtually no coating delamination.  
Overall, the incorporation of nitrogen and the strong adhesion at the rPPF-titanium interface, 
through the formation of titanium carbide bonds [286], resulted in a more robust film for the 20%N 
and 30%N rPPFs, with a slight improvement in the case of the 30%N coating. 
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Figure 3.3. Representative scanning electron microscopy (SEM) images of cell formation and rPPF integrity on 
the varying N% coatings at day 3 and day 7 growth time points compared to titanium. Day 3 x80 magnification 
shows clustered cell growth on all rPPF surfaces. rPPF swelling is visible for the 0%N and 10%N coatings under 
x80 (scale = 200 μm) and x600 (scale = 50 μm) magnifications. Day 7 SEM examination showed coating 
delamination on the 0%N and 10%N rPPFs.
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3.3.3 Surface topology analysis 
 
An increased surface roughness produced through surface modification techniques, such as acid 
and plasma treatments [365], has been shown to produce statistically significant improvements in the 
attachment, proliferation, differentiation, and mineralisation of bone lineage and stem cells over their 
smoother counterparts [76, 243, 366, 367]. Therefore, any potential difference in surface roughness 
produced from the nitric acid cleaning or rPPF deposition must be taken into account to determine if 
any biological preference exists for particular rPPF N:C ratios. The nitric acid and toluene cleaned Ti 
sheets produced a root mean square (RMS) roughness of 32 ± 6 nm and 34 ± 8 nm in a 30 μm x 30 μm 
square, respectively. Both nitric acid (Figure 3.4.a) and toluene (Figure 3.4.b) cleaned sheets showed 
pitting from the manufacturing, and skewness and kurtosis from polishing processes (Figure 3.4 c,d). 
The uncoated and 20%N rPPF-coated Ti foils showed no significant differences in measured roughness, 
with both possessing an RMS roughness between 7-18 nm as measured over 1 µm2. Therefore, surface 
roughness changes through cleaning treatments or coating deposition can be eliminated from 
consideration as contributing factors to the observed differences in cell behaviour. Any observed 
differences can, therefore, be attributed to the effects of the changes in nitrogen incorporation. 
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Figure 3.4. Representative surface topology traces obtained by AFM. The surface traces of polished Ti sheets 
cleaned via the nitric acid protocol (a) and the toluene protocol (b) showed little topological differences between 
the two surfaces. The surface profiles of nitric acid (c) and toluene (d) show similar height variations across the 
surface taking into account the kurtosis. No significant difference was found between the average surface RMS 
roughnesses. 
 
3.3.4 In vitro biological evaluation 
 
The biological compatibility of the varying N:C ratio rPPFs was examined with the AlamarBlue 
(AB), cell counting kit 8 (CCK-8), and cyQUANT NF cell assays. The cellular proliferation followed similar 
trends across the three assays with some deviation based on the targeted compound or detection 
pathway, as shown in Figure 3.5. Coating delamination was occasionally observed on the lower N% 
rPPF samples. 
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The AB absorbances and growth ratios are shown in Figure 3.5.a and Figure 3.5.b, respectively. 
The day 1 assay showed no significant difference between Ti and the rPPFs except for a lower 
absorbance on the 30%N surfaces. The day 3 absorbances again showed no statistically significant 
differences except for an increase on the 10%N rPPF. The day 3 growth ratios had statistically 
significant increases over Ti for the 10 - 30%N rPPFs. The day 7 absorbance results showed reductions 
in signal for the rPPF surfaces but no statistically significant differences in growth rate. Cell number 
determination by CCK-8 assay (Figure 3.5. c,d) showed similar levels of NADPH+ expression across all 
time points for all surfaces. No significant variation was found between the Ti and 0%N - 20%N rPPFs. 
The 30%N rPPFs produced a statistically significant reduction in absorbance signal relative to the bare 
Ti surfaces at the day 3 and day 7 time points. The cell growth rates also showed a lower ratio for the 
30%N rPPF coatings. The CyQUANT assays were used to determine the DNA quantity in each sample 
(Figure 3.5. e, f). The day 1 fluorescence results were equal within uncertainty across all surfaces. The 
day 3 results deviated from the previous assays and showed a reduction of DNA on the 0%N and 30%N 
surfaces relative to the Ti and 10 - 20%N rPPFs. No statistically significant differences in DNA quantity 
were observed by day 7 compared to the titanium surfaces. The MG63 growth rates of the surfaces 
were equivalent within uncertainty across all time points except for a significant increase on day 3 for 
the 10%N rPPF only. 
The coating stability is of primary importance for implantable devices, but the biological 
compatibility must also be examined as to prevent adverse immune responses. The incorporation of 
nitrogen has been shown to increase the biological acceptance through the presence of positively 
charged nitrogen-containing groups at the interface [237-243], and as such, the 20%N and 30%N were 
expected to be the most biologically beneficial. However, the proliferation assays showed that the 
30%N coating produced somewhat lower cell signals than the other surfaces. No significant 
differences in cell growth rates were observed between the 0 - 20%N rPPFs and the 30%N rPPFs. The 
lower cellular proliferation behaviour can be attributed to the lower initial cell attachment compared 
to the other surfaces observed in the day 1 measurements. Overall, by combining the SEM imaging of 
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coating robustness, which showed that only the coatings with over 20% nitrogen content had 
appropriate robustness, and the general biocompatibility observed across all rPPF coatings, the 
biologically favoured 20%N and the mechanically favoured 30%N rPPF coatings were selected for 
continued examination as potential orthopaedic coatings. 
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Figure 3.5. MG63 cell proliferation assay results over one week. AlamarBlue measurements of cell metabolism 
showing the absorbance (a) and proliferation ratio (b) over 7 days. Cell counting kit -8 measurements of the 
NADP/NADPH+ energy production indicating the relative live cell quantities as absorbance (c) and the growth 
rate (d). The DNA quantity was investigated with cyQUANT NF measuring the relative increases in cell mitosis 
shown as fluorescence data (e) and proliferation ratio (f). Mean values (n < 6) are shown. Uncertainties are 
determined by the standard deviations. Statistical significance (p < 0.05) against titanium is shown for day 1 (*), 
day 3 (#), and day 7 ($). No significant trends were found with the exception of a reduction in the cell quantity 
initially attached on the 30%N coating. 
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3.4 Conclusion 
 
A primary requirement for an orthopaedic coating is the ability to resist delamination during the 
surgical implantation process and the extended time in the body. In this chapter, a series of ratios for 
nitrogen: acetylene reagent gases were investigated to determine the precursor gas composition that 
produced robust and biologically compatible rPPF surfaces. The XPS results showed that increasing 
the N2:C2H2 gas ratio resulted in greater surface atomic concentrations of nitrogen. The SEM images 
demonstrated that the 20%N and 30%N rPPF coatings were more mechanically stable than the 0%N 
and 10%N. All rPPF surfaces demonstrated biocompatibility with the 30%N producing less initial cell 
proliferation compared to the 20%N, potentially due to a reduced cell attachment. Overall, the 
biologically favoured 20%N coating and mechanically favoured 30%N coating were selected for further 
examination. 
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Chapter 4: The effect of plasma polymer ageing on rPPF elemental 
composition and cellular activity 
 
 
In this chapter, the potential for radical-induced cytotoxicity originating from rPPF surfaces with high 
radical flux occurring soon after deposition was investigated. The surface properties of rPPFs were 
examined over the course of two weeks, and the changes were shown to be derived from the radical 
decay. rPPF surfaces with low and high radical fluxes showed no cytotoxicity to MG63 osteosarcoma 
cells or primary osteoblasts.  
Results from this chapter have been published in “Cellular responses to radical propagation from ion-
implanted plasma polymer surfaces” by Callum A.C. Stewart, Behnam Akhavan, Miguel Santos, 
JuiChien Hung, Clare L. Hawkins, Shisan Bao, Steven G. Wise, Marcela .M.M. Bilek, 2018, Applied 
Surface Science, https://doi.org/10.1016/j.apsusc.2018.06.111 [343].  
 
4.1 Introduction 
 
Biomolecule-functionalisation has the potential to vastly improve the biocompatibility and 
longevity of implanted medical devices, with significant improvements to patients’ quality of life [368, 
369]. Plasma polymers represent a promising method to bio-functionalise devices on the 
manufacturing scale [288].  Chemical-functionalised and radical-functionalised plasma polymer films, 
(cPPFs and rPPFs, respectively) have been proven to possess reproducible surface chemical 
composition regardless of the substrate chemistry, geometry, and size [286, 308, 353, 370-372] 
allowing for the biomolecule-functionalisation of any underlying surface.  
Both classes of PPFs are affected by a process known as ageing in which the surface chemistry 
changes over time [292, 300]. PPF ageing occurs due to the oxidation of carbon-centred radicals 
(referred to as autoxidation) [207, 292], chemical group oxidation [208, 254], and polymer chain 
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diffusion (hydrophobic recovery) [309, 373]. These ageing phenomena are explained in detail in 
Chapter 1.3.3.3. When relying on surface chemical groups for functionalisation, chemical instability 
from functional group oxidation [208, 212, 216, 240, 253, 254, 299, 300] and hydrophobic recovery 
[309, 373] may limit the applications in practice,  and can greatly impact the long-term functionality 
of cPPFs and cellular interactions [374]. Although strategies have been developed to mitigate 
hydrophobic recovery [375], cPPFs should be used immediately after deposition for best performance 
of biomolecule functionalisation.  
In the case of rPPFs, ageing does not directly affect the ability to immobilise biomolecules 
providing that sufficient reactive radicals are available in the coating structure [264, 355, 356, 376]. 
Biomolecule-functionalisation can be performed immediately after deposition or after various ageing 
periods (e.g. 15 days [58] or up to 4.5 months [283]) with only minimal changes in immobilisation time 
to account for variations in the flux of radicals diffusing to the surface. Hydrophobic recovery occurs 
over time, initially due to the conversion of radicals to polar groups upon reaction with atmospheric 
constituents at the surface. The polar groups possess lower free energy than the radicals they replace, 
and as such, the surface becomes more hydrophobic but stabilises in a mildly hydrophilic state [377]. 
In previous works, the rPPFs were aged to allow for the stabilisation of surface chemistry prior to 
biomolecule functionalisation and use in a biological context.  
The higher concentration of radicals at short ageing times, however, may have adverse biological 
consequences. Radical species are produced naturally as a consequence of cellular metabolism, and 
cells have antioxidative countermeasures to prevent oxidative damage [378, 379]. However, high 
concentrations of radicals are known to be cytotoxic. An imbalance favouring radical species 
production compared to their removal can induce oxidative stress within the cell, which can lead to 
DNA, protein, and lipid damage, dysregulation of signalling cascades, and cell death through apoptosis 
or necrosis [380, 381]. Radical-mediated cellular damage and dysfunction have been implicated in 
ageing and the pathology of numerous diseases, including osteoarthritis and osteoporosis [381, 382]. 
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Therefore, there are concerns about the potential radical-induced cytotoxicity of fresh rPPFs. The high 
flux of radicals emerging from fresh rPPFs may induce oxidative stress in the attached cells, resulting 
in cell death and/or detrimental biological activity. 
This chapter investigates the effects of radical flux and rPPF ageing on cells by comparing cellular 
responses to fresh and aged rPPFs. The surface chemistry, surface energy, and radical density of rPPFs 
were characterised at a series of time points from 15 min. to 2 weeks. Titanium was used as the 
substrate due to its extensive application in biomedical devices [34, 383]. Bone lineage cells, i.e. 
primary mouse osteoblasts and the MG63 bone osteosarcoma cell line, were chosen to reflect the 
prominence of Ti in orthopaedic devices [35, 383, 384]. The time points of 4 hours (fresh) and 11 days 
(aged) post-deposition were selected for cell studies as they represent the earliest possible implant 
time following surface treatment and the ageing conditions for rPPFs used without inducing 
cytotoxicity in prior experiments, respectively [58, 353, 356]. 
 
4.2 Methods 
 
4.2.1 Substrate preparation 
 
rPPF coatings were deposited onto Ti sheets (0.8 mm x 0.8 mm x 1 mm) and foils (70µm 
thickness) as described in Chapter 2. In short, the Ti substrates were cleaned with the nitric acid 
protocol before rPPF deposition. The surfaces were plasma cleaned with Ar for 10 min (Mass flow 
rate = 40 sccm, working pressure = 7 x 10-2 Torr, RF power = 75 W, substrate bias voltage = -500V, 
pulse frequency = 3 kHz, pulse width = 20 µs), followed by coating with 30%N rPPF. The rPPF was 
deposited for 6.5 min with mass flow rates of 2.5 sccm for acetylene, 12.5 sccm for nitrogen, and 15 
sccm for argon. The RF power was 50 W and the working pressure was 0.11 Torr. The rPPF coated 
substrates were stored in air as required. 
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4.2.2 X-ray photoelectron spectroscopy (XPS) 
 
A more comprehensive explanation of the XPS procedure is presented in Chapter 2. Briefly, the 
survey spectra were collected in an energy range of 0−1000 eV at a pass energy of 30 eV and a 
resolution of 0.5 eV. High-resolution (0.1 eV) C 1s spectra were collected at a pass energy of 20 eV. 
Pressures during measurement were below 5.0 × 10−8 mbar. The resulting spectra from the rPPF-
coated samples (0.8 cm x 1 cm) were then analysed with the CasaXPS software (version 2.3.18PR1.0). 
 
4.2.3 Fourier transform infrared spectroscopy (FTIR) 
 
The surface chemistry of the uncoated and rPPF coated Ti sheets was performed via FTIR as 
described in Chapter 2. Briefly, the FTIR spectra of the Ti and rPPF samples were recorded using a 
DigiLabFTS7000 FTIR spectrometer fitted with a multibounce ATR accessory and a trapezium 
germanium crystal at an incidence angle of 45˚. The titanium and rPPF- coated foils (1.5 cm x 2 cm) 
were measured at a resolution of 4 cm-1 within the mid-IR range of 4000 – 850 cm-1 and averaged over 
500 scans. The contributions from Ti, CO2, H2O, and the air-crystal interface spectra were subtracted 
using ‘Digilab Resolutions Pro 4.0’ software. 
 
4.2.4 Contact angle measurements and surface energy calculations 
 
The surface energy was measured as described in chapter 2. Briefly, the contact angles of water 
(polar) and diiodomethane (non-polar) droplets were measured (drop volume ≈ 5 µL). The contact 
angles were measured from captured images (n = 5), and the total, dispersive, and polar surface 
energies were calculated by the Owens–Wendt–Rabel–Kaelble model.  
4.2.5 Electron paramagnetic resonance (EPR) 
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The measurement of the concentration of unpaired electrons in the rPPF coating is described in 
detail in Chapter 2. Briefly, the rPPF was deposited on 25 μm polystyrene (PS) (7 cm x 8 cm). The 
spectra for each time point (n = 6) were examined alongside a weak pitch (WP) control of known 
radical density (∼1 × 1013 spins/cm) for calibration. The radical density of the rPPF samples was 
calculated in spins/cm3. 
 
4.2.6 Cell maintenance and examination 
 
The responses of MG63 cells and primary osteoblasts to extended contact with the bare Ti and 
coated substrates were examined. The cells were collected and maintained using the procedures 
outlined in Chapter 2. The rPPF substrates were prepared and sterilised before cells were seeded onto 
the surface, as per the protocols described there. Cell attachment fluorescent microscopy assays for 
both cell lineages on bare Ti foils, 4 hours (fresh) and 11 days (aged) rPPF surfaces were performed as 
described in Chapter 2. MG63 cell proliferation was examined with AlamarBlue assays at day 1, 3, and 
7 for comparison against previous publications, while, the proliferation of primary osteoblasts was 
examined with the MTS assay because of the slow doubling time of the cells and the consequent need 
to detect subtle proliferation differences. 
 
 
4.3 Results 
 
4.3.1 Surface analyses  
 
The surface chemistry as a function of ageing time was studied using XPS and FTIR spectroscopy. 
The composition of the rPPF, measured by XPS survey elemental scans as a function of ageing time is 
shown in Figure 4.1. The carbon content remained relatively unchanged, fluctuating around 
approximately 70%. Comparing the chemical composition of the fresh sample with that of a sample 
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aged for 14 days highlights the increase in oxygen concentration and the decrease in nitrogen. The 
nitrogen atomic concentration decreased from 24.69% for the as-deposited coating (15 min. after 
deposition) to 19.01% after 14 days of ageing; while the oxygen content increased from 5.96% to 
10.23%. These changes in surface chemistry derive from the well-documented autoxidation processes 
initiated from carbon-centred radicals [207, 292]. It has been shown in previous publications for ion-
implanted polymer substrates [385, 386] as well as rPPF surfaces [353], that nitrogen groups, such as 
the nitrile ions [283, 353], can react with air to form volatiles, e.g. nitroxide gasses (NOx), that diffuse 
out of the polymer [385]. The thermally activated production of nitrogen-containing volatiles during 
ageing could account for the loss of nitrogen over time.  
 
Figure 4.1. Elemental composition of the radical-functionalised PPFs as a function of time determined by XPS. 
The spectral analysis indicates a stable carbon atomic concentration of approximately 70% within error across 
all time points, while the oxygen atomic concentration increased considerably over the 14 days period (6% to 
10%). The corresponding decrease in nitrogen atomic concentration from 25% to 19% suggests the release of 
nitrogen from the rPPF during the oxidative process. The measurement uncertainty shown is derived from 
instrument sensitivity together with the accuracy of integration range selection in the CasaXPS software. 
 
Comparative analysis of curve-fitted high-resolution C1s spectra of the coatings with different 
ageing times, shown in Figure 4.2, further elucidates the variations of oxygen- and nitrogen- 
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containing carbon species. The C-C/C-H, C-N/C-O, N-C=O/C=O, and COOH chemical bond peaks are 
fitted at energies 284.6 ± 0.5, 286.5 ± 0.5, 287.4 ± 0.5 eV, and 289 ± 0.5 eV, respectively [286, 309, 
353]. The proportion of the total carbon counts attributed to each fitted component as a function of 
ageing time is summarised in Table 4.1. The increase in the N-C=O/C=O and COOH components as a 
function of ageing time is in agreement with the increase of atomic oxygen concentration measured 
in the survey spectra (Figure 4.2). The notable increase between the as-deposited and day 14 
conditions reiterates the significant changes to the surface chemistry through autoxidation. 
These element composition changes resemble those observed for cPPFs. The changes observed 
in XPS oxygen after 24 hours is consistent with those observed for ethylene/ ammonia and allylamine 
cPPFs [240, 387], which showed an oxygen increase of approximately 11% along with a nitrogen 
reduction of approximately 5.5% [240]. Amine-containing cPPFs lost up to 70% of the functional NH2 
groups over two weeks, although the total nitrogen content did not vary significantly due to the 
formation of amides and other oxidative products [234, 240]. The loss of nitrogen and autoxidation in 
the rPPF-coatings follow similar overall trends [388].    
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Figure 4.2. C1s XPS spectra recorded after various ageing times: 15 min, 4 h, 24 h, 48 h, 7 days, 11 days, and 14 
days time points. The red, blue, magenta and green lines represent the fitted component peaks: C-C/C-H, C-N/C-
O, N-C=O/C=O, and COOH bond energy spectra. C-C/C-H at 284.6 eV, C-N/C-O at 286.5 eV, N-C=O/C=O at 287.4, 
and COOH at 289.0 [286, 309, 353]. The percentage contributions of the total C 1s peak for each component at 
each time point is shown in Table 4.1. The percentage contribution of the N-C=O/C=O component (magenta) 
increases substantially over time from approximately 1.2% of the total area after 15 min of ageing to almost 10 
% by 14 days. The COOH component (olive/green) drastically increases from 1.1% of the total area after 15 min 
ageing to 2.4% after 14 days. 
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Table 4.1. The percentage concentration of the four fitted peaks to the C1s high-resolution peak. 
Percentage 
contribution 
to C1s peak 
15 min 4 Hr 24 Hr 48 Hr 7 days  11 days  14 days  
       
C-C/C-H 76.3 ± 0.9  66.1 ± 3.3  71.8 ± 0.2 69.7 ± 3.5 66.0 ± 0.7 66.2 ± 0.6 64.4 ± 0.3 
C-N/C-O 21.0 ± 1.6 29.7 ± 1.5  24.9 ± 1.2 25.7 ± 1.5 28.4 ± 1.0 27.3 ± 0.5 24.8 ± 0.5 
N-C=O/C=O 
COOH 
1.2 ± 0.3 
1.1 ± 0.4 
2.7 ± 0.3 
1.5 ± 0.2  
1.6 ± 1.2 
1.5 ± 0.3 
2.1 ± 1.8 
2.4 ± 0.6 
3.5 ± 0.9 
2.1 ± 0.5 
4.3 ± 1.1 
2.2 ± 0.6 
8.4 ± 1.4 
2.4 ± 0.7 
 
 
 
Figure 4.3 presents the FTIR spectra of rPPFs at various times after deposition, recorded over the 
spectral range of 3500 - 1000 cm-1. The broad peak observed in the region 1690 – 1450 cm-1 originates 
from the rPPF [58] and consists of C=O, C=C, C=N, N-H, and potentially also aromatic chemical groups. 
The peaks observed in the 1450 – 1250 cm-1 region derive from C-C, N-O, C-H, NH3+, and NO3- group 
vibrations, while C-O and C-N peaks are located in the 1200 – 1000 cm-1 range [58, 283, 389, 390]. The 
fluctuation in baseline signal from 3500 – 2500 cm-1 appears due to the subtraction of water and other 
background components, exacerbated by the differences in signal strengths. A relative increase in the 
intensity of oxygen species in the rPPF is observed when comparing the spectra of the as-deposited 
coatings (15 min.) to those of samples aged for various times (Figure 4.3). The separation of the 
nitrogen and carbon species peaks, observed between 1690 – 1450 cm-1 in the as-deposited spectrum, 
is lost as the rPPF ages. The emergence of peaks in the 1450 – 1250 cm-1 and 1200 – 1000 cm-1 regions 
compared to the as-deposited coating, corresponding to C-O, C-H, and C-C groups, further shows the 
formation of oxygen-containing groups as a function of ageing time.  The increase in oxygen group 
vibrations in the FTIR spectra agrees with the changes in surface chemistry indicated by the XPS data 
(Figure 4.1, 4.2 and Table 4.1). These FTIR spectral changes as a function of time are similar to those 
observed in the ageing of amine- and carboxyl- functionalised cPPFs deposited from ethylene, 
excluding the signature of the specific chemical functional groups [388, 391, 392].  
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Figure 4.3. ATR-FTIR spectra showing rPPFs surface chemistry after ageing times of 15 minutes, 4 hours, 11 days, 
and 14 days. Increasing quantities of oxygen-containing species are observed in the aged coatings, as 
demonstrated by an initial increase in double bonded oxygen groups at 4 hours (1690 – 1450 cm-1) and the 
subsequent increase in singly bonded groups at 11 days (1450 – 1250 cm-1). The labels showing the chemical 
groups are noted at their reported wavenumbers. Three dashed boxes have been used to separate the 1690 – 
1450 cm-1, 1450 – 1250 cm-1, and 1200 – 1000 cm-1 regions. 
 
The varying surface energy (SE) of the rPPFs was monitored via contact angle measurements. The 
water contact angle (WCA) and corresponding SE values are plotted as a function of ageing time in 
Figure 4.5. The WCA increased sharply from the as-deposited 41.5˚ ± 1.0˚ to 56.0˚ ± 1.0˚ at 48 hours, 
after which the WCA plateaued with fluctuations within uncertainty (blue curve in Figure 4.4). The 
diiodomethane contact angle increased continually from the as-deposited 27.0˚ ± 1.5˚ to 40.5˚ ± 0.5˚ 
at day 14. The contact angles for both water and diiodomethane were used to calculate the surface 
energy of the rPPFs. The total SE, shown in red in Figure 4.4, decreased overall as a function of time 
from an as-deposited 66.8 ± 0.5 mN/m2 to 54.5 ± 0.3 mN/m2 at 14 days. The reduction in surface 
energy and resulting decrease in wettability is a well-studied process called hydrophobic recovery, 
and it is also observed for cPPFs [295, 373, 387, 393-395]. The surface energy reduction observed in 
cPPFs is attributed to the oxidation of the chemical-functional groups [208, 240]. Over long time scales 
(t > week), the contact angles of cPPFs and rPPFs stabilise at similar values, however, there are 
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differences in the short time scale (t < week) water contact angle behaviour. In the case of cPPFs, the 
chemical degradation processes of the functional groups may lead to temporary reductions in WCA, 
such as amine functionalities converting to amides and imines [396]. In contrast, rPPFs typically have 
lower initial WCAs compared to cPPFs due to the high fluxes of radicals diffusing to the surface. The 
increases over time in the rPPF WCAs correspond to the energy differences between the strongly 
polar, reactive radicals diffusing to the rPPF surface from within the coating post-deposition and the 
more stable polar groups formed through their autoxidation [270, 354]. Wettability, as measured by 
WCA, has major effects on protein adsorption and subsequent biological response to a surface.  
Dowling et al. [374] demonstrated that MG63 cell line attachment was optimised for WCA in the range 
57˚- 64˚ on both rough and smooth polymeric surfaces. Therefore, the formation of polar groups from 
autoxidation and the transition from a highly hydrophilic to a mildly hydrophilic state suggests that 
the aged rPPF would present a more beneficial surface for cells.  
 
 
Figure 4.4. Surface energy and water contact angle for rPPF deposited on Ti foils as a function of time after 
deposition. The graph demonstrates a decrease in total surface energy corresponding to an increase in water 
contact angle, caused by plasma polymer autoxidation, radical recombination, and polymer chain migration. The 
green lines indicate the 4-hours and 11 days time points selected for cell assays in this study. Error bars 
correspond to standard deviations. 
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The quantification of unpaired electrons associated with radicals within the rPPF was performed 
via EPR. Figure 4.5.a shows the unprocessed spectra of rPPFs after 4 hours (fresh) and 11 days (aged) 
compared to the polystyrene control. The peaks are symmetrical and centred around 3505 G 
consistent with the radicals being predominantly carbon-centred (G-Factor = 2.002). The broadness of 
the peaks could show that there are a variety of carbon-centred radical species within the rPPF [58], 
and may also reflect that the radicals appear at the rPPF surface, which would also cause anisotropic 
spectra. A comparison of the two rPPF spectra shows a 27.1 ± 3.6 % reduction in signal intensity. The 
radical densities for the rPPF conditions calculated, following the double integration of the EPR spectra 
and comparison to the weak pitch (WP) standard, are plotted over 14 days (Figure 4.5.b). The resulting 
curve follows the double exponential decay previously observed for other plasma immersion ion 
implanted polymeric substrates [269, 385, 397]. The rPPFs demonstrate a rapid initial loss of radicals 
between the first reading at approximately 30 minutes and 24 hours, in-keeping with the trend of 
surface oxidation, after which the radical density loss tails-off. 
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Figure 4.5. a) The EPR spectrum of fresh and aged rPPF deposited on polystyrene. Double integration of the 
resulting spectra after background subtraction and scaling to the control, revealed a 27.1 ± 3.6 % loss in unpaired 
radical electrons between the 4 hours and 11 days time points. b) The radical density decay curve fitted to the 
double exponential trend, Y=A0 + A1*exp(-x/t1) + A2*exp(-x/t2) [269].The total radical loss from the initial 
measurement to the 14 days of examination demonstrates an approximately 60% reduction in radical density. 
 
The radical decay kinetics demonstrate a double exponential decay curve; Y=A0 + A1*exp(-x/t1) + 
A2*exp(-x/t2). The coefficients derived from the radical decay curve are A0 = 6.297 ± 0.256 x1017, A1 = 
3.236 ± 0.202 x1017, t1 = 6974 ± 1675, A2 = 9.130 ± 0.699 x1017, and t2= 152.2 ± 18.1; where A1 and A2 
are the multiplying constants, t1 and t2 are the respective time constants. These coefficients align with 
other plasma immersion ion implanted polymeric substrates treated for 240 seconds [269]. Overlaying 
Page 134 of 214 
 
the data for the fresh and aged conditions, the fresh rPPFs fall into the radical ageing region governed 
by rapid surface oxidation, and hence, possess a higher flux of reactive radicals than the aged rPPF 
which is governed by slower kinetics (lower radical flux). The rPPFs showed a radical density of 1-2 
orders of magnitude greater than conventional cPPFs deposited in the absence of enhanced ion-
bombardment [58, 353, 398]. The significantly increased radical density enables rPPFs to covalently 
immobilise biomolecules even after extended ageing times [283], meaning that the radicals described 
by the slower decay kinetics provided sufficient radical flux to the surface for biomolecule 
functionalisation. The high flux of rapidly decaying autoxidative radicals at early time points 
highlighted the potential for radical-derived cytotoxicity and warranting investigation. 
 
4.3.2 Cellular probing of rPPF surfaces 
 
The response of primary osteoblasts (OBs) (Figure 4.6) and MG63 cells (Figure 4.7) to the two 
rPPF samples aged for 4 hours (fresh) and 11 days (aged), as marked in Figures 4.2-5, were examined. 
These assays were performed to determine if the observed differences in surface chemistry, radical 
density, and surface energy would affect the immediate cell attachment and longer-term 
proliferation. Primary osteoblasts revealed no statistical difference in attached cell quantity between 
the two rPPF surfaces, with the average cell density of 89 ± 26 cells per field of view (x5 magnification) 
for the fresh and 100 ± 17 cells per field of view for aged surfaces, as shown in Figure 4.6.a. The cell 
attachment observed on the aged rPPF surface was significantly greater that of the bare titanium (75 
± 20 cells per field of view). Figure 4.6.b shows that the spreading of the OBs on fresh and aged rPPF 
surfaces, 1209 ± 58 µm2 and 1099 ± 199 µm2 respectively, were significantly larger than that on 
titanium alone, 774 ± 58 µm2. No significant difference was observed between the two rPPF surfaces. 
Representative fluorescence microscopy images of the cell attachment and spreading are presented 
in Figures 4.6.c-e. The elevated cell attachment and spreading observed on fresh and aged rPPFs 
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compared to bare Ti can be attributed to the presence of organic carbon and nitrogen groups, which 
have previously been shown to enhance cellular attachment and proliferation [243]. 
The MTS assay results, as shown in Figure 4.6.f, demonstrated no significant difference between 
the surfaces after 3 days of proliferation. The detected absorption signals for the Ti, fresh, and aged 
rPPF surfaces were 0.79 ± 0.11, 0.70 ± 0.11, and 0.66 ± 0.13, respectively. No significant difference 
was observed between the proliferation results of the two rPPF surfaces with absorbances for the 
fresh and aged surfaces being 1.05 ± 0.05 and 0.99 ± 0.04 for 7 days, 1.16 ± 0.03 and 1.19 ± 0.06 for 
11 days, and 1.31 ± 0.12 and 1.22 ± 0.10 for 14 days, respectively. This behaviour is consistent with 
the attachment and spreading data presented in Figure 4.6.a-b. The Ti absorbances were 1.19 ± 0.09, 
1.32 ± 0.07, and 1.44 ± 0.14 for the 7 days, 11 days, and 14 days time points, respectively. Overall, no 
significant difference was observed between the attachment and spreading or proliferation behaviour 
of the fresh and aged rPPF surfaces. These results indicate that the increased radical flux at the surface 
does not significantly alter cell metabolic activity compared to non-treated surfaces.  
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Figure 4.6. Osteoblast cell attachment (a) and spreading (b) on Ti, fresh rPPF, and aged rPPF. No significant 
difference (n.s.) was observed between the results for the fresh and aged rPPF surfaces. Fluorescence 
microscopy images of OBs stained with actinRED555 (red) and DAPI (blue) at 10x magnifications for Ti (c), fresh 
(d), and aged (e) rPPFs. No significant differences were observed between the two rPPF surfaces for cellular 
proliferation (f).   
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MG63 osteosarcoma cells were used to further probe the attachment and proliferation trends 
observed for the primary osteoblasts. The cell attachment and spreading results are shown in Figure 
4.7. a,b, with representative images for Ti, fresh rPPF, and aged rPPF in Figure 4.7.c-e. The attached 
cell numbers for fresh and aged rPPFs were 652 ± 108 and 742 ± 119 cells per field of view (x5 
magnification), respectively. These values are significantly higher than that of the Ti control (456 ± 116 
cells per field of view). The MG63 cells were significantly more spread on the rPPFs with average cell 
sizes of 696 ± 18 µm 2 and 619 ± 62 µm 2 for the fresh and aged surfaces respectively, compared to the 
Ti control, 489 ± 45 µm2. Again, the cells showed no preference for either the fresh or aged surface 
suggesting that the difference in radical flux between the surfaces does not affect the cellular 
responses.  
The AlamarBlue (AB) proliferation assays (Figure 4.7.f) produced absorbances of 67 ± 10, 98 ± 33, 
and 284 ± 28 for Ti on day 1, 3, and 7, respectively. Fresh rPPFs produced values of 66 ± 9, 95 ± 25, 
and 314 ± 43, while aged rPPFs had absorbances of 80 ± 7, 111 ± 31, and 358 ± 17. No statistical 
difference was observed between the fresh and aged rPPFs as predicted by the attachment and 
spreading. The cells reached confluence by day 7 and commenced mineralisation on all surfaces. 
Significance was seen between the day 7 Ti and aged sheets. This reflects the previously seen increase 
in cell attachment and spreading, given that the proliferation rates were equal across all samples. 
Overall, no significant differences were observed between the rPPF surfaces. Both surfaces increased 
cell affinity, and no radical-induced cytotoxicity was observed. The MG63 assays confirm the results 
observed in the primary osteoblasts; that rPPFs do not demonstrate radical-derived cytotoxicity. 
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Figure 4.7. MG63 Cell attachment and proliferation on untreated Ti, and the fresh and aged rPPF surfaces. The 
average cell number (a) and spreading (b) was increased significantly on the rPPFs compared to the Ti foils, 
where P < 0.05. However, no significance was observed between the rPPF surfaces. The elevated cell number 
can be visually observed by fluorescence microscopy. The images show cells on Ti (c), fresh (d), and aged (e) 
rPPFs. The proliferation as determined by AlamarBlue metabolism assays show a statistically significant increase 
between the aged rPPF compared to Ti sheets, but no significance between the two rPPF conditions (f). 
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4.4 Discussion 
 
Biomolecule-functionalisation utilising radical-functionalised plasma polymers represents a 
promising method of providing biological cues on the surfaces of biomedical devices which is readily 
translatable into manufacturing [288]. The functionalisability of rPPFs is derived from radicals in the 
form of unpaired electrons, whose density is highest immediately after polymerisation. The non-
specific covalent binding of macromolecules upon contact and reaction with emerging radicals allows 
for simple, single-step surface functionalisation with antimicrobial and osteogenic biomolecules [58, 
376]. However, a high flux of radicals in biological systems is known to generate oxidative stress in 
cells, and hence, there is a potential that fresh rPPF surfaces could elicit radical-induced cytotoxicity. 
An investigation of fresh and aged rPPFs with primary osteoblasts and MG63 osteosarcoma cells 
revealed that the higher flux of radicals in the fresh rPPFs produces no detrimental effects on either 
bone lineage cell type. The biocompatibility of the rPPFs was shown to be similar to that of titanium, 
with significant increases in initial cell attachment and spreading observed on both rPPF surfaces 
compared to titanium alone.  
The improvements in attachment and spreading observed on the rPPFs is believed to stem from 
the favourable oxidation and wettability of the coatings, and the lack of cytotoxicity is attributed to 
the inability of radicals to propagate through the biomolecule backbones [399]. When the rPPFs are 
placed in in vitro cell culture medium, the surface becomes coated with biomolecules from the 
medium that are covalently immobilised upon contact via reactions with radicals that have 
propagated to the surface from within the rPPF [264, 269, 386]. The unpaired electrons preferentially 
react with side chain groups [400, 401]. Reactions with the protein backbone may occur at the α-
carbon sites [400], but do not propagate through the peptide bonds along the protein backbone [399]. 
Cells then interact with the surface according to the biomolecules presented and their conformations 
[48, 50]. If the surface is favourable, the cells will establish an extracellular matrix (ECM) for 
proliferation and other biological functions. Should any free products of radical reactions at the 
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protein-surface interface penetrate through the cell wall into the cytoplasm, there are antioxidative 
enzymes, such as superoxide dismutase (SOD) and catalase. These enzymes regulate and remove 
reactive oxygen species and oxidative stress produced through metabolic functions [402]. The results 
demonstrate that the radical fluxes to the surface of freshly prepared rPPFs have minimal negative 
effects on the biological affinity and proliferation of bone lineage cells, suggesting that rPPFs, and 
other radical functionalised PP products [390], are appropriate for biological applications at any ageing 
time. Their ease of functionalisation makes them attractive platforms for the creation of 
simultaneously antibacterial and osteogenic implant surfaces.  
 
4.5 Conclusion 
 
Biomolecule functionalisation of medical devices, especially load bearing orthopaedics, 
represents the potential for vastly improving the quality of life for patients and the longevity of 
implanted biomedical devices through optimal tissue integration. The functionalisation potential of 
radical-functionalised plasma polymer films (rPPFs) was shown to be unaffected by ageing, but 
concerns existed regarding the potential for radical-induced cytotoxicity. The rPPFs were examined 
over 2 weeks of ageing. The potential for radical-induced cytotoxicity due to the higher radical flux of 
the fresh samples was examined with primary osteoblasts and the MG63 cell line. Enhanced cell 
attachment and spreading, as well as proliferation equivalent to titanium, was observed for both cell 
lineages on all rPPFs, regardless of ageing time. The biocompatibility is attributed to the mild 
hydrophilicity of the oxidised surfaces and the retention of native protein conformations. Radical-
induced damage to cells is limited by the inability of radicals to propagate along the peptide backbones 
of immobilised biomolecules. In conclusion, rPPFs demonstrate cellular affinity even when radical 
fluxes through the surface are at their highest. Their inherent ease of biomolecule functionalisation 
suggests a translatable approach for surface engineering of implantable orthopaedic devices. 
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Chapter 5: Quantification of protein-functionalised rPPF surfaces and 
the development of multi-protein interfaces.  
 
This chapter reports the development of radical-functionalised plasma polymer film (rPPF) based 
multifunctional and multi-protein interfaces. Enzyme-linked immunosorbent assays (ELISAs), derived 
from specific peptide sequence detection, were optimised for the proteins of interest and used to 
determine the optimum incubation concentrations for surface functionalisation. The monolayer 
protein solution concentrations for fibronectin, osteocalcin, and the fusion protein containing 
functional fragments of both fibronectin and osteocalcin were determined to be 15 µg/mL. The fraction 
of covalently bonded surface protein was found to be between 60% and 80% of the monolayer ELISA 
signal, depending on the protein. A series of rPPF surfaces co-immobilised with ratios of fibronectin: 
osteocalcin were developed and compared with the fusion protein functionalised surfaces.  
The results from this chapter are reported in “Multifunctional protein-immobilized plasma polymer 
coatings for orthopedic applications.” by Callum A.C. Stewart, Behnam Akhavan, Juichien Hung, Shisan 
Bao, Jun-Hyeog Jang, Steven G Wise, and Marcela M.M. Bilek (Accepted; ACS Biomaterials Science and 
Engineering). 
 
5.1 Introduction 
 
Protein-functionalisation of surfaces stemmed from peptide functionalisation, with only a few 
publications appearing through the early 1990’s [103, 167, 168, 403]. Since then, protein-
functionalisation has expanded into many interdisciplinary fields involving biological and medical 
applications, including titanium-based orthopaedics. Surface immobilisation of proteins and peptides 
through adsorption, chemical covalent linking, or physical covalent methods, allows for the 
bestowment of specific biological functions to titanium orthopaedic surfaces to overcome their 
biologically inert nature. A comprehensive evaluation of these surface immobilisation approaches can 
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be found in Chapter 1.  Protein-functionalisation can reduce the potential for post-operative 
complications that require revision surgeries to correct [1], such as antibiotic-resistant biofilm 
formation [7, 404-406] or fibrotic encapsulation of the implant from negative foreign body reactions 
(FBR) [3-5]. 
The single protein approach to biomolecule functionalisation has shown some success [57, 407, 
408], but a deeper understanding of the osseointegration process reveals that a multifunctional 
protein-coated surface is required. The synergistic combination of biological functionalities would 
allow for increased cellular attachment in conjunction with more rapid bone formation, leading to 
greater osseointegration.  A few avenues have been explored for the multifunctionalisation of 
biointerfaces. One approach investigated the immobilisation of an incomplete monolayer of protein 
onto a biologically-active linker molecule, thereby expressing properties from both the linker molecule 
and the protein [145-147]. Another avenue to multi-functionalisation is the immobilisation of cocktail 
solutions containing multiple proteins onto a single surface through physical adsorption or chemical 
methodologies [316, 409-412]. However, immobilisation from protein cocktails faces the same hurdles 
as immobilisation from single protein solutions, namely displacement by the Vroman effect for 
physically adsorbed proteins or the need to control complicated wet chemical reactions to achieve 
covalent attachment. The ratio of the proteins on the functionalised surface is difficult to control and 
does not reflect that in the solution due to differences in the relative protein surface affinities and 
protein-protein complexing. An alternative approach is to use a series of multiple protein solution 
exposures to achieve a multi-protein functionalised surface, but unfortunately, this approach is not 
feasible for most immobilisation methodologies, due to protein displacement when the layers are 
physically adsorbed, or the potential for reagent incompatibilities and reversible or side reactions in 
chemical linker methodologies. However, the on-contact covalent immobilisation capability of radical-
functionalised plasma polymer films (rPPFs) may enable controllable multi-functionalisation using 
multiple single protein exposures to form successive covalently immobilised partial monolayers.  
Page 143 of 214 
 
An alternative direction to multi-functionalisation involves the immobilisation of synthetic 
multifunctional biomolecules, known as fusion proteins [316, 411]. Fusion proteins are synthesised 
through recombinant processes to incorporate multiple peptide sequences responsible for various 
cellular interactions into a single protein [413], allowing for surface functionalisation via simpler single 
molecule immobilisation methodologies. A few fusion biomolecules have been utilised for 
orthopaedic applications such as a branched antibacterial/attachment protein [414], a composite 
attachment protein [124, 415], and an attachment/signalling protein (fibronectin/BMP-2 fusion) 
[416].  
In this study, the non-specific bonding capacity of the radical-functionalised plasma polymer films 
(rPPFs) were optimised for the immobilisation of the extracellular matrix (ECM) protein fibronectin 
(FN) (440 kDa), the bone-signalling osteocalcin (OCN) protein (5.9 kDa), and a fusion protein containing 
the FN9,10 domains and the OCN22-49 sequence (FN-OCN/ Fusion protein) (40 kDa) produced by our 
collaborators at Inha University, Korea [287, 316]. For comparison, a co-immobilised FN and OCN 
multi-protein interface was developed through the sequential exposure of the rPPF surface to multiple 
protein solutions. These optimised surfaces were examined for their in vitro osteogenic potency in 
Chapter 6. 
   
5.2  Method 
 
5.2.1 Substrate preparation and analysis 
 
rPPFs were deposited on nitric acid cleaned Ti foils following the procedure and deposition 
conditions for 20%N rPPFs outlined in Chapters 2 and 3. Briefly, the foils were nitric acid cleaned to 
remove surface contaminants. The surface was argon plasma cleaned, and the 20%N rPPF was 
deposited. The rPPF- coated foils were allowed to age for 5 - 7 days before use.  
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Surface characterisation of the 20%N coatings was performed via X-ray photoelectron 
spectroscopy (XPS), contact angle measurements, and electron paramagnetic resonance (EPR) 
spectroscopy following the protocols previously described in Chapter 2. Briefly, the surface 
composition of the rPPF was examined using XPS survey spectrum collected in the energy range of 0 
– 1000 eV with a resolution of 0.5 eV. High-resolution (0.1 eV) C 1s spectra were collected at a pass 
energy of 20 eV. The contact angles of water (polar) and diiodomethane (non-polar) droplets (≈ 50 µl) 
were measured (n = 5). The angles were used to calculate the total, dispersive, and polar surface 
energies via the Owens–Wendt–Rabel–Kaelble (OWRK) model. The radical density of the rPPFs was 
measured via EPR on polystyrene films (7 cm × 7 cm). The EPR spectrometer was calibrated using a 
weak pitch sample (∼1 × 1013 spins/cm) before measuring the rPPF. Ten scans were averaged per 
sample and the radical density calculated per cm3. The surface characterisation of 20%N rPPFs has 
also been previously reported by Martin et al [356]. 
  
5.2.2 Fusion protein synthesis and purification 
 
The FN-OCN fusion protein was produced by Jang et al. as previously described [287, 316] and 
outlined in Chapter 2. Briefly, protein synthesis was initiated via polymerase chain reaction (PCR) 
amplification of the OCN-FN genetic sequence. The amplified PCR products were digested, ligated, 
and transfected into E.coli for overnight expression of the protein. The bacteria were harvested and 
the supernatant collected and purified. The final protein was measured to be approximately 40 kDa 
via western plotting [316].  
 
5.2.3 Proteins, antibodies, and reagents  
 
Antibodies were acquired for the detection of FN, OCN, and FN-OCN proteins. Fibronectin (F2006, 
Sigma Aldrich) was detected with a rabbit-anti-FN primary antibody (F3648, Sigma Aldrich). 
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Osteocalcin (O5761, Sigma Aldrich) was detected using three primary antibodies corresponding to the 
N-terminal, C-terminal, and an internal sequence of the protein. The N-terminal and internal sequence 
were rabbit-derived antibodies (ab14173 and ab93876, respectively), while the C-terminal antibody 
was derived from goat (ab175453). The FN-OCN fusion protein was detected using the OCN internal 
sequence and a rabbit-derived 6x histidine (6His) tag primary antibody (ab125262). The rabbit primary 
antibodies were coupled to a goat-anti-rabbit secondary antibody (ab6721) and the goat-derived 
primary was coupled with a donkey-anti-goat secondary (ab205723) Both secondary antibodies were 
conjugated with horseradish peroxidase (HRP) for colourimetric detection of 3, 3’, 5, 5’, -
tetramethylbenzidine (TMB), purchased as 1-Step™ Ultra TMB - ELISA Substrate (cat. 34022, 
Thermofisher Scientific). 
 
5.2.4 ELISA calibration and protein quantification 
 
5.2.4.1 Calibration 
 
The principles of ELISA detection and the general procedure of the biochemical protein 
quantification technique are explained in Chapter 2. Calibration of each ELISA for the optimal specific 
signal was performed in a 96 well plate. 150 μL of 10 µg/mL protein solution was aliquoted into the 
wells according to the grid setup presented in Figures 5.2.a,b, 5.3.a,b , and 5.4.a,b. The well plate was 
incubated in the protein solution overnight at 4˚C. The protein solution was removed and the wells 
were gently washed with PBS. A BSA solution was added into the protein-incubated and non-
incubated wells for 1 hr at room temperature. Following the removal of BSA, primary Ig dilutions of 
1:1000, 1:2000, 1:5000, and 1:10,000 were dispensed into their corresponding column positions and 
incubated. The primary Ig was replaced with secondary Ig dilutions of 1:10,000, 1:20,000, 1:50,000, 
and 1:100,000 in their corresponding rows. The wells were then incubated with TMB for 30 min and 
the HRP-substrate reaction stopped with 0.2 M H2SO4. The absorbance of the 96 well plate was 
measured at 450 nm. A negative control consisting of TMB and 0.2 M H2SO4 only was measured to 
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account for TMB oxidation in the absence of HRP. The protein-specific signal was calculated by 
background subtraction of the BSA blocked wells from their protein coated counterparts. The signal 
to noise ratio (protein: blocked) was calculated for each condition. 
5.2.4.2 Protein detection and quantification via ELISA 
 
All protein dilutions were done under sterile conditions so as not to contaminate the protein 
stocks for cell culturing. The desired protein was equilibrated to 37˚C and transferred into a sterilised 
Biological safety cabinet (BSC). A series of protein solutions between 1 – 30 μg/mL were diluted from 
the stock solutions according to the dilution equation (Eqn 2.1): 
 
C1V1 = C2V2       Equation 2.1 
 
The 20%N rPPF foils were cut into 0.8 cm x 0.6 cm rectangles and the top right-hand corner was 
removed to indicate coating-side-up orientation. The foils were transferred into a 48 well plate, and 
75 μL of protein solution was deposited on the substrates via droplet deposition. This method was 
chosen to conserve the expensive and limited supplies of osteocalcin and fusion proteins. The foils 
were incubated with the protein solution overnight at 4˚C. The excess protein solution was removed 
the next day and the substrates were gently washed with PBS. The ELISA procedure was carried out 
with the optimised conditions. The absorbance values for each protein solution concentration were 
plotted to produce a titration curve and indicate the solution concentration of protein at which a full 
monolayer was attached to the rPPF.   
To determine the covalently immobilised proportion of protein, bare Ti and rPPF samples were 
incubated overnight in the protein solution concentration that yielded a monolayer. The samples were 
then transferred into an Eppendorf tube containing 1 mL of 5% sodium dodecyl sulphate (SDS) solution 
and incubated at 90˚C for 15 min [58, 354]. SDS is a surfactant that disrupts physical interactions 
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leaving only covalently bonded protein. Pre- and post- SDS washing samples were then examined 
together in ELISAs. The ratio of signals between the background subtracted values indicated the 
relative amount of covalently immobilised protein. 
 
5.3 Results 
5.3.1 Material characterisation 
 
The 20%N rPPF coatings were used for the protein immobilisation and primary cell studies 
(reported in Chapter 6). The rPPF surface chemistry was analysed using XPS, and a typical survey 
spectrum is shown in Figure 5.1.a. The atomic composition was 71 ± 4 % carbon, 20 ± 1 % nitrogen, 
and 9 ± 1 % oxygen. The large concentration of carbon is typical of amorphous carbon deposited from 
carbon-based monomers, such as acetylene, that have been highly cross-linked through ion 
bombardment. The nitrogen was incorporated into the gas mixture to promote sp2 bonding and 
relieve internal stresses in the deposited film [361, 362]. The presence of 9 ± 1 % of oxygen suggests 
that the rPPF has undergone autoxidation reactions between carbon-centred radicals and 
atmospheric oxygen [207, 292, 363]. The C1s high-resolution peak was curve-fitted with binding 
energies corresponding to C−C/C−H (284.6 ± 0.5 eV), C−O/C−N (286.5 ± 0.5 eV), C=O/N−C=O (287.5 ± 
0.5 eV), and COOH (289 ± 0.5 eV) [309, 353, 364]. The peak fitting further illustrates autoxidation with 
the presence of single and double bonded carbon-oxygen groups (blue and magenta curves in Figure 
5.1.b, respectively) and the minor formation of carboxylic acid functionalities (cyan peak at 289 ± 0.5 
eV). The organic polar groups formed as autoxidative products are known to be beneficial for cellular 
attachment and proliferation [243]. Unlike for chemical-functionalised PPFs, the formation of 
autoxidative products does not diminish the protein immobilisation potential of the rPPFs [58, 264, 
283, 357].  
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The water contact angle (WCA) of the rPPF surface, measured one week after deposition, was 
approximately 59.4˚ (Figure 5.1.c) and that diiodomethane contact angle was 31.4˚. The total surface 
energy was 56.2 mJ.m-2 with dispersive and polar components of 43.6 and 12.6 mJ.m-2, respectively 
[356]. The hydrophilic nature of the rPPF is derived from the free energy of radicals and polar oxidative 
products formed by exposure to atmospheric oxygen [58, 343, 357]. The WCA shows the surface has 
a mildly hydrophilic range (WCA < 90) [65, 66] and, therefore, allows proteins to retain a native 
conformation and biological activity [68]. The 59.4˚ WCA places the rPPF within the optimal wettability 
range for bone lineage cell attachment [374].  
The unpaired electrons representing radicals contained in the rPPF were detected using EPR 
(Figure 5.1.d).  The spectrum contains a symmetrical peak centred at a g-value of 2.003 indicating the 
presence of surface-embedded radicals. The broadness of the peak indicates a variety of carbon-
centred radicals and/or signal anisotropy due to the radicals appearing at the rPPF surface [58, 279, 
343].  The rPPFs have been shown to possess radical densities 1-2 orders of magnitude greater than 
conventional PPFs deposited in the absence of enhanced ion-bombardment [58, 353, 398]. 
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Figure 5.1. Characterisation of the rPPF surface. (a) The elemental composition was 71 ± 4 % carbon, 20 ± 1 % 
nitrogen, and 9 ± 1 % oxygen as calculated from the XPS survey spectrum. (b) The high resolution C1s spectrum 
was curve-fitted with components at binding energies (284.6 ± 0.5 eV (C−C/C−H), 286.5 ± 0.5 eV (C−O/C−N), 
287.5 ± 0.5 eV (C=O/N−C=O), and 289 ± 0.5 eV (COOH). (c) A representative image of the water drop placed on 
the rPPF-coated Ti showing a water contact angle (WCA) of 59.4o. d) A representative EPR spectrum of the rPPF 
deposited on polystyrene. Signal broadening originates from a variety of carbon-centred radicals and/or 
anisotropic signal due to the presences of surface radicals. 
 
5.3.2 Optimisation and characterisation of fibronectin- functionalised rPPF surfaces 
 
The absorbance signal from the FN-ELISA calibration assay increased proportionally to the 
concentration of the primary and secondary antibodies (Figure 5.2.a). The maximum protein-specific 
signal was observed at the concentration of primary 1:2000/ secondary 1:10,000, followed by primary 
1:5000/ secondary 1: 10,000, and primary 1:5000/ secondary 1:20,000. An examination of the signal 
to noise ratios (S:N) showed that the signal sensitivity was maximised using the primary 1:5000/ 
secondary 1:20,000 conditions (S:N = 3.3)(Figure 5.2.b). These dilutions were selected as they 
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provided a strong protein-specific signal and the highest signal sensitivity, according to the signal-to-
noise ratio. The titration curve showed a monolayer formation at approximately 15 µg/mL solution 
concentration (3.4 x 10-8 M), as indicated by the signal plateau in Figure 5.2.c.  
SDS washing of surface with immobilised FN demonstrated significant differences in the covalent 
binding capacities. The rPPF surfaces produced a significant increase in initial absorbance compared 
to the bare titanium, most likely due to changes in adsorption-desorption equilibrium dynamics. The 
rPPF surfaces demonstrated a protein retention ratio of 79 ± 7% after SDS washing. The post-SDS 
washed rPPF surfaces demonstrated an absorbance equivalent to the pre-SDS washing Ti surfaces. A 
significant reduction of surface protein concentration was observed on the bare Ti with only  15 ± 6% 
of the adsorbed protein retention after SDS washing.  
 
Figure 5.2. Fibronectin ELISA surface quantification. a) The calibration of the FN-ELISA conditions showed a 
general signal increase proportional to the concentration of the primary and secondary antibodies. b) The signal 
to noise ratio was calculated for each condition and the optimum is highlighted in purple (S/N = 3.3). c) The 
titration curve of FN suggests that a monolayer of protein is immobilised at a solution concentration of 
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approximately 15 µg/mL. d) SDS washing of FN immobilised on Ti and rPPF show that 79 ± 7% of the adsorbed 
protein on rPPFs is retained after SDS washing while only 15 ± 6% on Ti. Significant differences (p < 0.01) 
compared to non-SDS washed Ti (*) and non-SDS rPPF (#) are indicated. 
 
Many FN-functionalisation concentrations have been reported in the literature for a variety of 
materials and processes. A FN solution concentration of 5 - 10 µg/mL was reported for cyanate-
modified PEEK [87],  20 µg/mL for ion implanted polymers, 50 µg/mL for the ligation of FN to chemical 
brushes via EDC/NHS chemistry [215], while 100 µg/mL was reported for the tresylation process [108, 
109] and silanisation [417]. Concentrations ranging from 500 – 1000 µg/mL have also been reported 
for more complex protein immobilisation processes [185, 214]. The monolayer concentration of 15 
µg/mL required for the functionalisation of rPPF surfaces is placed at the lower end of these reported 
concentrations. The post-SDS FN retention also aligns with the previously reported approximately 80% 
FN retention on cyanate-modified PEEK [87]. Overall, the FN-functionalised rPPFs demonstrate 
significant improvements in protein immobilisation and retention quantities compared to Ti without 
the need for extensive chemical modification.  
 
5.3.3 Optimisation and characterisation of osteocalcin- functionalised rPPF surfaces 
 
Characterisation of the osteocalcin (OCN)-functionalised surfaces via ELISA experienced 
complications due to primary antibody selection. The OCN protein is predominately detected in 
solution via an orientation-independent sandwich ELISA [418, 419] and no information regarding 
attachment to non-bone tissue surfaces was available. Three antibodies aligning with the amino acid 
(AA) sequences for the N-terminal (AA 1-21), mid-sequence (AA 22-35), and C-terminal (AA 36-49) 
were sourced.  
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The N-terminal ELISA calibration assay showed elevated baseline absorbance signals of 0.8-0.9. A 
protein-specific signal of 0.12 was found at primary 1:1000/ secondary 1:10,000 concentrations. 
However, no other combination produced any signal above the baseline. Further testing with blocker 
proteins showed that the absorbances on OCN-functionalised rPPF surfaces were lower than the 
baseline. The consistently elevated baseline signal indicated that the N-terminal primary Ig could be 
interacting non-specifically with the BSA blocking protein. As such, the N-terminal antibody was 
replaced with the mid-sequence and C-terminal primary Igs. 
The mid-sequence OCN-ELISA calibration array was performed. A maximum protein-specific 
absorbance signal of 0.15 was found at the primary 1:2000/ secondary 1:10,000 dilution, as shown in 
Figure 5.3.a. The maximum signal was the most sensitive with a signal to noise ratio (S:N) of 2.7 (Figure 
5.3.b). The titration curve demonstrated a protein-specific signal maximum at 20 μg/mL, but the 30 
μg/mL signal decreased to be level with the 15 μg/mL concentration. This signal decrease, in 
combination with the uncertainty, indicated that the 20 μg/mL might be artificially increased, and the 
15 μg/mL (2.5 x 10-6 M) concentration was taken to be the monolayer concentration (Figure 5.3.c). No 
previous surface immobilisation work could be found to compare with the experimental values. The 
ELISA examination of immobilised protein concentration after SDS washing showed that the rPPFs 
immobilised and retained a significantly greater quantity of protein compared to the bare Ti (Figure 
5.3.d). The rPPF surfaces retained 62 ± 8% of the physically adsorbed OCN. By comparison, the OCN 
was almost completely removed on the bare Ti surfaces. 
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Figure 5.3. OCN mid-sequence ELISA quantification. (a) The calibration of the mid sequence OCN-ELISA antibody 
dilution conditions showed a general signal increase proportional to the secondary Ig concentration. The optimal 
signal is highlighted in purple. (b) The signal to noise ratio was calculated for each condition and the optimum is 
highlighted in purple (S:N = 2.7). (c) The titration curve of OCN produced a monolayer at a protein solution 
concentration of approximately 15 µg/mL. (d) SDS treatment of monolayer OCN surfaces showed SDS resistant 
fractions of 62 ± 8% on rPPF surfaces and near complete removal on Ti. Statistical significance (p < 0.05) is shown 
for absorbances compared to non-SDS washed Ti (*) and rPPF (#). 
 
The C-terminal ELISA system was calibrated, demonstrating a maximum signal at the primary 
1:1000 /secondary 1:10,000 dilution conditions, with an absorbance signal of 0.76 and a signal to noise 
ratio of S:N ≈7.3. The optimised ELISA dilution conditions were used to obtain an OCN titration curve. 
The protein titration curve produced signal strengths that were independent of the protein solution 
concentration over the range of 1 - 30 µg/mL. The absorbance plateau of Abs = 0.09 - 0.1 was thought 
to be due to over-saturation of the secondary-HRP antibody and a rapid reaction of the TMB substrate 
solution. The two surrounding conditions of primary 1:1000/ secondary 1:20,000, and primary 1:2000/ 
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secondary 1:10,000 were used to examine rPPF surfaces with 0 µg/mL, 1 µg/mL, and 15 µg/mL 
immobilised OCN to determine if a difference in protein signal could be produced. However, no 
difference was found between the protein conditions with either ELISA condition. The signal 
saturation across all protein concentrations for the three sets of antibody concentrations suggests 
that the OCN surface is fully saturated by the c-terminal ELISA antibodies. The primary Igs for the 
ELISAs are generally ≈ 10-12 kDa while the secondary Igs conjugated with HRP are ≈ 37-42 kDa (as 
stated on the product information). The difference in the produced absorbance signal between 
individual ELISA systems can be attributed to the catalysed TMB reduction kinetics, given the protein 
functionalised surfaces and the Ig molecular weights are consistent. 
The inability to accurately detect the N-terminal of OCN above the large background was 
unexpected. OCN attaches to the positively charged Ca+ minerals in bone through the negatively 
charged Gla side chains in the 1-22 AA sequence at physiological pH [420]. The net negative charge at 
the 20%N rPPF surface at physiological pH [356] should orient the 1-22 AA sequence away from the 
surface. However, given the protein detection by the C-terminal and mid-sequence antibodies, the 
assays suggest that the pyramidal conformation of OCN was oriented predominately with the N-
terminal contacting the rPPF surface and C-terminal exposed the aqueous environment. 
 
5.3.4 Optimisation and characterisation of fusion protein - functionalised rPPF 
surfaces 
 
The FN-OCN fusion protein was initially examined with a 6x histidine (6His) primary Ig to detect 
the 6His tag inserted at the N-terminal. No significant trend was observed in the ELISA calibration 
performed on the 96 well plates (Figure 5.4.a). The maximum signal was produced at the primary 
1:5,000/ secondary 1:20,000 dilution conditions and possessed a S:N ≈ 2 (Figure 5.4.b). The titration 
curve was performed using the optimised 6His ELISA conditions, but no significant signal beyond the 
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baseline fluctuations could be observed, with the largest signal of Abs = 0.005 ± 0.004 being detected 
on the 10 µg/mL concentration (Figure 5.4.c). Further repetitions confirmed the lack of protein-
specific signal. The inability to detect protein signal could come from the orientation of the protein on 
the tissue culture plastic wells compared to the rPPF surfaces. The 6xhistidine sequence is positively 
charged at physiological pH due to the imidazole side chains on the individual amino acids and could 
influence the fusion protein orientation when in close proximity to the negatively charged rPPF 
surface. However, there are also other factors that influence surface protein orientation as discussed 
in Chapter 1.2. Overall, the 6xhis primary antibody ELISA did not produce sufficient absorbance signals 
for quantification.  
The fusion protein-coated surfaces were examined with the optimised FN and mid-sequence OCN 
ELISAs to determine which of the component protein ELISAs produced the optimal protein-specific 
signal. The OCN and FN ELISAs demonstrated protein-specific signals of 0.091 ± 0.003 and 0.058 ± 
0.002, and S:N ratios 0f 2.02 ± 0.11 and 1.34 ± 0.04, respectively (Figure 5.4.d). The mid-sequence 
OCN ELISA was selected for the titration curve (Figure 5.4.e) and the SDS washing experiments (Figure 
5.4.f). The titration curve showed that the protein concentration signal plateaued between 10 - 15 
µg/mL and plateaued within variation for the greater protein solution concentrations. The optimal 
protein concentration for the FN-OCN proteins was previously reported as 20 µg/mL, so 15 µg/mL (3.8 
x 10-7 M) concentration was selected as a suitable solution concentration to form an adsorbed 
monolayer. The results after SDS washing showed 5 ± 7% protein retention on the Ti, and 73 ± 13% on 
the rPPF surfaces. 
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Figure 5.4. ELISA optimisation and quantification of FN-OCN fusion protein-coated surfaces. The calibration of 
the 6His-ELISA conditions showed an inconsistent relationship between the primary and secondary antibodies 
(a). The signal to noise ratio (b) produced a S:N ≈ 2 for the optimised condition highlighted. (c) The 6xhistidine 
titration curve produced no significant signal after background subtraction. d) The fusion protein surface showed 
considerable signal on both the optimised FN- and OCN- ELISAs. The OCN-mid sequence ELISA was selected due 
to the greater S:N. e) The fusion titration via OCN-ELISA demonstrated a signal saturation at 10 – 15 µg/mL. f) 
SDS washing of monolayers on Ti and rPPF showed fractions of  5 ± 7% and 73 ± 13% were retained, respectively. 
Statistical significance (p < 0.05) is shown for absorbance signals compared to non-SDS washed Ti (*) and rPPF 
(#). 
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5.3.5 Synthesis, optimisation, and characterisation of co-immobilised fibronectin: 
osteocalcin rPPF surfaces 
 
Surfaces comprising of co-immobilised FN and OCN were developed for comparison with the FN-
OCN fusion protein. The potential for cross-reaction between the ELISAs and their non-target proteins 
needed to be investigated before the quantification of the co-immobilised FN:OCN ratios could 
proceed. FN and OCN surfaces were exposed to the opposite ELISA system to gauge for non-specific 
signal that might influence the co-immobilisation results. The assays showed marginal increases in 
signal compared to the corresponding BSA controls. The FN surface examined with the OCN-ELISA 
produced an absorbance of 0.212 ± 0.025, a significant increase (p < 0.05) over the BSA control value 
of 0.172 ± 0.012. The OCN surface examined with FN-ELISA demonstrated a slight increase (0.085 ± 
0.006) over the BSA control signal 0.068 ± 0.008 (p > 0.05). The relative increases in signal on the OCN 
or FN compared to their controls could be due to the difference in non-specific binding affinities of 
the primary Igs. A comparison of primary antibody targeted genetic sequences to the full FN and OCN 
proteins using the web-based Pairwise sequence alignment “Needle” software (EMBOSS) showed no 
correlation between the OCN and FN-primary Ig. However, a strong partial match was found between 
the FN protein and the OCN-primary Ig, which could account for the significant increase on the FN-
functionalised surface. Overall, the cross-reactivity ELISAs revealed that the slightly elevated signals 
on the OCN surfaces compared to their respective controls is due to non-specific binding, while the 
cross-reactivity of the FN surface can be taken into account for the co-immobilisation results. 
 
A sequential 2-step exposure was used to co-immobilised FN and OCN in various ratios. The first 
incubation was carried out with OCN and the FN was then adsorbed onto the OCN fractionally coated 
surface. The solution concentrations used were determined according to the desired monolayer 
fraction as per their individual titration curves. A series of ratios were examined pre- and post- SDS 
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washing with the FN and OCN ELISAs, as shown in Figure 5.5.a. The 100% protein surfaces show similar 
post-SDS proportional retentions as in Figures 5.2.d and 5.3.d, indicative of covalent immobilisation. 
The same conditions resulted in near complete removal of the corresponding protein layers on Ti 
surfaces (Figure 5.5.b). When co-immobilised, the signals of OCN and FN decrease compared to their 
100% controls, most noticeably for OCN prior to SDS washing. The transition from a 100% to 90% OCN 
surface with FN produced a signal reduction resembling SDS washing due to competitive adsorption-
desorption of OCN. The OCN immobilisation follows the expected trends, while the FN shows minimal 
variation across the given ratios. The co-immobilisation sequential 2-step approach accounts for the 
reduction in ELISA signal from competitive adsorption-desorption and the titration trend for the OCN, 
but not the FN behaviour.  
 
Figure 5.5. ELISA quantification of the co-immobilised rPPF surfaces. a) The rPPF surfaces, both pre- and post-
SDS washing, show a non-linear correlation between the OCN and FN concentrations and signal strength. The 
FN signal maintained a near-monolayer signal, while a titration trend was observed in the OCN. b) Ti surface 
showed the drastic removal of the adsorbed proteins under the same SDS washing conditions. c) SDS washed 
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co-immobilised surfaces were compared to their FN concentration equivalent, demonstrating a non-titration 
like signal generation.  
 
The unusual FN-ELISA signal was initially thought to result from adsorbed FN occupying the 
surface. However, the behaviour remained unchanged post-SDS treatment. As such, the observed 
plateau in the FN-ELISA may originate from FN reorientation. For comparison, the immobilisation 
ratios and their monolayer concentration counterparts were investigated side-by-side. The 100%FN, 
50%FN, and 25%FN monolayers appears to produce a signal reduction resembling the titration curve 
(Figure 5.2.c), however, the difference in values is not significant. The 1:1 and 1:3 FN:OCN ratios 
produced equivalent signal (Figure 5.5.c) and showed no significant changes from the 100% 
monolayer signal. The preliminary test suggests that in the co-immobilisation process, changes the FN 
protein conformation or orientation due to altered surface conditions by the presence of the 
incomplete OCN layers. Overall, the 1:3 ratio of FN:OCN was selected for cellular examination as it 
provided optimal signals from both ELISAs, while expressing a substantial difference in surface protein 
composition.   
 
5.4 Discussion 
 
In this study, protein-specific ELISAs were used to optimise the protein immobilisation conditions 
for fibronectin (FN), osteocalcin (OCN), and the custom fusion protein that combined functional 
domains from both of these proteins. The quantities of adsorbed and immobilised proteins on the 
20%N rPPF surfaces was increased over the bare Ti in all cases. The information derived from the 
titration curves and the relative size difference of FN and OCN was used to develop a multi-protein 
interface.  
The quantity of proteins on the Ti and rPPF surfaces, via single or sequential exposures, is 
determined by a competitive adsorption-desorption equilibrium [71, 113, 421]. Proteins will adsorb 
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to the exposed surface based on hydrophobic and electrostatic interactions and become displaced by 
incoming proteins through transitional complexes with the rearrangement driven by relative solution 
partial concentrations and surface affinity [111-113]. The effective monolayer for any given surface 
occurs when the adsorption-desorption dynamic has reached equilibrium. The protein adsorption-
desorption equilibrium on rPPFs is influenced by the probability of covalent bond formation between 
a surface migrating radical and the adsorbed proteins, thus preventing desorption. The competitive 
exchange of proteins will continue but with a reducing effective surface area, as depicted in Figure 
5.6. This mechanism accounts for the observed increase in protein specific signal from the rPPFs 
compared to the Ti, and the significantly different protein retention values [280]. 
 
 
Figure 5.6. A visual representation of protein equilibrium on Ti and rPPF surfaces. The proteins initially adsorb 
onto the Ti and rPPF surfaces. The adsorbed surface proteins will undergo competitive adsorption-desorption 
dynamics as the system reaches equilibrium and the on-rates equal off-rates for each type of protein. The 
adsorbed proteins on the rPPF surfaces form covalent bonds with the surface migrating radicals preventing 
desorption and leading to greater surface protein retention.  
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The differences in mobilities and binding affinities between proteins makes it difficult to translate 
the single protein titration results into a mixed solution yielding the desired surface coverage ratios 
post immobilisation [113]. Thus, the co-immobilisation of fibronectin and osteocalcin was performed 
by sequential protein solution exposures to allow for greater control of the competitive adsorption–
desorption dynamics and surface composition. In principle, the covalently bound proportions of OCN 
would reduce the effective area, limiting the available sites for FN immobilisation at the surface. The 
rPPF surfaces must have sufficient protein exposure time to ensure the optimal covalent attachment. 
The osteocalcin, immobilised in various ratios, reproduced a concentration behaviour consistent with 
the titration curve, as expected for the first incubated protein solution. During the subsequent 
incubation, the FN bonded to the available surface and displaced the non-covalently bonded OCN 
[111-113].  This explains why the ELISA signal was equivalent to that obtained post-SDS washing in the 
initial OCN retention experiments (Figure 5.5.a). The observed fibronectin signal plateau across all 
protein concentration ratios, both pre- and post SDS washing, contradicts the expected titration curve 
behaviour (Figure 5.2.c, 5.5.a). The uniform signal strength suggests a change in FN adsorption 
dynamics that could invoke a protein reorientation or refolding in response to the partially OCN-
functionalized rPPF surfaces. A reorientation of the bi-polypeptide FN structure (2x 220kDa 
polypeptide units [422]) could potentially double the availability of the primary antibody targeted 
genetic sequence presented in solution. The ELISA signal would then increase by a fraction equivalent 
to the proportion of reoriented FN present. Such unexpected increases in target sequence 
presentation reduce the reliability of ELISA detection for the quantification of immobilised protein 
ratios. 
The examination of protein ratios is a time and resource-intensive process. The quantification of 
multi-protein surfaces via ELISA requires the examination of each protein ratio with all the required 
ELISA systems to determine the concentrations of the individual proteins. Thus, the samples required 
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increase exponentially as more different proteins are included onto the surface. In addition to the 
signal discrepancies from protein reorientation or refolding, the ELISA technique can also introduce 
effective area discrepancies related to the size differences between the proteins and the antibodies 
(Igs). The ELISA signal produced is considered representative of the protein quantity if the target 
protein is larger than the primary (≈ 10 – 12 kDa) and secondary (≈ 37 – 42 kDa) antibodies, e.g., 
fibronectin. However, smaller proteins and peptides can experience an ELISA detection limit based on 
steric hindrance due to the large footprint of the antibodies, which understates the surface protein 
quantity. In contrast, the multi-functionalisation of an implant surface with fusion proteins reduces 
the number of samples required for the characterisation of an immobilisation protocol and increases 
the ELISA accuracy.  For example, the combination of the FN9,10 and OCN 22-49 sequences in a single 
protein allows for protein quantification via a single ELISA using an antibody targeting either of the 
sequences. The fusion protein in this study is reported to be approximately 40 kDa [287, 316] which 
reduces the potential for misrepresentation via ELISA antibody steric hindrance. Overall, the utilisation 
of the fusion protein allows for simpler and more accurate ELISA quantification and greatly simplify 
surface immobilisation protocols. 
ELISAs are one of the most widely used methods of protein quantification being used to detect a 
vast number of proteins both surface bound and in free solution [331]. However, other physical 
techniques can be used for determining the concentrations of immobilised proteins through the 
detection of distinctive heavier elements, such as Br, F, or Cl. Alternatively, the inclusion of fluorescent 
or radionucleotide markers allow for the direct examination of protein quantity and adsorption-
deposition kinetics. Typically, these approaches require the chemical modification of the proteins 
before surface immobilisation. These modifications may alter the protein conformations and, 
therefore, the adsorption-desorption behaviours. The ELISA methodology provides a reproducible and 
reliable approach for protein quantification of both single and co-immobilised protein surfaces. 
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5.5 Conclusions 
 
The optimisation of fibronectin, osteocalcin, and FN-OCN fusion protein-functionalised rPPF 
surfaces was performed with protein-specific, enzyme-linked immunosorbent assays (ELISAs). Protein 
concentrations required to form a saturated monolayer during the 4˚C overnight incubation was 
determined to be approximately 15 µg/mL. Covalent binding ratios after this length of incubation were 
between 60-80% depending on the protein. A 2-step sequential exposure approach was used for the 
co-immobilisation of OCN and FN to rPPF surfaces to better control the competitive adsorption-
desorption dynamics compared to multiple protein solutions. The subsequently incubated FN 
demonstrated different binding behaviours from the expected single protein behaviour established 
on rPPF surfaces due to the FN interactions with the partially OCN-functionalised surface. Overall, it 
was demonstrated that i) rPPF coated surfaces present a simple and reproducible platform for 
producing single and multifunctional biointerfaces and ii) the optimisation of multi-protein 
biointerfaces is substantially more complex relative that required for multifunctional fusion protein 
biointerfaces. 
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Chapter 6: In vitro investigation of protein-functionalised rPPF 
surfaces to determine osteogenic potential 
 
This chapter reports the osteogenic potency of the protein-functionalised surfaces, as characterised in 
chapter 5, with primary osteoblasts (OBs) and mesenchymal stem cells (MSC). The OB attachment, 
proliferation, and mineralisation were investigated. The fibronectin-osteocalcin fusion protein 
functionalised surfaces demonstrating high levels of cellular attachment and increased mineralisation 
compared to those functionalised with the component proteins. The MSC differentiation was shown to 
be on par with the osteocalcin functionalised signalling surfaces.  
The results from this chapter are reported in “Multifunctional protein-immobilized plasma polymer 
coatings for orthopedic applications.” by Callum A.C. Stewart, Behnam Akhavan, Juichien Hung, Shisan 
Bao, Jun-Hyeog Jang, Steven G Wise, and Marcela M.M. Bilek (Accepted; ACS Biomaterials Science and 
Engineering). 
 
6.1 Introduction 
 
Protein and peptide surface functionalisation provides a versatile approach to improve the 
osseointegration of orthopaedics. The goal of protein functionalisation is to increase the beneficial 
interactions between the implant surface and the biological environment, thereby, leading to more 
optimised osseointegration, as outlined in chapter 1. An increased degree of cellular recruitment and 
bone formation on implant surfaces can reduce the potential for adverse non-integration conditions, 
such as biofilm formation [6, 7, 423] and fibrotic encapsulation [3-5], which require revision surgery 
to correct [2, 3]. Biomolecule-functionalisation may also mitigate the long-term effects of bone 
resorption caused by the lack of mechanotransductive forces (Wolff’s Law) [29-32]. Thus, modifying 
orthopaedic devices to promote osseointegration with the body has the potential to increase patient 
quality of life and implant longevity. 
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The plethora of proteins and peptides investigated to improve osseointegration can be broadly 
classified into three main categories: i) anti-microbial, ii) adhesive extracellular matrix (ECM), and iii) 
bone signalling proteins. Anti-microbial functionalised surfaces focus on the prevention of bacterial 
and fungal infections at the implant site [249, 424]. The biomolecules investigated include bacitracin 
[156, 425], caspofungin [349, 357, 426, 427], and the linker molecule chitosan [136, 145-147, 428-
430], along with hundreds of antimicrobial peptide sequences [431, 432]. The approaches to anti-
microbial surfaces have been reviewed elsewhere [433, 434]. ECM proteins are involved in the 
recruitment and establishment of osteoblasts and stem cells at the surface of the implant. Fibronectin 
and collagen, for example, contain the canonical RGD cell binding motif that interacts with a range of 
cell-surface integrins, including α5β1, α2β1, and αvβ3, to adhere the cells to the protein-
functionalised surface [411]. Bone formation at the ECM-functionalised surface occurs through 
natural mineralisation processes and is typically increased due to the greater cell coverage rather than 
enhanced mineralisation activity [435, 436]. The signalling proteins, for example BMP-2 [409], and 
other signalling molecules, such as Simvastatin [95, 437, 438], increase the rate of bone formation by 
accelerating the differentiation and mineralisation of the adherent cells through the upregulation of 
osteogenic metabolic products, e.g. osteocalcin (OCN/BGlaP), osteopontin (OPN), and alkaline 
phosphatase (ALP) [287, 439, 440]. Osteogenic proteins that promote cell attachment and bone 
formation resemble the natural physiological environment more closely and stimulate native tissue to 
win the ‘race for the surface’ [441, 442], outcompeting bacteria. Osteogenic protein-functionalisation, 
therefore, addresses both biofilm and foreign body reactions as well as providing functional 
integration of the implant.  
The single protein approach to biomolecule functionalisation has shown some success, but a 
deeper understanding of the osseointegration process reveals that a multifunctional protein-coated 
surface is required. The synergistic combination of biological functionalities would allow for increased 
cellular attachment in conjunction with more rapid bone formation, leading to greater 
osseointegration. In this chapter, the osteogenic potency of the multifunctional protein surfaces 
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developed in chapter 5 were comparatively investigated against the single component proteins: FN 
and OCN. The osteoblast (OB) cell affinity for the surfaces were examined through short-term 
attachment and spreading, the longer-term biocompatibility through proliferation, and the osteogenic 
potential through the OB calcium deposition. The protein-functionalised surfaces were examined for 
their differentiation potential with mesenchymal stem cells (MSCs). 
 
6.2 Methods 
 
6.2.1 Substrate preparation 
 
Ti and the biologically favourable 20%N rPPF coated foils were prepared as previously described 
in Chapter 2. In short, the Ti foils were cut to size and cleaned with nitric acid before the deposition of 
the 20%N rPPF. The surfaces were left for 5-7 days before use to ensure the surface chemical and 
physical properties had stabilised (see Chapter 4). An examination of their surface chemical 
composition, wettability, and radical density is outlined in Chapter 5. 
 
6.2.2 Primary cell harvesting and culturing 
 
Primary osteoblasts (OBs) and mesenchymal stem cells (MSCs) were utilised in this study. The 
experiments were conducted in accordance with the Australian Code of Practice for the Care and Use 
of Animals for Scientific Purposes. All personnel involved in the animal procedures have completed an 
approved animal care and ethics course. Primary OBs were harvested from mouse long bones and the 
cultured as described in Chapter 2 [333, 334]. Briefly, mouse long bones were collected, cleaned, and 
cut into 1-2mm2 pieces before being placed in non-differentiating cell media to allow for OB 
outgrowth. The cells were expanded into working cultures and monitored for cell health. 
MSC harvesting and culturing were performed as described in the standard protocol [341] and 
Chapter 2.2.7. Long bones were collected from 7-week-old mice and washed with 70% EtOH. The ends 
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of the bone were removed as for the primary osteoblast extraction. The bone marrow was flushed out 
with DMEM solution and collected. The marrow solution was resuspended and filtered through a 70 
μm cell sieve before being transferred to a well plate for culturing. The cells were cultured in complete 
DMEM without ascorbic acid as not to stimulate osteoblast differentiation and the media changed 
every 3 days. The cells were expanded to working stocks and closely monitored for differentiation or 
ingrowth of other cell types. 
In vitro cell assays play a necessary screening role in the overall biomedical evaluation process 
[443]. Primary cells were chosen to investigate the biological efficacy of the protein-functionalised 
surfaces over their cell line equivalents, like the MC3T3 transformed rat pre-osteoblast cell line [108, 
134, 139, 444-449], as they are more sensitive to chemical cues. Overall, primary cells should be more 
representative of the in vivo environment [332]. 
 
6.2.3 Cell attachment and spreading 
 
The cell attachment and spreading assay was performed on the protein functionalised surfaces 
as described in Chapter 2. Briefly, the 20%N rPPF-coated Ti foils were cut to 0.8 cm x 1 cm to fit the 8-
well chamber slides and protein-functionalised as described in Chapter 2 and 5. The OBs were seeded 
at 10,000 cells per well. The OB seeding media was removed after 1 hr and the surfaces fixed with 
70%EtOH. After washing the samples in a 0.1% Triton solution, the cell cytoskeleton and nucleus were 
stained with ActinRED555™ and DAPI, respectively, and mounted between two glass slides. The cell 
number and spreading on the different surfaces were examined under 5x (≈ 4 mm2) and 10x (≈ 1 mm2) 
magnification (n > 9) on a fluorescence microscope at the corresponding wavelengths. The images 
were analysed with ImageJ. 
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6.2.4 Proliferation assay 
 
The samples for the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium (MTS) proliferation assay were prepared according to the protocol in Chapter 2 and 4. 
The OBs were seeded at 4,000 cells per well and allowed to grow for 14 days. The proliferation was 
measured at day 3, day 6, day 11, and day 14 post seeding, with the media being replaced every 3 
days. At the stated examination time points, the media was removed, and the samples were incubated 
in 40 mM MTS in DMEM solution for 2 hr under dark conditions. 150 µL aliquots were taken after the 
incubation time and the absorbance measured at 490 nm. 
 
6.2.5 Alizarin red mineralisation assays 
 
The mineralisation capacity of the different protein conditions was examined with the AlizarinRed 
stain (ARS) as described in Chapter 2. The Ti, rPPF, and protein-functionalised surfaces were prepared 
as previously described in Chapters 2 and 5, and primary osteoblasts were seeded at 10,000 cells per 
well. The cells were maintained for 1 month washed in PBS, and stained with ARS for 2 hr. The excess 
was removed, and the samples washed gently before being transferred into individual Eppendorf 
tubes. 400 μL of 10% (v/v) acetic acid was added before vortexing and heating to 85˚C for 10 min.  The 
samples were then centrifuged at 16000 g for 15 min, and 50 μL of ammonia hydroxide added to each 
sample. 200 μL aliquots were transferred to a 96 well plate, and the absorbance read at 405 nm. 
 
6.2.6 Mesenchymal stem cell differentiation 
 
ALP production in MSCs was measured via fluorescent microscopy as outlined in Chapter 2. MSCs 
were seeded at 8000 cells/well on the protein-functionalised rPPF surfaces in an 8-well chamber slide. 
The media was changed every 3 days to ensure sufficient nutrients. After 10 and 20 days, the cells 
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were fixed to the foils with EtOH and washed in 0.1% Triton solution. The surfaces were stained with 
Vector Red Alkaline Phosphatase dye (Vector) and DAPI fluorescent mounting media (Agilent). The 
surfaces were then examined with a Zeiss Axio Imager.Z2 fluorescence microscope at 365/560 nm for 
the ALP dye and 358⁄461 nm for the DAPI. The images were analysed with the ‘ImageJ’ software. The 
degree of differentiation was determined by dividing the total area of the Vector Red (µm2) by the 
number of cells (blue nuclei).    
 
6.3 Results 
 
6.3.1 Primary osteoblast attachment and spreading 
 
Osteoblast attachment and spreading were analysed via fluorescence microscopy. The average 
cell number, shown in Figure 6.1.a, revealed that the FN-OCN fusion protein-coated surfaces had the 
highest cell average of 174 ± 35 cells/field of view, followed by the FN and FN:OCN coated surfaces, 
157 ± 35 and 149 ± 38, respectively. All three demonstrate cell attachments significantly greater than 
the 73 ± 25 cells/field of view observed for uncoated titanium surfaces. The OCN and rPPF surfaces 
had cell attachments of 78 ± 30 and 97 ± 25, respectively, showing no significant increase over Ti. The 
average cell size of the OBs (Figure 6.1.b) on the FN, FN:OCN, and fusion protein-coated surfaces were 
2664 ± 421, 2569 ± 529, and 1999 ± 278 µm2, respectively, showing a significant increase in spreading 
over cells on Ti alone (912 ± 203 µm2). The rPPF surfaces also induced a significant increase in cell 
spreading (2213 ± 331 µm2), while OCN (1214 ± 345 µm2) produced a slight, but not significant, 
increase in size compared to Ti. The cell population and spreading for each surface can be observed in 
the corresponding representative fluorescence image panels in Figure 6.1.c. 
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Figure 6.1. Average osteoblast cell quantity (a) and cell size (b) after 1-hour incubation as determined by 
fluorescence cell staining with DAPI/ActinRED. Uncertainties are determined from the standard deviation 
between samples (n = 9). (c) Representative 10x magnification fluorescence microscope images of osteoblast 
cell attachment on bare titanium, rPPF coatings, fibronectin-functionalised (FN), osteocalcin-functionalised 
(OCN), FN-OCN fusion protein-functionalised, and FN:OCN ratio-functionalised surfaces. The cell viability was 
determined by staining with DAPI (blue - nuclei) and cell spreading was determined by staining with ActinRED 
(red - cytoskeletons). 
 
The increased cell number and spreading on the FN, FN:OCN, and fusion surfaces is attributed to 
the presence of the RGD binding sequence in the FN (9, 10) domains. The RGD sequence is one of the 
primary binding sequences in ECM proteins responsible for cellular attachment [124, 414]. Both multi-
functionalised protein-coated surfaces demonstrated cell attachment and spreading on par with the 
FN-functionalised surface, indicating that the RGD sequence was well presented and accessible to the 
cells. OCN and rPPF surfaces provided equivalent cell attachment to Ti as they do not possess binding 
motifs. The cell spreading was significantly increased on the rPPF compared to Ti, possibly due to the 
presence of nitrogen- and oxygen-containing carbon groups at the interface [450]. An examination of 
the overall cellular affinity for the surfaces agrees with the expected trends: the RGD containing 
surfaces (the fusion, FN, and FN:OCN) are favoured most for cell attachment and spreading, followed 
by the organic surfaces (rPPF and OCN), and the inorganic Ti surfaces being least favoured; i.e.  
RGD motif (FN, FN:OCN, fusion) > organic non-binding (OCN, rPPF) > inorganic (Ti) 
 
6.3.2 Osteoblast proliferation  
 
The proliferation of OBs on the proteins functionalised surfaces was determined with MTS. The 
absorbances were observed on day 3, 6, 11, and 14 as shown in Figure 6.2. On day 3, the Ti (0.87 ± 
0.04), FN (1.00 ± 0.21), and FN:OCN (0.96 ± 0.18) surfaces demonstrated elevated absorbance 
compared to the rPPF (0.74 ± 0.01), OCN (0.74 ± 0.04), and fusion (0.78 ± 0.07) protein-functionalised 
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surfaces.  The Ti, rPPF, FN, and FN:OCN surfaces showed steady growth through the day 6 and day 11 
time points. Unfortunately, the day 6 and day 11 samples for OCN and fusion, shown with black strips, 
were compromised due to media leakage and fungal contamination, respectively. The day 14 MTS 
absorbances demonstrate equal proliferation on the Ti (1.20 ± 0.04) and rPPF (1.19 ± 0.05), with the 
FN (1.32 ± 0.09) and FN: OCN (1.33 ± 0.13) surfaces remaining slightly elevated. The OCN (1.10 ± 0.14) 
and fusion (1.01 ± 0.11) protein-functionalised surfaces produced less proliferation signal relative to 
the rPPF and Ti. The osteoblast growth rates showed insignificant variations across all samples. 
 
 
Figure 6.2. MTS proliferation signal for OBs on Ti, rPPF, FN, Ratio, OCN, and fusion surfaces at day 3, day 6, day 
11, and day 14 post seeding. Analysis of the growth ratios showed no difference between the surfaces. The day 
6 and 11 OCN and FN-OCN (black striped) experienced contamination and media leakage. The osteoblasts 
demonstrated steady growth across the time points. The observed statistical significances compared to Ti are 
shown in their representative colours (p < 0.05 - *, p < 0.01 - #). Uncertainty comes from the standard deviation 
(n = 3). 
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The OB proliferation is correlated with the extent of cell attachment and spreading.  The general trend 
of the FN-containing surfaces producing more MTS signal than the OCN and rPPF is based on the 
elevated cell numbers at the attachment stage (figure 6.1. a,b), as the proliferation rates are similar.  
The FN-OCN fusion protein batch utilised in this assay was stored frozen upon delivery by mistake. A 
repeating assay was unsuccessfully attempted due to failed OB surface establishment and premature 
culture apoptosis. The mineralisation assays were prioritised to make most effective use of the 
remaining fusion protein. Primary osteoblasts were unavailable after completion of the mineralisation 
assays due to time constraints. Overall, the Ti, rPPF, and the protein-functionalised surfaces supported 
the attachment, spreading, and proliferation of osteoblasts. 
 
6.3.3 Osteoblast mineralisation  
 
 
The mineralisation potency of the multifunctional surfaces, as determined by the calcium 
concentration, was probed with an Alizarin Red stain (ARS) (Figure 6.3). The first ARS assay on the day 
17 fusion-protein coated surface (Abs = 0.47 ± 0.04) showed a significant increase in calcium (p < 0.05) 
compared to the OCN-functionalised and rPPF surfaces, Abs = 0.32 ± 0.04 and 0.28 ± 0.10, respectively. 
The fusion-functionalised surfaces also produced a highly significant increase (p < 0.01) compared to 
Ti (Abs = 0.25 ± 0.03) (Figure 6.3.a). The following day 25 and day 32 ARS results showed that the 
calcium content of rPPF and protein-functionalised surfaces were equal to or greater than the bare Ti 
surface.  
The second mineralisation assay (Figure 6.3.b) showed some variation on the previous trends. 
The day 20 ARS results showed a considerable increase across all surfaces compared to the Ti, with FN 
producing a significant increase (P < 0.05). The day 26 assay results demonstrated a significant calcium 
increase on the OCN and rPPF surfaces compared to Ti and non-statistical increases on the remaining 
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surfaces. The day 32 mineralisation measurements showed statistically significant increases on the 
protein-functionalised surfaces except for the rPPF and OCN surfaces. 
 
Figure 6.3. The calcium content deposited by primary osteoblasts on the protein-functionalised surfaces was 
determined by the alizarin red assays. Variations in mineralisation trends were observed at the earlier time 
points between the two individual tests performed. The commonalities between the two tests show that: i) the 
protein-functionalised surfaces substantially increase mineralisation compared to Ti, and ii) Signalling surfaces 
(fusion and OCN) induce larger degrees of mineralisation at earlier time points. Statistical significance (p < 0.05) 
compared to Ti is shown for the first (*), second (#), and third ($) time points. Uncertainty comes from the 
standard deviation between samples (n = 3). 
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The mineralisation observed on the single protein-functionalised surfaces is derived from the 
increased cell quantity for the FN and the enhanced mineralisation rate due to OCN signalling, as 
shown by comparing their attachment and mineralisation assays. The two multifunctional surfaces, 
FN: OCN and fusion, presented different mineralisation behaviours related to the nature of the multi-
functionalisation. The FN:OCN ratio surfaces did not demonstrate an enhancement beyond the single 
protein surfaces, potentially due to the inhomogeneous presentation of the two proteins. In contrast, 
the fusion protein-coated surfaces accelerated calcium deposition as the protein is designed to 
uniformly present both signalling and attachment motifs by combining the adhesive FN9-10 domain 
with the signalling capability of the OCN (22-49 amino acid sequence) in a single molecule [287, 316]. 
Overall, the fusion protein demonstrated the greatest mineralisation potential in shorter time frames, 
indicating the significant benefits of its application in orthopaedic implants. 
 
6.3.4 Differentiation of mesenchymal stem cells 
 
The specific fluorescence (SF) of alkaline phosphatase (ALP), as calculated by the total 
fluorescence area per cell quantity (µm2/cell), was used to quantify the differentiation of MSCs into 
osteoblasts under non-differentiating conditions. The samples were examined at day 10 and day 20 
(Figure 6.4). The day 10 SF results demonstrated three statically distinct bands. Titanium produced 
the most ALP with an SF of 592 ± 166 and constituted the statistically increased band relative to the 
rPPF surfaces. The rPPFs (SF = 376 ± 112), fusion-functionalised surfaces (SF = 353 ± 86), OCN-
functionalised surfaces (392 ± 94), and OB conditioning media controls (SF = 323 ± 41) formed the 
middle band. The FN (SF = 224 ± 22) and FN:OCN (SF = 243 ± 24) surfaces demonstrate a significantly 
reduced SF. The day 20 SF results show that the middle band results from day 10 had equalised with 
the titanium. The FN and FN:OCN functionalised surfaces had increased slightly but demonstrated 
significantly less differentiation than the other surfaces. 
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Figure 6.4. Specific fluorescence (SF) indicating the alkaline phosphatase (ALP) production of mesenchymal stem 
cells (MSCs) via fluorescence microscopy. Statistical significance (p < 0.05) between the rPPF and other surfaces 
are shown for day 10 (*) and day 20 (#). Uncertainty comes from the standard deviation (n = 3). 
 
The ALP quantification assay further examined the osteogenic potential of the protein-
functionalised surfaces through their capacity for signalling MSC differentiation. This is an important 
function for orthopaedic surfaces as the osseointegration process involves interactions with 
undifferentiated and pre-osteoblastic cells, as well as fully differentiated osteoblasts. The FN- 
functionalised surfaces produced less MSC differentiation overall as FN is known to be non-
differentiating [451]. The equivalent values for the FN:OCN and FN surfaces confirmed the trends 
observed in the OB mineralisation assays, suggesting that the biological responses to the FN:OCN 
surfaces are dominated by the FN proteins. However, the expected increase in ALP production on the 
OCN and fusion protein surfaces relative to the uncoated Ti was not observed. MSC differentiation is 
governed by the cellular response to the surface topology and chemistry [241, 244, 366, 452] and 
through biological cues from neighbouring cells and the extracellular matrix [366, 453-455]. The day 
10 results showed that the specific fluorescence of the fusion protein surfaces was on par with the 
OCN and rPPF, but the cell number was significantly lower than those for the other surfaces (p < 0.01). 
The drastic reduction in MSC population would greatly impact the intercellular signalling and rates of 
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differentiation relative to the other surfaces. The cell population was equalised across all surfaces by 
the day 20 time point. Further examinations would assist in clarifying the differentiation potential of 
the fusion protein surfaces. 
 
6.4 Discussion 
 
The functionalisation of orthopaedic implants with biological cues for rapid osseointegration is 
essential for reducing the post-operative complications associated with fibrotic encapsulation and 
biofilm formation [4, 356]. This biofunctionalisation strategy requires the development of easily 
reproducible, multifunctional surfaces that encourage rapid cellular attachment and accelerate 
mineralisation. Protein and biomolecule immobilisation represents one direction for producing 
multifunctional orthopaedic interfaces through the co-immobilisation of multiple proteins. 
Alternatively, the benefits may be more practically achieved through the utilisation of synthetic 
multifunctional biomolecules. In this chapter, the osteogenic potential of a surface with co-
immobilised fibronectin and osteocalcin (1:3 FN:OCN) was compared with that of a multifunctional 
fusion protein surface. Both protein surfaces utilised radical-functionalised plasma polymer films 
(rPPFs) to achieve direct covalent bonding of the proteins to the Ti surfaces.   
The most critical component of both multi-functionalisation approaches is the presentation of 
the desired motifs to the biological environment. The primary osteoblasts demonstrated that both 
multifunctional surfaces presented the RGD sequence by the observed increase in cellular attachment 
and spreading (Figure 6.1). However, a significant increase in mineralisation was observed only on the 
fusion protein surfaces (Figure 6.3). This suggests that the OCN signalling sequence in the fusion 
protein is freely available to the biological environment, whereas, the OCN proteins on the FN:OCN 
surfaces are inefficiently presented, whether through obstruction by the FN or below a critical 
concentration. The difference in cellular response was also confirmed in the MSC differentiation assay, 
which showed that the FN:OCN surfaces exhibited non-differentiating effects while the fusion protein 
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surfaces signalled ALP production at lower cell populations. Similar observations of the effectiveness 
of co-immobilised vs fusion protein surfaces were noted in other biomolecule functionalisation work 
[124, 415], where a composite attachment fusion peptide outperformed the 50:50 mixture of the 
component peptides on the surface. The compromised performance was attributed to the 
inhomogeneity of the surface biomolecule layer [124, 415]. The 1:3 FN:OCN ratio selected is a close 
approximation to the 50:50 surface ratio but with a more inhomogeneous surface coverage due to 
the significant size difference between the FN (440 kDa) and the OCN (5.9 kDa) proteins. In contrast, 
the FN-OCN fusion protein surfaces presented the required densities of both the RGD cell binding 
sequence and the OCN signalling sequence homogenously across the surface, resulting in significantly 
greater osteogenic potency. Overall, the multifunctional fusion protein coated rPPF surfaces 
presented the most significant potential for osseointegrating orthopaedic implants based on the 
simplicity of the protein functionalisation and the homogenous availability of cell adhesive RGD and 
mineralisation signalling OCN sequences [124, 415, 416]. 
 
6.5 Conclusions 
 
The functionalisation of titanium orthopaedics with proteins or peptides is a versatile approach to 
improve osseointegration, allowing for the bestowment of active biological functionality onto inert 
implant surfaces. While the current single protein-functionalisation approach has shown success, a 
multifunctional surface is often required for optimal implant osseointegration. In this chapter, the 
osteogenic potential of the two multi-functionalisation surfaces was comparatively examined with 
their single protein counterparts. Osteoblast attachment, spreading, proliferation, and mineralisation 
of the FN-OCN fusion protein surfaces were shown to be equal or greater than the FN and OCN single 
component proteins, while, the cellular responses on the co-immobilised FN:OCN ratio surfaces were 
similar to those on the FN-functionalised surfaces. The differentiation of MSCs on the fusion protein 
surfaces was on par with the OCN protein surfaces, whereas, the ratio surfaces portrayed the non-
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differentiation behaviour of FN. Overall, the findings indicated that the FN-OCN fusion-protein coated 
rPPF surfaces hold significant potential for improving the osseointegration of implantable orthopaedic 
devices. 
  
Page 180 of 214 
 
Chapter 7: Concluding summary and Future directions 
 
7.1 Conclusions 
 
Titanium orthopaedic devices are becoming increasingly common with the demand for load-
bearing implants growing annually. However, the biochemical inertness of the devices leads to 
complications requiring additional surgeries. This thesis focussed on developing novel protein-
functionalised plasma polymer biointerfaces to provide a robust, biologically active surface that 
stimulates bone-integration of the devices in a process that is translatable to an industrial context. 
Plasma polymer films (PPFs) are of great interest for biomaterial applications because of their 
versatility and substrate-independence. Conventional PPFs bind proteins through chemical reactions 
with surface chemical functionalities such as amine and carboxyl groups, which require specific 
reagents and complex monitoring. In contrast, the radical-functionalised PPFs (rPPFs) utilised in this 
thesis are able to immobilise multiple proteins onto a surface without the need for chemical reagents. 
Such radical-functionalised coatings were investigated as platforms to biologically functionalise 
titanium for orthopaedic applications. 
A series of rPPFs with varied nitrogen atomic concentrations were investigated to determine the 
optimum coating for titanium surfaces based on the mechanical stability and cellular responses. The 
SEM images of rPPF coatings demonstrated that the 20%N and 30%N coatings were more robust 
under the mechanical stresses of cellular proliferation, aqueous swelling, and dehydration. A slight 
advantage in mechanical stability was observed on the 30%N rPPF. The proliferation assays showed a 
non-significant increase in cell quantity for the 20%N coating over the 30%N based on the day 1 and 
day 3 proliferation results, potentially deriving from a relatively elevated cellular attachment. Both 
rPPF coatings demonstrated the required mechanical stability and stimulated beneficial cellular 
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responses. Hence, these two rPPF-coatings were selected for continued material and biological 
examinations. 
The relatively large quantity of radical electrons and radical flux to the surface of the rPPF coatings 
[217, 264] represent potential complications for biological applications through radical-induced 
cytotoxicity [381, 382]. The changes in surface properties of the 30%N rPPF, observed over 2 weeks, 
followed radical decay dynamics similar to plasma immersion ion implantation (PIII) treated polymers 
[269]. The fluorescence microscopy analysis and proliferation assays of bone lineage cells 
demonstrated no significant biological differences between the high radical flux (aged for only 4 hr) 
and low radical flux (aged for 11 days) rPPFs. The inability of the radical electrons to propagate through 
the peptide bonds in protein backbones is believed to protect cells at the interface from the 
detrimental effects of excess radicals. Thus, rPPF biointerfaces can be used in timeframes favouring 
the desired physical or chemical surface properties, such as wettability for protein attachment, 
without concerns over radical-induced cytotoxicity.  
The 20%N rPPFs were functionalised with fibronectin (FN), osteocalcin (OCN), and a custom-
made FN-OCN fusion protein. Full monolayer functionalisation was achieved at protein solution 
concentrations of 15 µg/mL, lower than the previously published studies using wet chemical methods. 
The majority of this monolayer (60-80%) was retained even when subject to rigorous SDS washing. 
The surfaces possessed greater protein quantities than bare Ti due to covalent binding through surface 
migrating radicals in the adsorption-desorption equilibrium dynamics. The rPPFs were also shown to 
permanently immobilise multiple proteins through a sequential incubations approach not possible 
with chemical or adsorption-based techniques. An unusual FN absorption signal behaviour was 
observed on the ratio surfaces potentially due to the altered surface conditions of the partially OCN 
functionalised interfaces. A 1:3 ratio of FN:OCN was selected for comparative osteogenic examination 
against a multifunctional fusion protein and the individual component proteins. Finally, a simple and 
effective methodology to create multifunctional protein surfaces was demonstrated. 
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A deepening understanding of the osseointegration process revealed that a multifunctional 
surface, that stimulates cell attachment and bone formation simultaneously, is required for optimal 
osseointegration. Primary mouse osteoblasts demonstrated significantly increased cell attachment on 
both multifunctional surfaces; however, only the fusion protein surfaces demonstrated accelerated 
calcium deposition. The considerable difference in osteogenic potency was due to the presentation 
and availability of the canonical RGD and the OCN 22-49 motifs. The homogenous presentation of 
both motifs across the fusion protein surfaces resulted in greater cellular attachment and signalling 
for bone formation. In contrast, the inhomogeneity derived from the random protein immobilisation 
and size difference presented by the co-immobilised ratio surface stimulated cell attachment only. 
The osteogenic potency of the co-immobilised surfaces was also confirmed by a mesenchymal stem 
cell differentiation on par with the non-differentiating FN. This thesis was an initial investigation 
focussing on the rPPF coating properties and examining the protein functionalised surfaces to 
determine the optimal combination. In vivo examination of the optimised surfaces is planned for 
future projects. Overall, the fusion protein-functionalised rPPFs present a highly osteogenic and 
scalable approach for the biofunctionalisation of orthopaedic devices.  
 
7.2 Future directions 
 
This thesis investigated the development of protein-functionalised biointerfaces based on 
radical-functionalised plasma polymer films (rPPFs) for orthopaedic titanium implants. The project 
covered the optimisation of the rPPFs, the characterisation of the multifunctional biointerfaces, and 
the in vitro biological studies to demonstrate their efficacy. The research performed opens multiple 
avenues for further exploration.   
The rPPFs produced in this thesis provide a foundation for other 2D biointerface research [58, 
356, 357]. The non-specific protein-functionalisation capacity of rPPFs provides a versatile platform to 
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investigate the efficacy on a surface of other untested osteogenic biomolecules, such as osteopontin 
or periostin [214, 456-464]. The incorporation of micro-patterning techniques into protein-
functionalisation could be explored to determine if biomolecule patterning improves the osteogenic 
potential of orthopaedics. Alternatively, rPPFs could be transferred to microarray and biosensing 
technologies. The chemical tailoring of rPPFs could also be investigated through the addition of 
reagent monomers containing elements or compounds for specific applications, e.g. strontium, 
calcium, or phosphate groups, to improve bone formation [465].  
The interdisciplinary field of biomaterials and tissue engineering has been transitioning from 2D 
surfaces towards more complex 3D structures, such as those produced through additive 
manufacturing [466-468]. The coating of 3D structures via plasma deposition processes is difficult 
especially when shadowed cavities, such as internal porosity, are present. The coating stability is a 
major issue because of the chemically and mechanically aggressive nature of the in vivo environment, 
and the long-term stability required. The importance of coating stability is further elevated by the 
medical consequences of a delamination event. The rPPF coatings address the stability issues through 
the formation of carbide bonds on the Ti substrates and a high degree of crosslinking created by 
employing more energetic deposition conditions during early stages of the plasma polymerisation 
[285, 309]. Research into the homogenous deposition of rPPFs throughout complex 3D scaffolds and 
the subsequent biomolecule functionalisation would further improve the osseointegration of porous 
3D orthopaedic implants [469]. 
In vivo examination of potential biomedical products, including implantable biointerfaces, is a 
requirement for clinical certification. In vivo animal models provide information that cannot be 
accurately obtained through current 2D in vitro testing, e.g. regarding bone formation rates, foreign 
body reactions, the effects of nutrient and oxygen gradients, and cell ‘cross talk’ [470]. The disparity 
between in vitro and in vivo is an ongoing issue for all forms of biomedical and pharmacological 
research [471] as a significant increase in effectiveness in vitro does not guarantee transfer to the 
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animal model. A significant osseointegration increase in vivo for mouse, rabbit or large animal models 
for protein-functionalised rPPFs would ease the transition of this research into the clinic. 
Plasma polymerisation, unlike wet chemistry methods, has the capacity to be easily scaled and 
incorporated into manufacturing processes, as evident by the application of plasma enhanced 
chemical vapour deposition processes in optics, electronics, and solar cells [288, 289]. The post-
production modification of orthopaedic devices with rPPFs would allow for the transfer of protein-
functionalisation into an implantable device [288, 289]. The unique non-specific immobilisation of 
rPPFs has a greater degree of versatility in the application of proteins; permitting the surfaces to be 
functionalised as part of the manufacturing process or to be functionalised onsite before implantation. 
Previous work has shown at least a 4.5 month longevity for biomolecule functionalisation of rPPFs in 
air [264], allowing for feasible storage and transportation times. The process of implant fabrication, 
rPPF deposition, and device storage will need to be optimised but the potential advantages for 
improved osseointegration and implant lifetime could significantly increase patient quality of life. In 
conclusion, the substrate-independent nature of rPPF surfaces and the scalability of plasma deposition 
techniques allow for the transfer of these easily-producible, multifunctional biointerfaces into the 
next generation of implantable devices.  
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